UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File No. 000-53029

 

 

C-BOND SYSTEMS, INC.

(Exact name of Registrant as Specified in its Charter)

  

Colorado   26-1315585
(State or Other Jurisdiction of
Incorporation or Organization)
  (IRS Employer
Identification No.)
     
2029 Pat Booker Rd.    
San Antonio, Texas   78148
(Address of Principal Executive Offices)   (Zip Code)

 

210-490-3977 

(Registrant’s telephone number, including area code)

 

N/A

 (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company “, and “emerging growth company”, in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No 

 

There were 550,503,623 shares of the registrant’s common stock, par value $0.001 per share, issued and outstanding as of August 14, 2024.

 

 

 

 

 

  

C-BOND SYSTEMS, INC.

FORM 10-Q

JUNE 30, 2024

 

TABLE OF CONTENTS

 

    Page
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements 1
  Consolidated Balance Sheets - As of June 30, 2024 (unaudited) and December 31, 2023 1
  Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2024 and 2023 (unaudited) 2
  Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Six Months Ended June 30, 2024 and 2023 (unaudited) 3
  Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 (unaudited) 4
  Notes to Unaudited Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 39
Item 3. Quantitative and Qualitative Disclosures About Market Risk 50
Item 4. Controls and Procedures 50
PART II - OTHER INFORMATION
Item 1. Legal Proceedings 51
Item 1A. Risk Factors 51
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 51
Item 3. Defaults Upon Senior Securities 51
Item 4. Mine Safety Disclosures 51
Item 5. Other Information 52
Item 6. Exhibits 52
Signatures 53

 

i

 

 

PART I - FINANCIAL INFORMATION 

 

ITEM 1. FINANCIAL STATEMENTS

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   June 30,   December 31, 
   2024   2023 
   (Unaudited)     
ASSETS        
CURRENT ASSETS:        
Cash  $196,315   $736,461 
Accounts receivable, net   243,369    424,091 
Inventory   162,052    181,663 
Prepaid expenses and other current assets   107,807    28,503 
Due from related party   71,961    
-
 
Contract assets   59,856    2,400 
Total Current Assets   841,360    1,373,118 
           
OTHER ASSETS:          
Property and equipment, net   147,842    171,606 
Right of use asset, net   128,722    158,484 
Intangible asset, net   204,163    229,414 
Goodwill   350,491    350,491 
Total Other Assets   831,218    909,995 
TOTAL ASSETS  $1,672,578   $2,283,113 
           
LIABILITIES AND SHAREHOLDERS’ DEFICIT          
CURRENT LIABILITIES:          
Convertible note payable - current portion  $180,000   $180,000 
Notes payable, net of discount - current portion   474,014    81,908 
Accounts payable   798,827    710,222 
Accrued expenses   390,258    474,515 
Accrued compensation   54,462    717,204 
Contract liabilities   148,784    500,720 
Lease liabilities, current portion   60,773    60,503 
Total Current Liabilities   2,107,118    2,725,072 
           
LONG-TERM LIABILITIES:          
Convertible notes payable, net of current portion   828,091    918,091 
Notes payable, net of current portion and discount   33,477    42,109 
Lease liabilities, net of current portion   67,949    97,249 
Total Long-term Liabilities   929,517    1,057,449 
Total Liabilities   3,036,635    3,782,521 
           
Commitments and Contingencies (See Note 10)   
 
    
 
 
           
Series B convertible preferred stock: $0.10 par value, 100,000 shares designated; 1,189 and 1,144 shares issued and outstanding on June 30, 2024 and December 31, 2023, respectively ($1,245,313 redemption and liquidation value on June 30, 2024)
   1,245,313    1,203,967 
           
Series C convertible preferred stock: $0.10 par value, 100,000 shares designated; 14,750 and 15,150 shares issued and outstanding on June 30, 2024 and December 31, 2023, respectively ($2,363,855 redemption and liquidation value at June 30, 2024)
   1,575,903    1,621,160 
           
SHAREHOLDERS’ DEFICIT:          
Preferred stock: $0.10 par value, 2,000,000 shares authorized; 100,000 Series B and 100,000 Series C designated, no shares issued and outstanding   
-
    
-
 
Common stock: $0.001 par value, 4,998,000,000 shares authorized; 545,253,623 and 532,818,051 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively   545,254    532,818 
Additional paid-in capital   56,561,018    55,852,477 
Accumulated deficit   (61,447,146)   (60,851,714)
Total C-Bond Systems, Inc. shareholders’ deficit   (4,340,874)   (4,466,419)
Noncontrolling interest   155,601    141,884 
Total Shareholders’ Deficit   (4,185,273)   (4,324,535)
Total Liabilities and Shareholders’ Deficit  $1,672,578   $2,283,113 

 

See accompanying notes to the unaudited consolidated financial statements.

 

1

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
SALES  $863,533   $414,055   $1,800,337   $929,275 
                     
COST OF SALES (excluding depreciation expense)   424,959    209,071    886,888    454,431 
                     
GROSS PROFIT   438,574    204,984    913,449    474,844 
                     
OPERATING EXPENSES:                    
Compensation and related benefits (including stock-based compensation of $0 and $30,046 for the three months ended June 30, 2024 and 2023, and $376,968 and $42,183 for the six months ended June 30, 2024 and 2023, respectively)   (373,548)   (441,181)   (1,152,667)   (868,053)
Professional fees   (88,030)   (193,263)   (229,614)   (380,953)
General and administrative expenses   (169,357)   (142,404)   (365,048)   (321,304)
                     
Total Operating Expenses   (630,935)   (776,848)   (1,747,329)   (1,570,310)
                     
OTHER OPERATING INCOME:                    
Gain on sale of product line   
-
    4,051,709    
-
    4,051,709 
                     
(LOSS) INCOME FROM OPERATIONS   (192,361)   3,479,845    (833,880)   2,956,243 
                     
OTHER INCOME (EXPENSES):                    
Gain on debt extinguishment, net   
-
    462,581    347,990    462,581 
Interest expense   (53,608)   (166,189)   (67,727)   (361,975)
Interest expense - related party   
-
    (1,964)   
-
    (5,663)
                     
Total Other Income (Expenses), net   (53,608)   294,428    280,263    94,943 
                     
NET (LOSS) INCOME BEFORE NONCONTROLLING INTEREST   (245,969)   3,774,273    (553,617)   3,051,186 
                     
Net (income) loss of subsidiary attributable to noncontrolling interest   (4,207)   18,640    (13,717)   35,362 
Preferred stock dividend   (13,749)   (13,618)   (28,098)   (27,305)
                     
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
                     
NET (LOSS) INCOME PER COMMON SHARE:                    
Basic  $(0.00)  $0.01   $(0.00)  $0.01 
Diluted  $(0.00)  $0.00   $(0.00)  $0.00 
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                    
Basic   543,165,027    493,056,689    539,431,386    458,283,435 
Diluted   543,165,027    2,349,380,186    539,431,386    2,314,606,932 

 

See accompanying notes to the unaudited consolidated financial statements.

 

2

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024 AND 2023

(Unaudited)

 

   Common Stock   Additional
Paid-in
   Accumulated   Noncontrolling   Total
Shareholders’
 
   # of Shares   Amount   Capital   Deficit   Interest   Deficit 
Balance, December 31, 2023   532,818,051   $532,818   $55,852,477   $(60,851,714)  $141,884   $(4,324,535)
                               
Common stock issued for conversion of Series C preferred stock   11,554,535    11,555    28,445    
-
    
-
    40,000 
Cancellation of common stock and Series B preferred shares   (5,250,000)   (5,250)   132,890    
-
    
-
    127,640 
Preferred stock dividends and deemed dividend   -    
-
    
-
    (14,349)   
-
    (14,349)
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation   -    
-
    326,968    
-
    
-
    326,968 
Net loss   -    
-
    
-
    (317,158)   9,510    (307,648)
                               
Balance, March 31, 2024   539,122,586    539,123    56,340,780    (61,183,221)   151,394    (4,151,924)
                               
Common stock issued for conversion of Series C preferred stock   6,131,037    6,131    13,869    
-
    
-
    20,000 
Cancellation of Series B preferred shares   -    
-
    206,369    
-
    
-
    206,369 
Preferred stock dividends and deemed dividend   -    
-
    
-
    (13,749)   
-
    (13,749)
Net loss   -    
-
    
-
    (250,176)   4,207    (245,969)
Balance, June 30, 2024   545,253,623   $545,254   $56,561,018   $(61,447,146)  $155,601   $(4,185,273)

 

   Common Stock   Additional
Paid-in
   Accumulated   Noncontrolling   Total
Shareholders’
 
   # of Shares   Amount   Capital   Deficit   Interest   Deficit 
Balance, December 31, 2022   350,270,172   $350,270   $55,141,503   $(62,693,184)  $150,742   $(7,050,669)
                               
Common stock issued for cash and accrued compensation   54,545,455    54,545    245,455    
-
    
-
    300,000 
Common stock issued for professional fees   6,666,667    6,667    33,333    
-
    
-
    40,000 
Common stock issued for accrued compensation   9,636,364    9,636    43,364    
-
    
-
    53,000 
Common stock issued for conversion of Series C preferred stock   26,585,614    26,586    74,814    
-
    
-
    101,400 
Preferred stock dividends   -    
-
    
-
    (13,687)   
-
    (13,687)
Accretion of stock-based compensation   -    
-
    12,137    
-
    
-
    12,137 
Net loss   -    
-
    
-
    (706,365)   (16,722)   (723,087)
                               
Balance, March 31, 2023   447,704,272    447,704    55,550,606    (63,413,236)   134,020    (7,280,906)
                               
Common stock issued for professional fees   6,500,000    6,500    32,950    
-
    
-
    39,450 
Common stock issued for compensation   2,500,000    2,500    23,500    -    
-
    26,000 
Common stock issued for conversion of Series C preferred stock   23,157,922    23,158    59,442    
-
    
-
    82,600 
Common stock issued for conversion of debt, accrued interest and fees   43,371,481    43,372    157,017    
-
    
-
    200,389 
Preferred stock dividends   -    
-
    
-
    (13,618)   
-
    (13,618)
Accretion of stock-based compensation   -    
-
    4,046    
-
    
-
    4,046 
Net income   -    
-
    
-
    3,792,913    (18,640)   3,774,273 
Balance, June 30, 2023   523,233,675   $523,234   $55,827,561   $(59,633,941)  $115,380   $(3,167,766)

 

See accompanying notes to the unaudited consolidated financial statements.

 

3

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   For the Six Months Ended 
   June 30, 
   2024   2023 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net (loss) income  $(553,617)  $3,051,186 
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Depreciation and amortization expense   49,015    41,395 
Amortization of debt discount to interest expense   22,459    95,922 
Interest expense for put premium on convertible notes   
-
    29,212 
Non-cash interest expense from fees on debt conversion   
-
    2,250 
Stock-based compensation   376,968    42,183 
Stock-based professional fees   
-
    97,817 
Non-cash gain on debt extinguishment   (347,990)   (462,581)
Gain from sale of nanoShield product line   
-
    (4,051,709)
Lease costs   732    660 

Non-cash compensation claw back

   (21,961)   
-
 
Bad debt expense   25,833    
-
 
Change in operating assets and liabilities:          
Accounts receivable   154,889    188,934 
Inventory   19,611    (51,196)
Prepaid expenses and other assets   (79,304)   (15,434)
Contract assets   (57,456)   (52,487)
Due from related party   (50,000)   
-
 
Accounts payable   88,605    (50,027)
Accrued expenses   (84,257)   8,040 
Accrued interest - related party   
-
    5,663 
Accrued compensation   (3,645)   49,812 
Contract liabilities   (351,936)   157,363 
           
NET CASH USED IN OPERATING ACTIVITIES   (812,054)   (912,997)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Proceeds from sale of nanoShield product line   
-
    4,042,631 
           
NET CASH PROVIDED BY INVESTING ACTIVITIES   
-
    4,042,631 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from sale of common stock   
-
    275,000 
Proceeds from notes payable   405,550    175,000 
Repayment of notes payable   (43,642)   (1,792,448)
Repayment of note payable - related party   
-
    (200,000)
Proceeds from convertible notes payable   
-
    50,000 
Repayment of convertible notes payable   (90,000)   (222,750)
           
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   271,908    (1,715,198)
           
NET (DECREASE) INCREASE IN CASH   (540,146)   1,414,436 
           
CASH, beginning of period   736,461    97,091 
           
CASH, end of period  $196,315   $1,511,527 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for:          
Interest  $26,561   $199,122 
Income taxes  $
-
   $
-
 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:          
Common stock issued as prepaid for services  $
-
   $79,450 
Common stock issued for accrued compensation  $
-
   $78,000 
Series B preferred stock issued for accrued compensation  $312,000   $144,000 
Preferred stock dividend accrued  $28,098   $27,305 
Conversion of Series C preferred stock to common stock  $60,000   $184,000 
Conversion of notes payable to common stock  $
-
   $194,000 
Reclassification of Series B preferred stock to additional paid-in capital  $334,009   $
-
 

 

See accompanying notes to the unaudited consolidated financial statements.

 

4

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

NOTE 1 – NATURE OF ORGANIZATION

 

Nature of Organization

 

C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and owner and developer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Prior to May 8, 2023, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™. Since May 8, 2023, the date that the nanoShieldTM product line and related technologies were sold (see Note 16), the Company has operated in one segment. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry-resistant system.

 

On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder. Pursuant to the Exchange Agreement, on July 22, 2021, the Company acquired 80% of Patriot Glass’s units (the “Patriot Glass Shares”). The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement (the Exchange Agreement as amended, or the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending at 5:00 P.M. EST on the date that is 30 calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions, LLC.

 

On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShieldTM division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The Company’s unaudited consolidated financial statements include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot Glass. All significant intercompany accounts and transactions have been eliminated in consolidation. 

 

Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its financial position and the results of its operations for the periods presented. The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

 

5

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Certain information and note disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP has been condensed or omitted from these statements pursuant to such accounting principles and, accordingly, they do not include all the information and notes necessary for comprehensive consolidated financial statements. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the year ended December 31, 2023 of the Company which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024.

 

Going Concern

 

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. On June 30, 2024, the Company had cash of $196,315. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail its operations. These unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the six months ended June 30, 2024 and 2023 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. 

 

Fair Value of Financial Instruments and Fair Value Measurements

 

The carrying amounts reported in the unaudited consolidated balance sheets for cash, accounts receivable, contract assets and liabilities, notes payable, convertible note payable, accounts payable, accrued expenses, accrued compensation, and lease liabilities approximate their fair market value based on the short-term maturity of these instruments.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company did not identify any assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 820.

 

ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

 

Cash and Cash Equivalents

 

For the purposes of the unaudited consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. The Company had no cash equivalents as of June 30, 2024 and December 31, 2023.

 

6

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Accounts Receivable

 

The Company recognizes an allowance for losses on accounts receivable and notes receivable in an amount equal to the estimated probable losses net of recoveries under the current expected credit loss method. The allowance is based on an analysis of historical bad debt experience, current receivables aging and expected future write-offs, as well as an assessment of specific identifiable customer accounts and notes receivable considered at risk or uncollectible. On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make the required payments (current expected losses). The amount of the allowance is determined principally based on past collection experience and known financial factors regarding specific customers. The expense associated with the allowance for doubtful accounts on accounts receivable is recognized in general and administrative expenses.

 

Inventory

 

Inventory, consisting of raw materials and finished goods, are stated at lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed the expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are recorded based on estimates and included in cost of sales.

 

Property and Equipment

 

Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, which range from one to seven years. Leasehold improvements are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.

 

Goodwill and Intangible Assets

 

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over a useful life of 5 years.

 

Goodwill is not subject to amortization but is subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill by reporting unit at least annually, or when indicators of impairment are present, to determine if goodwill may be impaired. To evaluate goodwill impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of goodwill is less than its carrying value. The Company would not be required to quantitatively determine the fair value of goodwill unless it determines, based on the qualitative assessment there are indicators of impairment. Under the quantitative test of goodwill, the Company compares the fair value of the reporting unit to its carrying value, including goodwill. If the carrying value exceeds the fair value, then the goodwill is impaired by the excess amount. The Company performs its annual testing for goodwill during the fourth quarter of each fiscal year or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit.

 

Intangible assets determined to have finite lives are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset is the period over which the asset is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates both finite and indefinite lived intangible assets for impairment upon occurrence of events or changes in circumstances that indicate the carrying amount of intangible assets may not be recoverable.

 

As of December 31, 2023, the Company performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s annual impairment test indicated that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill or intangibles assets was recorded as of December 31, 2023.

 

Impairment of Long-Lived Assets

 

In accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.

 

7

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Warranty Liability

 

The Company provides limited warranties on its products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying unaudited consolidated balance sheets and amounted to $1,000 on June 30, 2024 and December 31, 2023, respectively. During the six months ended June 30, 2024 and 2023, warranty costs were de minimis.

 

Revenue Recognition

 

The Company follows ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.

 

The Company sells its products, which include standard warranties, primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped to the customer and the title is transferred and is recorded net of any discounts or allowances. The warranty does not represent a separate performance obligation.

 

Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.

 

Cost of Sales

 

Cost of sales includes inventory costs, packaging costs and warranty expenses.

 

Cost of revenues from fixed-price contracts for the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements, are accounted for as changes in estimates in the current period. 

 

Shipping and Handling Costs

 

Shipping and handling costs incurred for product shipped to customers are included in general and administrative expenses and amounted to $10,272 and $5,577 for the six months ended June 30, 2024 and 2023, respectively. Shipping and handling costs charged to customers are included in sales.

 

8

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Research and Development

 

Research and development costs incurred in the development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated costs incurred. For the six months ended June 30, 2024 and 2023, research and development costs incurred in the development of the Company’s products were $0.

 

Advertising Costs

 

The Company may participate in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the six months ended June 30, 2024 and 2023, advertising costs charged to operations were $38,874 and $10,986, respectively, and are included in general and administrative expenses on the accompanying unaudited consolidated statements of operations. These advertising expenses do not include cooperative advertising and sales incentives which shall been deducted from sales.

 

Federal and State Income Taxes

 

The Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

 

The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of June 30, 2024 and December 31, 2023, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. Tax years that remain subject to examination are the years ending on and after December 31, 2018. The Company recognizes interest and penalties related to uncertain income tax positions in other expense. However, no such interest and penalties were recorded as of June 30, 2024 and December 31, 2023.

 

Stock-Based Compensation

 

Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.

 

Leases

 

The Company accounts for leases in accordance with ASC 842. The lease standard requires certain leases to be reported on the consolidated balance sheets as right-of-use assets and lease liabilities. The Company has elected the practical expedients permitted under the transition guidance of this standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company does not reassess whether any contracts entered into prior to adoption are leases or contain leases.

 

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company does not have any finance leases as of June 30, 2024 and December 31, 2023. The Company’s leases generally have terms that range from three to four years for property and equipment and five years for property. The Company elected the accounting policy to include both the lease and non-lease components of our agreements as a single component and account for them as a lease.

 

9

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on the Company’s current borrowing rate. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

 

When the Company has the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that the Company will exercise the option, the Company considers these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

 

Loss Per Common Share

 

ASC 260 “Earnings Per Share”, requires dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in the future.

 

The following table presents a reconciliation of basic and diluted net income (loss) per common share:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Net (loss) income per common share - basic:                    
Net (loss) income attributable to common shareholders  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Net (loss) income per common share – basic  $(0.00)  $0.01   $(0.00)  $0.01 
                     
Net (loss) income per common share - diluted:                    
Net (loss) income attributable to common shareholders - basic  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Add: preferred stock dividends   
-
    13,618    
-
    27,305 
Add: interest of convertible debt   
-
    52,618    
-
    102,639 
Numerator for (loss) income per common share – diluted  $(263,925)  $3,845,531   $(595,432)  $3,189,187 
                     
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Add: dilutive shares related to:                    
Convertible debt   
-
    1,145,833,333    
-
    1,145,833,333 
Series B preferred   
-
    324,240,164    
-
    324,240,164 
Series C preferred   
-
    386,250,000    
-
    386,250,000 
Weighted average common shares outstanding – diluted   543,165,027    2,349,380,186    539,431,386    2,314,606,932 
Net (loss) income per common share – diluted  $(0.00)  $0.00   $(0.00)  $0.00 

 

For the three and six months ended June 30, 2023, stock options and warrants were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income. For the three and six months ended June 30, 2024, all potentially dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net losses. As of June 30, 2024 and 2023, common share equivalents and potentially dilutive securities consisted of the following: 

 

   June 30, 
   2024   2023 
Stock options   7,345,698    8,445,698 
Warrants   33,400,000    34,000,000 
Series B preferred stock   357,819,360    324,240,164 
Series C preferred stock   450,258,000    386,250,000 
Convertible debt   1,220,101,111    1,145,833,333 
    2,068,924,169    1,898,769,195 

 

10

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Segment Reporting

 

Prior to May 8, 2023, the Company operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions. The Company’s reportable segments were strategic business units that offered different products and were managed separately based on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond nanoShield™ product line and the remaining segment (1) as described above was combined into segment (2) and is now being managed together (see Note 16).

  

Noncontrolling Interest

 

The Company accounts for noncontrolling interest in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total shareholders’ deficit on the unaudited consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest be clearly identified and presented on the face of the unaudited consolidated statements of operations.

 

Risk and Uncertainties

 

The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

 

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The adoption of this standard on January 1, 2024 had no impact on the Company’s unaudited consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

NOTE 3 – ACCOUNTS RECEIVABLE

 

On June 30, 2024 and December 31, 2023, accounts receivable consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Accounts receivable  $304,525   $459,414 
Less: allowance for doubtful accounts   (61,156)   (35,323)
Accounts receivable, net  $243,369   $424,091 

 

For the six months ended June 30, 2024 and 2023, bad debt expense amounted to $23,094 (net of bad debt recovery of $2,739) and $0, respectively.

 

11

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

NOTE 4 – INVENTORY

 

On June 30, 2024 and December 31, 2023, inventory consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Finished goods  $162,052   $181,663 
Total Inventory  $162,052   $181,663 

 

For the six months ended June 30, 2024 and 2023, the Company did not record any allowance for slow moving inventory.

 

NOTE 5 – PROPERTY AND EQUIPMENT

 

On June 30, 2024 and December 31, 2023, property and equipment consisted of the following: 

 

   Useful Life  June 30,
2024
   December 31,
2023
 
Machinery and equipment  57 years  $73,411   $73,411 
Furniture and office equipment  37 years   2,061    2,061 
Vehicles  15 years   68,050    68,050 
Leasehold improvements  35 years   110,645    110,645 
       254,167    254,167 
Less: accumulated depreciation      (106,325)   (82,561)
Property and equipment, net     $147,842   $171,606 

  

For the six months ended June 30, 2024 and 2023, depreciation expense was included in general and administrative expenses and amounted to $23,764 and $16,143, respectively. 

 

NOTE 6 – INTANGIBLE ASSETS AND GOODWILL

 

On June 30, 2024 and December 31, 2023, intangible assets and goodwill, which were acquired from Patriot Glass in 2021, consisted of the following:

 

   Useful life  June 30,
2024
   December 31,
2023
 
Customer relations  5 years  $212,516   $212,516 
Non-compete  5 years   40,000    40,000 
Trade name (non-amortizable) 
-
   100,000    100,000 
       352,516    352,516 
Less: accumulated amortization      (148,353)   (123,102)
Intangible assets, net     $204,163   $229,414 

 

   Useful life  June 30,
2024
   December 31,
2023
 
Goodwill  -  $350,491   $350,491 

 

12

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

For the six months ended June 30, 2024 and 2023, amortization expense of amortizable intangible assets amounted to $25,251 and $25,252, respectively. On June 30, 2024, accumulated amortization amounted to $124,853 and $23,500 for the customer relations and non-compete, respectively. On December 31, 2023, accumulated amortization amounted to $103,602 and $19,500 for the customer relations and non-compete, respectively.

 

Amortization of intangible assets with identifiable useful lives that is attributable to future periods is as follows:

 

Twelve months ending June 30:  Amount 
2025  $50,503 
2026   50,503 
2027   3,157 
Total  $104,163 

  

NOTE 7 – CONVERTIBLE NOTES PAYABLE

 

Mercer Convertible Debt

 

On October 15, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity Fund, LLC (the “Investor”), pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000 (the “Mercer Note”) and five-year warrants to purchase up to 16,500,000 shares of the Company’s common stock at an initial exercise price of $0.05 per share, an amount equal to 50% of the conversion shares that were issued (the “Mercer Warrants”). The Company received net proceeds of $680,000, which was net of original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000. The transactions contemplated under the SPA closed on October 18, 2021.

 

The Mercer Note matured 12 months after issuance, bore interest at a rate of 4% per annum through the date of default, and was initially convertible beginning on the six-month anniversary of the original issue date into the Company’s common stock at a fixed conversion price of $0.025 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described in the Initial Note.

 

The Mercer Note and Mercer Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

Upon the occurrence of an event of default under the Mercer Note, the Investor has the right to be prepaid at 125% of the outstanding principal balance and accrued interest, and interest accrues at 18% per annum. Events of default included, among other things,

 

(i)any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days;

 

(ii)the Company or any Subsidiary shall be subject to a Bankruptcy Event;

 

(iii)the SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor;

 

(iv)the Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);

 

(v)the Company incurs any Indebtedness other than Permitted Indebtedness;

 

  (vi) the Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following Trading Day. The Company filed a Report on Form 8-K announcing the restatement of its financial statements for the year ended December 31, 2020. Following the first public announcement or disclosure that a restatement occurred, the VWAP on the next Trading Day was not 20% less than the VWAP on the prior Trading Day and accordingly, the default provisions were not triggered.

 

13

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

The Company has also granted the investor a 12-month (or until the Notes are no longer outstanding) right to participate in specified future financings, up to a level of 30%.

 

On April 20, 2022, the Company and the Investor entered into an Exchange Agreement (the “Exchange Agreement”). The original SPA remains in effect. Per the terms of the Exchange Agreement, the Parties agreed to exchange (i) the Mercer Note for a new Convertible Promissory Note (the “New Note”) and (ii) the Mercer Warrant for a new five-year warrant to purchase, in the aggregate, 33,000,000 shares of the Company’s common stock at an exercise price of $0.025 per share (the “New Warrant” and together with the New Note, the “New Securities”), according to the terms and conditions of the Exchange Agreement. On April 20, 2022, pursuant to the terms of the Exchange Agreement, the Investor surrendered the Prior Securities in exchange for the New Securities. Other than the surrender of the Prior Securities, no consideration of any kind whatsoever was given by the Investor to the Company in connection with the Exchange Agreement. The terms of the New Securities are the same as the Prior Securities except for the pricing of the shares issuable under the New Note and the shares issuable upon exercise of the New Warrant. The New Securities are composed of the New Note, which is a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000, and the New Warrant. The New Note matured on October 15, 2022, bore interest at a rate of 4% per annum through the date of default, and was initially convertible into the Company’s common stock at a fixed conversion price of $0.0125 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described in the New Note. If the average Closing Price during any 10 consecutive Trading Day period beginning and ending during the 60 Day Effectiveness Period (the “Average Closing Price”) is below the Conversion Price than the conversion price will be reduced to such Average Closing Price but in no event less than $0.00875.

 

On October 15, 2022, the due date of the New Note, the New Note defaulted due to non-payment. Accordingly, the Company added a default penalty of $206,250, or 25%, to the principal balance and recorded interest expense of $206,250, and interest shall accrue at 18% per annum.

 

On December 4, 2023, the Company entered into a letter agreement (the “Agreement”) with the Investor to eliminate the convertible features and implement a standstill on the interest due under the Convertible Promissory Note Dated October 15, 2021 (the “Note”). This Note is the only remaining convertible note on the Company’s balance sheet. Per the terms of the Agreement, provided that the Company continues making the Payments as outlined in the Agreement and meets its obligations under the Agreement, the Investor shall not have the right to convert the Note into the Company’s common stock. The Company shall make the Payments on the 15th of every month. “Payments” shall mean $15,000 per month for 35 months with a balloon payment of $588,091 on the 36th month, for aggregate payments of $1,113,091.

 

Additionally, the Company shall pay Mercer 20% of the gross proceeds from capital raised by the Company through the issuance of securities or incurrence of any Debt (regardless of whether the incurrence of debt includes of the sale of any securities) (“Capital Raise Payments”). Capital Raise Payments shall only be required for capital raises resulting in the Company receiving gross proceeds of at least $500,000. By way example, if the Company receives $600,000 from the issuance of Debt, the Company shall make a Capital Raise Payment of $120,000 to Mercer. Any Capital Raise Payments shall be first be applied to the then outstanding Balloon Payment and thereafter to the last Payments (35th, 34th and so on). “Debt” means borrowed money including the sale of any existing and future receivables. The Capital Raise Payments shall be made within two business days of the receipt of the funds under such raise. Any failure to make the Payments within the cure period or from the Capital Raise Payments by the required date shall make this Agreement null and void.

 

Additionally, provided that the Company is in compliance with this Agreement, Mercer agrees to a standstill on the interest due under the Note beginning with the date that the first $15,000 Payment is made which the Company paid on December 15, 2023 as required by the Note. Further, if the Company pays off the entire principal and accrued interest by the dates detailed below, the Investor agrees to reduce the total amount due on the Note (principal and interest) by the percentages as follows: 20% if fully paid by March 31, 2024, 15% if fully paid by June 30, 2024, 10% if fully paid by September 30, 2024, and 5% if fully paid by December 31, 2024. All rights and obligations under the original Note shall remain the same. Mercer is not waiving any of its rights under the original Note, including but not limited to, rights available prior to this Agreement.

 

As of June 30, 2024 and December 31, 2023, the principal balance of the New Note was $1,008,091 and $1,098,091, respectively. Additionally, as of June 30, 2024 and December 31, 2023, accrued interest payable amounted to $176,184 and $176,184, respectively, which is reflected in accrued expenses on the accompanying unaudited consolidated statements of operations. Under the terms of the Agreement, $176,184 of accrued interest is subject to forgiveness if the Company complies with the terms of the Agreement. As of the date of this report, the Company has made all required payments.

 

14

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

At any time this Note or any amounts accrued and payable thereunder remain outstanding, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any common stock or common stock equivalents entitling any Person to acquire shares of the Company’s common stock at an effective price per share that is lower than the conversion price then in effect (such lower price, the “Base Conversion Price” and each such issuance or announcement a “Dilutive Issuance”), then the conversion price shall be immediately reduced to equal the Base Conversion Price. Such adjustment shall be made whenever such common stock or common stock equivalents are issued. On September 6, 2022, the Company issued common stock equivalents with an initial conversion price of $0.009 per share and accordingly, the conversion price and warrant down-round provisions were triggered. As a result, the conversion price of the New April 2022 Note was reduced to $0.009 per share and the exercise price of the New April 2022 Warrant was lowered to $0.009.

 

Pursuant to the provisions of ASC 815-40 – Derivatives and Hedging – Contracts in an Entity’s Own Stock, the convertible note and related warrants issued in connection with the Mercer convertible note was analyzed and it was determined that the terms of the convertible note and warrants contained terms that were not considered derivatives.

 

1800 Diagonal Lending Convertible Debt

 

On November 9, 2022, the Company closed a Securities Purchase Agreement dated November 4, 2022, with 1800 DIAGONAL LENDING LLC (“Diagonal”), pursuant to which a Promissory Note (the “November 2022 Diagonal Note”) dated November 4, 2022, was made to Diagonal in the aggregate principal amount of $104,250 and the Company received net proceeds of $100,000 which was net of fees of $4,250. The November 2022 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on May 4, 2024. In May 2023, the November 2022 Diagonal Note and any interest due was repaid in full (See Note 16).

 

On December 27, 2022, the Company closed a Securities Purchase Agreement dated December 27, 2022, with 1800 Diagonal pursuant to which a Promissory Note (“December 2022 Diagonal Note”) dated December 27, 2022, was made to Diagonal in the aggregate principal amount of $64,250 and the Company received net proceeds of $60,000 which was net of fees of $4,250. The December 2022 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on June 27, 2024. In May 2023, the December 2022 Diagonal Note and any interest due was repaid in full (See Note 16).

 

On March 17, 2023, the Company closed a Securities Purchase Agreement dated November 4, 2022, with Diagonal pursuant to which a Promissory Note (the “March 2023 Diagonal Note”) dated March 17, 2023, was made to Diagonal in the aggregate principal amount of $54,250 and the Company received net proceeds of $50,000 which was net of fees of $4,250. The March 2023 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on March 17, 2024. In May 2023, the March 2023 Diagonal Note and any interest due was repaid in full (See Note 16).

 

The Company accounted for the November 2022 and December 2022 Diagonal Notes as stock settled debt under ASC 480 and recorded an aggregate debt premium of $90,731 with a charge to interest expense. The Company has accounted for the March 2023 Diagonal Note as stock settled debt under ASC 480 and recorded an aggregate debt premium of $29,212 with a charge to interest expense. On May 11, 2023, upon repayment of the November 2022, December 2022 and March 2023 Diagonal Notes, the Company reversed the debt premium of $119,943 and recorded a gain on debt extinguishment of $119,943 on the accompanying unaudited consolidated statement of operations.

 

For the six months ended June 30, 2024 and 2023, amortization of debt discounts related to the convertible notes payable amounted to $0 and $2,627, respectively, which has been included in interest expense on the accompanying unaudited consolidated statements of operations.

 

On June 30, 2024 and December 31, 2023, accrued interest payable under all outstanding convertible notes discussed above amounted to $176,184 and $176,184, respectively, and was included in accrued expenses on the accompanying unaudited consolidated balance sheets.

 

On June 30, 2024 and December 31, 2023, convertible notes payable consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Convertible note payable  $1,008,091   $1,098,091 
Convertible note payable, net   1,008,091    1,098,091 
Less: current portion of convertible note payable   (180,000)   (180,000)
Convertible note payable – long-term  $828,091   $918,091 

  

On June 30, 2024, future annual maturities of convertible note payable are as follows:

 

June 30,  Amount 
2025  $180,000 
2026   180,000 
2027   648,091 
Total convertible note payable on June 30, 2024  $1,008,091 

 

15

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

NOTE 8 – NOTES PAYABLE

 

On June 30, 2024 and December 31, 2023, notes payable consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Notes payable  $553,469   $105,958 
Note payable – PPP note   13,864    18,823 
Total notes payable   567,333    124,781 
Less: unamortized debt discount   (59,842)   (764)
Note payable, net   507,491    124,017 
Less: current portion of notes payable, net of discount   (474,014)   (81,908)
Notes payable – long-term  $33,477   $42,109 

 

Notes Payable

 

BOCO Investment Note

 

On November 14, 2018, the Company entered into a Revolving Credit Facility Loan and Security Agreement (“Loan Agreement”) and a Secured Promissory Note (the “Note”) with BOCO Investments, LLC (the “Lender”). Subject to and in accordance with the terms and conditions of the Loan Agreement and the Note, the Lender agreed to lend to the Company up to $400,000 (the “Maximum Loan Amount”) against the issuance and delivery by the Company of the Note for use as working capital and to assist in inventory acquisition. In 2018, the Lender loaned $400,000 to the Company, the Maximum Loan Amount. The outstanding principal advanced to Company pursuant to the Loan Agreement initially bore interest at the rate of 12% per annum, compounded annually. Upon the occurrence of an Event of Default under the Loan Agreement and Note, all amounts then outstanding (including principal and interest) bore interest at the rate of 18% per annum, compounded annually until the Event of Default is cured.

 

In May 2023, the Company and the Lender entered into a Debt Exchange and Release Agreement in regard to the $400,000 Note discussed above, whereby the Company paid the Lender cash of $200,000 and issued the Lender 22,000,000 shares of Common Stock of the Company (see Note 9) in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 16). The 22,000,000 shares issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with the repayment and settlement of this debt, in May 2023, the Company recorded a gain from debt extinguishment of $385,293 consisting of a) $68,000 calculated as the difference in the principal amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000, and b) the forgiveness of interest due of $317,293.

 

On June 30, 2024 and December 31, 2023, the principal amount due and accrued interest payable under this Note amounted to $0.

 

Mercer Street Global Opportunity Fund Notes

 

On March 14, 2022, the Company entered into an Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”) in the principal amount of $197,500 with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note was funded on March 14, 2022 and the Company received net proceeds of $175,000 which is net of an original issue discount and investor legal fees of $22,500. The original issue discount was recorded as a debt discount to be amortized over the life of the March 2022 note. On June 30, 2024 and December 31, 2023, the principal balance due and accrued interest payable on the March 2022 Note amounted to $0. In May 2023, the March 2022 Note and all accrued interest due was paid in full (See Note 16). 

 

On November 22, 2022, the Company entered into a Promissory Note and Security Agreement (the “November 2022 Note”) with a principal amount of $65,000 with the Investor. The November 2022 Note was funded on November 22, 2022 and the Company received net proceeds of $62,500 which is net of Investor legal fees of $2,500. The legal fees were recorded as a debt discount to be amortized over the life of the November 2022 note. The November 2022 Note was to mature on August 22, 2023 and bore interest at a rate of 8% per annum. On June 30, 2024 and December 31, 2023, the principal balance due and accrued interest payable on the November 2022 Note amounted to $0. In May 2023, the November 2022 Note and all accrued interest due was paid in full and the Company recorded a gain on debt extinguishment of approximately $18,900 (See Note 16).

 

16

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

GS Capital Debt

 

On June 23, 2022, the Company entered into a Securities Purchase Agreement (“Agreement”) with GS Capital Partners, LLC (“GS Capital”), pursuant to which a Promissory Note (the “GS Capital June 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital June 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on June 24, 2022 (less legal and other administrative fees). The Company received net proceeds of $148,420. In 2022, the Company issued GS Capital a total of 1,750,000 commitment shares (“Commitment Shares”) as additional consideration for the purchase of this Note. Through December 31, 2022, the Company paid $53,512 of principal balance and during the year ended December 31, 2023, paid principal balance of $79,488. During April and May 2023, the Company issued 21,371,481 shares of its common stock upon the conversion of the remaining principal amount of $62,000, accrued interest of $4,139, and fees of $2,250 (See Note 9). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital Note and accrued interest payable amounted to $0 (See Note 16). 

 

On July 26, 2022, the Company closed a Securities Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“GS Capital July 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital July 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on July 28, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. In 2022, the Company issued GS Capital a total of 2,600,000 commitment shares (“July 2022 Commitment Shares”) as additional consideration for the purchase of the July 2022 Note. In addition, in 2022, the Company issued 998,008 of its common stock to the placement agent as a fee for the capital raise, respectively. The July Commitment Shares and the placement agent shares were recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the Note. Principal and interest payments were payable in 10 installments of $21,060 each beginning on the 90th-day anniversary following the issue date and continuing thereafter each 30 days for nine months. The GS Capital July 2022 Note was to mature 12 months after issuance and bore interest at a rate of 8% per annum. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital July 2022 note by 60 days. Specifically, the maturity date of the GS Capital July 2022 note was extended to September 26, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid $34,120 of principal balance and in May 2023, the Company paid the remaining principal balance of $160,880 and all accrued interest due in full (See Note 16). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital July 2022 Note and accrued interest payable amounted to $0.

 

On September 6, 2022, the Company closed a Securities Purchase Agreement (“September 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“September 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The September 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on September 6, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. In 2022, the Company issued GS Capital a total of 3,300,000 commitment shares (“September 2022 Commitment Shares”) as additional consideration for the purchase of the September 2022 Note. In addition, in 2022, the Company issued 773,626 of its common stock to the placement agent as fee for the capital raise, respectively. The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the Note. Principal and interest payments were payable in 9 installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note was to mature 12 months after issuance and bore interest at a rate of 8% per annum. In the event that following the Issue Date the closing trading price of the Company’s common stock was then being traded below $0.009 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. In May 2023, the GS Capital September 2022 Note and all accrued interest due was paid in full (See Note 16). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital September 2022 Note and accrued interest payable amounted to $0

 

In May 2023, the GS Capital June 2022 Note, the GS Capital July 2022 Note, and the September 2022 Note were paid in full without any default penalty and the Company recorded a gain on debt extinguishment of approximately $25,400 (see Note 16).

 

17

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

1800 Diagonal Lending Note Payable - March 2024

 

On March 1, 2024, the Company executed a Promissory Note (the “Note”) in favor of Diagonal in the aggregate principal amount of $157,000 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4, 2024, in the amount of $125,000, which is net of an original issue discount of $13,000 and a one-time interest charge at 12% (the “Interest Rate”) of approximately $19,000 was applied on the issuance date to the Principal. Under the terms of the Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and the Note matures on December 30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”). Monthly payments of principal and interest was as follows:

 

Payment Date:  Amount 
August 30, 2024  $87,920 
September 30, 2024   21,980 
October 30, 2024   21,980 
November 30, 2024   21,980 
December 30, 2024   21,980 
Total  $175,840 

  

Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of the Company’s Common Stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the Note be converted into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock.

 

On June 30, 2024 and December 31, 2023, the principal balance due on the March 2024 Note amounted to $157,000 and $0, respectively. 

 

On August 15, 2024, The Company and Diagonal amended this Note to change the payment schedule and change the conversion terms (See Note 17).

 

1800 Diagonal Lending Note Payable – April 2024

 

On April 8, 2024, the Company executed a Promissory Note (the “April 2024 Note”) in favor of Diagonal in the aggregate principal amount of $127,693 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the April 2024 Note convertible into shares of the Company’s common stock. The Note was funded on April 10, 2024, in the amount of $100,000. A one-time interest charge of 12% (the “Interest Rate”) shall be applied on the issuance date to the Principal. Under the terms of the April 2024 Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).

 

Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the April 2024 Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this April 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this April 2024 Note to the date of payment plus Default Interest, if any.

 

At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount of this April 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the April 2024 Note be converted into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock.

 

Monthly payments of principal and interest on the April 2024 Note was as follows:

 

Payment Date:  Amount 
August 15, 2024  $85,810 
September 15, 2024 through February 15, 2025 (6 monthly payments)   57,206 
Total  $143,016 

 

On June 30, 2024 and December 31, 2023, the principal balance due on the April 2024 Note amounted to $127,693 and $0, respectively.

 

On August 15, 2024, the Company and Diagonal amended the April 2024 Note to change the payment schedule and change the conversion terms (See Note 17).

 

18

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

  

1800 Diagonal Lending Note Payable – June 2024

 

On June 5, 2024, the Company executed a Promissory Note (the “June 2024 Note”) in favor of Diagonal in the aggregate principal amount of $67,500 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the June 2024 Note convertible into shares of the Company’s common stock. The Note was funded on June 5, 2024, in the amount of $50,000, net of original issue discount and fees of $17,500. Under the terms of the June 2024 Note, the Company is required to make nine monthly payments of principal and interest of $8,775 beginning on July 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).

 

Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the June 2024 Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this June 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this June 2024 Note to the date of payment plus Default Interest, if any.

 

At any time following an Event of Default, the Holder shall have the right, to convert all or any part of the outstanding and unpaid amount of this June 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the June 2024 Note be converted into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock.

 

On June 30, 2024 and December 31, 2023, the principal balance due on the June 2024 Note amounted to $67,500 and $0, respectively. 

 

On August 15, 2024, the Company and Diagonal amended the June 2024 Note to change the conversion terms (See Note 17).

 

Other Notes Payable

 

On May 10, 2021, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) and a Secured Promissory Note (the “Promissory Note”) in the amount of $500,000 with a lender. The Promissory Note accrued interest at 8% per annum, compounded annually, and all outstanding principal and accrued interest was due and payable on May 10, 2023. In May 2023, this Promissory Note and all accrued interest was paid in full (See Note 16).

 

On July 22, 2021, in connection with the acquisition of Patriot Glass, the Company’s subsidiary, Patriot Glass, assumed vehicle and equipment loans in the amount of $95,013. These loans bear interest at rates ranging from 6.79% to 8.24% and are payable monthly through April 2025. On June 30, 2024 and December 31, 2023, notes payable related to these vehicle and equipment loans amounted to $5,526 and $8,250, respectively.

 

On November 8, 2022, the Company entered into a Promissory Note (the “November 2022 Note”) with a lender investor (the “Private Investor”) in the principal amount of $200,000 and received net proceeds of $200,000. The November 2022 Note bore interest at a rate of 8% per annum and all outstanding principal and accrued and unpaid interest was due on November 8, 2024. In May 2023, the November 2022 Note and all unpaid interest was paid in full (See Note 16). 

 

During the year ended December 31, 2023, in connection with the acquisition of a vehicle and an air conditioner unit, the Company’s subsidiary, Patriot Glass, entered into three vehicle and equipment loans in the amount of $117,721. These loans bear interest at rates ranging from 10.0% to 35.1% and are payable monthly through September 2028. On June 30, 2024 and December 31, 2023, notes payable related to the vehicle and equipment loans amounted to $71,006 and $97,708, respectively. The net book value on June 30, 2024 relating to the collateralized assets was $98,573.

 

19

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

On February 21, 2024, the Company’s subsidiary, Patriot Glass, entered into a Promissory Note (the “February 2024 Note”) with a lender in the principal amount of $50,000 and received net proceeds of $49,000, net of original issue discount of $1,000, which was reflected as a debt discount to be amortized into interest expense over the term of the note. The February 2024 Note bears interest at an effective rate of 33.4% per annum and all outstanding principal and accrued and unpaid interest is due on August 21, 2025. On June 30, 2024, the principal amount due on the February 2024 Note is $40,920

 

On June 17, 2024, the Company’s subsidiary, Patriot Glass, entered into a Merchant Loan (the “June 2024 Merchant Loan”) with a lender in the principal amount of $85,000 and received net proceeds of $81,550, net of fees of $3,450, which was reflected as a debt discount to be amortized into interest expense over the term of the note. The June 2024 Merchant Loan requires a weekly payment of principal and interest of $2,988 through March 19, 2025 for an effective interest rate of 85.9%. On June 30, 2024, the principal amount due on the June 2024 Merchant Loan is $83,824

 

For the six months ended June 30, 2024 and 2023, amortization of debt discounts related to all the above notes payable amounted to $22,459 and $93,295, respectively, which has been included in interest expense on the accompanying unaudited consolidated statements of operations.

 

PPP Loan

 

On April 28, 2020, the Company entered into a Paycheck Protection Program Promissory Note (the “PPP Note”) with respect to a loan of $156,200 (the “PPP Loan”) from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES act”) administered by the U.S. Small Business Administration (“SBA”). The PPP Loan matured on April 28, 2022 and bears interest at a rate of 1.00% per annum. The PPP Loan was payable in 18 equal monthly payments of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Company applied for forgiveness of its PPP Loan, and on November 4, 2021, the Company was notified that the Small Business Administration forgave $95,000 of the principal loan amount and $1,442 of interest. On February 29, 2029, the Company entered into a payment plan arrangement with the SBA and agreed to pay the remaining balance of $17,824 by making 17 monthly payments of $990 and a final payment of $994. On June 30, 2024 and December 31, 2023, the principal amount due under the PPP Loan amounted to $13,864 and $18,823, respectively. As of June 30, 2024 and December 31, 2023, accrued interest payable amounted to $0 and $358, respectively.

 

On June 30, 2024, future annual maturities of notes payable are as follows:

 

June 30,  Amount 
2025  $533,856 
2026   16,654 
2027   7,013 
2028   7,751 
2029   2,059 
Total notes payable on June 30, 2024  $567,333 

 

NOTE 9 – SHAREHOLDERS’ DEFICIT

 

Preferred Stock

 

Series B Preferred Stock

 

On December 12, 2019, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series B Convertible Preferred Stock (the “Series B”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series B, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing.

 

The Series B ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The Series B has a stated value per share of $1,000, subject to adjustment as provided in the Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value.

 

20

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

The Series B is subject to redemption (at Stated Value, plus any accrued, but unpaid dividends (the “Liquidation Value”) by the Company no later than three years after a Deemed Liquidation Event and at the Company’s option after one year from the issuance date of the Series B, subject to a ten-day notice (to allow holder conversion). A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.

 

The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).

 

In the event of a conversion of any Series B, the Company shall issue to the holder a number of shares of common stock equal to the sum of the Stated Value plus accrued but unpaid dividends multiplied by the number of shares of Series B Preferred Stock being converted divided by the Conversion Price.

 

Upon liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders of any preferred stock ranking senior to the Series B but prior to any distribution to the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series B, the holders of Series B will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series B equal to the Liquidation Value.

 

The Series B has voting rights per Series B Share equal to the Liquidation Value per share, divided by the Conversion Price, multiplied by fifty (50). Subject to applicable Colorado law, the holders of Series B will have functional voting control in situations requiring shareholder vote.

 

These Series B preferred share issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the issuer, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of the Series B preferred stock agreements, Series B preferred stock is redeemable for cash and other assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since Series B preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series B preferred stock is classified as temporary equity.

 

The Company concluded that the Series B Preferred Stock represented an equity host and, therefore, the redemption feature of the Series B Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the conversion rights under the Series B Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the conversion rights feature on the Series B Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.

 

21

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

On January 17, 2023, the Board of Directors of the Company agreed to satisfy $144,000 of accrued compensation owed to its executive officers (collectively, the “Management”) which, as of December 31, 2022 was included in accrued compensation on the accompanying unaudited consolidated balance sheet. Management agreed to accept 144 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The beneficial conversion feature of the Series B Preferred Stock at the time of issuance was determined to be deminimis on the commitment date. 

 

On January 2, 2024, the Board of Directors of the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers (collectively, the “Management”) as of December 31, 2023, which was included in accrued compensation on the accompanying unaudited consolidated balance sheet. Management agreed to accept 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $281,807 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. The beneficial conversion feature amount of $281,807 was determined by calculating the number of excess common shares to be received upon conversion of the accrued compensation of $312,000 on the grant date based on (i) the quoted closing price of the Company’s common stock on the grant date of $0.059 and (ii) the initial conversion of the Series B Preferred Stock of $0.0031, multiplied by the quoted closing price of the Company’s common stock on the grant date of $0.059.

 

On January 2, 2024, the Board of Directors of the Company agreed to issue 50 shares of the Company’s Series B convertible preferred stock to a director for services rendered. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $95,161, which consisted of (i) $50,000 of Series B stated value and (ii) $45,161 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. The beneficial conversion feature amount of $45,161 was determined by calculating the number of excess common shares to be received upon conversion of the $50,000 of Series B stated value on the grant date based on (i) the quoted closing price of the Company’s common stock on the grant date of $0.059 and (ii) the initial conversion of the Series B Preferred Stock of $0.0031, multiplied by the quoted closing price of the Company’s common stock on the grant date of $0.059.

 

On February 8, 2024, 120 shares of Series B Preferred Stock were forfeited. In connection with this forfeiture, the Company reclassified an aggregate amount of $127,640 from Series B convertible preferred stock to additional paid-in capital, which consisted of (i) stated value of $120,000, and (ii) $7,640 of accrued dividends.

 

On May 20, 2024, the Company’s chief executive officer returned 197 shares of Series B Preferred Stock to the Company granted to him in January 2022, per the terms of the Securities and Exchange Commissions’ Order issued to the Company on May 8, 2024 (See Note 10). In connection with this forfeiture, the Company reclassified an aggregate amount of $206,369 from Series B convertible preferred stock to additional paid-in capital, which consisted of (i) stated value of $197,000, and (ii) $9,369 of accrued dividends.

 

During the six months ended June 30, 2024 and 2023, the Company accrued dividends of $13,355 and $11,226, respectively, which was included in Series B convertible preferred stock on the accompanying unaudited consolidated balance sheets.

 

As of June 30, 2024, the net Series B Preferred Stock balance was $1,245,313, which includes stated value of $1,189,623 and accrued dividends payable of $55,690 As of December 31, 2023, the net Series B Preferred Stock balance was $1,203,967, which includes stated value of $1,144,624 and accrued dividends payable of $59,343. The net Series B Preferred Stock balance is included on the accompanying unaudited consolidated balance sheets.

 

During the six months ended June 30, 2024 and 2023, Series B preferred stock activity is as follows:

 

   For the Six Months Ended
June 30, 2024
   For the Six Months Ended
June 30, 2023
 
   Number of
Shares
   Amount   Number of
Shares
   Amount 
Balance at beginning of period   1,144   $1,203,967    1,000   $1,037,201 
Shares issued for accrued compensation   312    312,000    144    144,000 
Shares issued for compensation   50    50,000    
-
    
-
 
Shares and accrued dividends forfeited   (317)   (334,009)   
-
    
-
 
Dividends accrued   
-
    13,355    
-
    11,226 
Balance at end of period   1,189   $1,245,313    1,144   $1,192,427 

 

22

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Series C Preferred Stock

 

On August 20, 2020, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series C Convertible Preferred Stock (the “Series C”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series C, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing.

 

The Series C ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The Series C has a stated value per share of $100, subject to adjustment as provided in the Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value.

 

The Company has no option to redeem the Series C Preferred Stock. If the Company determines to liquidate, dissolve or wind-up its business and affairs, or effect any Deemed Liquidation Event as defined below, each of which has been approved by the holders of a majority of the shares of Series C Preferred Stock then outstanding, the Company will redeem all of the shares of Series C Preferred Stock outstanding immediately prior to such mandatory redemption event at a price per share of Series C Preferred Stock equal to the aggregate Series C Liquidation Value, which is 150% of the sum of the Stated Value plus accrued and unpaid dividends, for the shares of Series C Preferred Stock being redeemed.

 

The Company will deliver ten-day advance written notice prior to the consummation of any mandatory redemption event via email or overnight courier (“Notice of Mandatory Redemption”) to each Holder whose shares are to be redeemed. The Series C is subject to redemption at liquidation Value noted above by the Company. Upon receipt by any Holder of a Notice of Mandatory Redemption, if Holder does not choose to convert, such Holder will promptly submit to the Company such Holder’s Series C Preferred Stock certificates on the Redemption Payment Date. Upon receipt of such Holder’s Series C Preferred Stock certificates, the Company will pay the applicable redemption price to such Holder in cash. A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company. Since the Company has determined that a deemed liquidation event is not probable, the Series C is stated at the Stated Value plus accrued and unpaid dividends rather than redemption value, which is liquidation value.

 

The Series C is convertible at the option of a holder at any time following the issuance date. In the event of a conversion of any Series C Preferred Stock, the Company shall issue to such Holder a number of Conversion Shares equal to (x) the sum of (1) the Stated Value per share of Series C Preferred Stock plus (2) any accrued but unpaid dividends thereon multiplied by (y) the number of shares of Series C Preferred Stock held by such Holder and subject to the Holder Conversion Notice, divided by (z) the Conversion Price with respect to such Series C Preferred Stock. Conversion Price means a price per share of the common stock equal to the lowest daily volume weighted average price of the common stock for any trading day during the two years preceding the date of delivery of the conversion notice, subject to adjustment as otherwise provided in the Series C Certificate of Designation.

 

23

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Upon liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders of any preferred stock ranking senior to the Series C but prior to any distribution to the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series C, the holders of Series C will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series C equal to the Liquidation Value.

 

On April 28, 2021, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights, and Limitations of Series C Convertible Preferred Stock (the “Amended Certificate”). The Amended Certificate changed the voting rights of the Series C Preferred Stock on any matters requiring shareholder approval or any matters on which the common shareholders are permitted to vote. Series C Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the common shareholders (or other preferred stock of the Company which may vote with the common shareholders) are permitted to vote. With respect to any voting rights of the Series C Preferred Stock set forth herein, the Series C Preferred Stock shall vote as a class, each share of Series C Preferred Stock shall have one vote on any such matter, and any such approval may be given via a written consent in lieu of a meeting of the Holders of the Series C Preferred Stock. Any reference herein to a determination, decision or election being made by the “Majority Holders” shall mean the determination, decision or election as made by Holders holding a majority of the issued and outstanding shares of Series C Preferred Stock at such time. It also adjusts the conversion feature of the Series C Preferred Stock so that any Holder of Series C Preferred Stock cannot convert any portion of the Series C in excess of that number of Series C Preferred Stock that upon conversion would result in beneficial ownership by the Holder of more than 4.99% of the outstanding shares of common stock of the Company.

 

These Series C preferred stock issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the holder, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of the Series C preferred stock agreements, Series C preferred stock is redeemable for cash and other assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since Series C preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series C preferred stock is classified as temporary equity.

 

The Company concluded that the Series C Preferred Stock represented an equity host and, therefore, the redemption feature of the Series C Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the conversion rights under the Series C Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the conversion rights feature on the Series C Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.

 

During the three months ended March 31, 2023, the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.

 

During the three months ended June 30, 2023, the Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.

 

During the three months ended September 30, 2023, the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares of Series C preferred with a stated redemption value of $30,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On February 1, 2024, the Company issued 5,772,973 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On March 1, 2024, the Company issued 5,781,562 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares. 

 

During the six months ended June 30, 2024 and 2023, the Company accrued dividends of $14,743 and $16,079, respectively, which was included in Series C convertible preferred stock on the accompanying unaudited consolidated balance sheets.

 

As of June 30, 2024, the net Series C Preferred Stock balance was $1,575,903, which includes stated liquidation value of $1,455,000 and accrued dividends payable of $120,903. As of December 31, 2023, the net Series C Preferred Stock balance was $1,621,160, which includes stated liquidation value of $1,515,000 and accrued dividends payable of $106,160. The net Series C Preferred Stock balance is included on the accompanying unaudited consolidated balance sheets.

 

24

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

During the six months ended June 30, 2024 and 2023, Series C preferred stock activity is as follows:

 

   For the Six Months Ended
June 30, 2024
   For the Six Months Ended
June 30, 2023
 
   Number of Shares   Amount   Number of Shares   Amount 
Balance at beginning of period   15,150   $1,621,160    17,290   $1,803,731 
Conversion of Series C shares to common shares   (600)   (60,000)   (1,840)   (184,000)
Dividends accrued   
-
    14,743    
-
    16,079 
Balance at end of period   14,550   $1,575,903    15,450   $1,635,810 

 

Common Stock

 

Common Stock Issued for Cash and Accrued Compensation

 

On January 17, 2023, the Company entered into a Subscription Agreement with its Chairman and Chief Executive Officer, Scott R. Silverman (the “Subscription Agreement”), whereby Mr. Silverman purchased 54,545,455 shares (the “Subscription Shares”) of the Company’s common stock for $300,000, or $0.0055 per share, based on the quoted closing price of the Company’s common stock on the measurement date (the “Consideration”). The Consideration consisted of a cash payment of $275,000 the conversion of $25,000 of accrued compensation owed to Mr. Silverman. 

 

On January 17, 2023, Barry Edelstein, a member of the Company’s Board of Directors, elected to convert $53,000 of accrued compensation into 9,636,364 shares of unregistered common stock of the Company. The shares were valued at $53,000, or $0.0055, based on the quoted closing price of the Company’s common stock on the measurement date.

 

Issuance of Common Stock for Services

 

Issuance of Common Stock for Professional Fees

 

2023

 

On February 6, 2023, the Company issued 6,666,667 shares of its common stock for public relations services to be rendered. These shares were valued at $40,000, or $0.006 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, during the six months ended June 30, 2023, the Company recorded stock-based professional fees of $11,667 and prepaid expense of $28,333, which was amortized into professional fees over the remaining term of the agreement.

 

On April 3, 2023, the Company issued 5,000,000 shares of its common stock for investor relations services to be rendered. These shares were valued at $22,500, or $0.0045 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company recorded stock-based professional fees of $22,500, which was amortized into professional fees over the term of the agreement.

 

On June 3, 2023, the Company issued 1,500,000 shares of its common stock for investor relations services to be rendered. These shares were valued at $16,950, or $0.0011 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company recorded stock-based professional fees of $5,650 and prepaid expenses of $11,300, which will be amortized into professional fees over the remaining term of the agreement.

 

During the six months ended June 30, 2024 and 2023, the Company recorded stock-based professional fees of $0 and $38,000 in connection with the amortization to prepaid expenses related to common shares previously issued, respectively.

 

25

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Issuance of Common Stock for Stock-Based Compensation

 

On June 7, 2023, the Company issued 2,500,000 shares of its common stock to employees for services for services rendered. These shares were valued at $26,000, or $0.0104 per common share, based on the quoted closing price of the Company’s common stock on the measurement date.

 

During the six months ended June 30, 2024 and 2023, aggregate accretion of stock-based compensation expense on granted common shares amounted to $0 and $42,183, respectively. Total unrecognized compensation expense related to these unvested common shares on June 30, 2024 and December 31, 2023 amounted to $0. By mutual agreement between the parties, the vesting date of previously granted shares was extended through May 2025.

 

The following table summarizes activity related to non-vested shares:

 

   Number of
Non-Vested
Shares
   Weighted
Average
Grant Date
Fair Value
 
Non-vested, December 31, 2023   14,970,120   $0.132 
Shares vested   
-
    
-
 
Non-vested, June 30, 2024   14,970,120   $0.132 

 

Common Stock Forfeited

 

On February 8, 2024, 5,250,000 shares of the Company’s common stock were forfeited. In connection with this forfeiture, the Company reclassified the amount of $5,250 from common stock, par value to additional paid-in capital.

 

Common Stock Issued in Connection with Notes Payable

 

During April and May 2023, the Company issued 21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest of $4,139, and fees of $2,250.

 

In May 2023, the Company issued the Lender 22,000,000 shares of common stock of the Company in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 8 - BOCO Investment Note). The 22,000,000 shares issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with the issuance of these shares, the Company recorded a gain from debt extinguishment of $68,000 calculated as the different in the principal amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000.

 

Common Stock Issued for Conversion of Series C Preferred Stock

 

2023

 

During the three months ended March 31, 2023, the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.

 

During the three months ended June 30, 2023, the Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.

 

25

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

2024

 

On February 1, 2024, the Company issued 5,772,973 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On March 1, 2024, the Company issued 5,781,562 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares. 

 

Stock Options

 

For the six months ended June 30, 2024 and 2023, the Company recorded no compensation expense related to stock options. Total unrecognized compensation expense related to unvested stock options on June 30, 2024 and December 31, 2023 amounted to $0.

 

Stock option activities for the six months ended June 30, 2024 are summarized as follows:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Balance Outstanding, December 31, 2023   8,445,698   $0.40    2.43    
       -
 
Expired   (1,100,000)   
-
    
-
    
-
 
Balance Outstanding, June 30, 2024   7,345,698   $0.44    2.25   $
-
 
Exercisable, June 30, 2024   7,345,698   $0.44    2.25   $
-
 

  

Warrants

 

Warrant activities for the six months ended June 30, 2024 are summarized as follows:

 

   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Balance Outstanding December 31, 2023   34,000,000   $0.011    2.73   $
      -
 
Expired   (600,000)   
-
    
-
    
-
 
Balance Outstanding June 30, 2024   33,400,000   $0.01    2.28   $
-
 
Exercisable, June 30, 2024   33,400,000   $0.01    2.28   $
-
 

 

26

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

2018 Long-Term Incentive Plan

 

On June 7, 2018, a majority of the Company’s shareholders and its board approved the adoption of a 2018 Long-Term Incentive Plan (the “2018 Plan”). The purpose of the 2018 Plan is to advance the interests of the Company, its affiliates and its stockholders and promote the long-term growth of the Company by providing employees, non-employee directors and third-party service providers with incentives to maximize stockholder value and to otherwise contribute to the success of the Company and its affiliates, thereby aligning the interests of such individuals with the interests of the Company’s stockholders and providing them additional incentives to continue in their employment or affiliation with the Company. The Plan was adopted on June 7, 2018 and effective on August 2, 2018. Under the 2018 Plan, the Plan Administrator may grant:

 

options to acquire the Company’s common stock, both incentive stock options that are intended to satisfy the requirements of Section 422 of the Internal Revenue Code and nonqualified stock options which are not intended to satisfy such requirements. The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.

 

stock appreciation rights, or SARs, which allow the recipient to receive the appreciation in the fair market value of the Company’s common stock between the date of grant and the exercise date. The amount payable under the stock appreciation right may be paid in cash or with shares of the Company’s common stock, or a combination thereof, as determined by the Administrator.

 

restricted stock awards, which are awards of the Company’s shares of common stock that vest in accordance with terms and conditions established by the Administrator.

 

restricted stock units, which are awards that are based on the value of the Company’s common stock and may be paid in cash or in shares of the Company’s common stock.

 

other types of stock-based or stock-related awards not otherwise described by the terms and provision of the 2018 Plan, including the grant or offer for sale of unrestricted shares of the Company’s common stock, and which may involve the transfer of actual shares of the Company’s common stock or payment in cash or otherwise of amounts based on the value of shares of the Company’s common stock and may be designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.

 

other cash-based awards to eligible persons in such amounts and upon such terms as the Administrator shall determine.

 

An award granted under the 2018 Plan must include a minimum vesting period of at least one year, provided, however, that an award may provide that the award will vest before the completion of such one-year period upon the death or qualifying disability of the grantee of the award or a change of control of the Company and awards covering, in the aggregate, 25,000,000 shares of our common stock may be issued without any minimum vesting period.

 

The aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted stock have been issued as of June 30, 2024. All shares underlying grants are expected to be issued from the Company’s unissued authorized shares available.

 

27

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, the Company may be involved in litigation related to claims arising out of its operations in the normal course of business. As of June 30, 2024, other than discussed below, the Company is not involved in any other pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations, or cash flows.

 

On January 20, 2022, we received an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of 1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition. On April 15, 2022, the Company filed an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The restatement had the cumulative effect of decreasing the Company’s reported revenue for fiscal year 2020 by $102,569 and decreasing the Company’s bad debt expense for the same period by $102,569. There was no effect on the Company’s reported net loss for fiscal year 2020 or on the financial condition of the Company on December 31, 2020. The Company received a subpoena from the SEC on April 25, 2022, requesting all documents and communications concerning the review of C-Bond’s revenue recognition practices for fiscal year 2020. In response, the Company provided the requested information and its Chief Executive Officer provided his testimony regarding this Formal Order in October 2022. The Company also filed a request to withdraw its Registration Statement on Form S-1 (“S-1”) (File No. 333-261472) (the “Registration Statement”), filed by the Company with the SEC on December 3, 2021. The S-1 related to shares of common stock underlying certain convertible promissory notes held by selling securityholders. The S-1 was not declared effective and no securities were sold in reliance thereon. The Company and its Chief Executive Officer submitted offers to settle and close the pending SEC investigation, and on May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s findings, C-Bond and its Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled (See Note 9) and the Chief Executive Officer issued a check to the Company in the amount of $21,961, which the Company expects to deposit before year end. The amount due of $21,961 is included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024.  As of December 31, 2023, based on the settlement offers, the Company had accrued $175,000 of settlement expense associated with this matter which was included in accrued expenses on the accompany unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to the SEC and accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024, which amount was repaid in August 2024.

 

On March 8, 2021, a former officer of the Company resigned. Both parties alleged certain claims against the other, including with respect to certain compensation claims. Neither party has filed litigation. The Company intends to vigorously defend itself against any possible claims and assert any relevant claims against the former executive and believes it will prevail. The Board of Directors of the Company has resolved and taken action in February 2024 to cause the forfeiture of equity and deferred compensation owed/outstanding by said officer. Accordingly, on February 8, 2024, the Board of Directors of the Company determined that 120 shares of Series B convertible preferred stock and 5,250,000 shares of the Company’s common stock shall be forfeited (See Note 9). Additionally, on February 8, 2024, the Company reversed accrued compensation that was outstanding to this former officer as of December 31, 2023 of $347,097 and accordingly, during the six months ended June 30, 2024, the Company recorded a gain on debt extinguishment of $347,097.

 

28

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Employment Agreements

 

On October 18, 2017, the Company entered into an employment agreement with Mr. Scott Silverman, pursuant to which he serves as the Chief Executive Officer of the Company for an initial term of three years that extends for successive one-year renewal terms unless either party gives 30-days’ advance notice of non-renewal. As consideration for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits: 

  

  An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward.
     
  After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company.
     
  Annual cash performance bonus opportunity as determined by the Board.
     
  An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives.
     
  Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits.

 

The receipt of $1,240,000 in connection with the April 25, 2018 financing triggered the right of the employee to receive the deferred salary and the 5% bonus provision disclosed above.

 

Mr. Silverman’s employment agreement provides that, in the event that his employment is terminated by the Company without “cause” (as defined in his employment agreement), or if Mr. Silverman resigned for “good reasons” (as defined in his new employment agreement), subject to a complete release of claims, he will be entitled to (i) retain all stock options previously granted; and (ii) receive any benefits then owed or accrued along with one year of base salary and any unreimbursed expenses incurred by him. All amounts shall be paid on the termination date. In the event that Mr. Silverman’s employment is terminated by the Company for “cause” (as defined in his employment agreement), or if Mr. Silverman resigned without “good reasons” (as defined in his employment agreement), subject to a complete release of claims, he will be entitled to receive any unpaid base salary and benefits then owed or accrued and any unreimbursed expenses incurred by him. Additionally, if a change of control (as defined in his employment agreement) occurs during the term of this agreement, all unvested stock options will vest in full and if the valuation of the Company in the change of control transaction is greater than $0.85 per common share, then Mr. Silverman shall be paid a bonus equal to two times his minimum base salary and minimum target bonus. Pursuant to the employment agreement, Mr. Silverman will be subject to a confidentiality covenant, a two-year post-termination non-competition covenant and a two-year post-termination non-solicitation covenant. On June 30, 2020, the Company amended the employment agreement of Mr. Silverman to provide for successive one-year extensions until either the executive or the Board of Directors of the Company gives notice to terminate the employment agreement per its terms. This employment agreement amendment also includes an allowance of up to $10,000 per year to cover uncovered medical/dental expenses for Mr. Silverman and his family.

 

On July 21, 2021, the Company entered into the Employment Agreement with Mr. Wanke, the President of Patriot Glass, to serve as the President of C-Bond’s Safety Solutions Group. Under the three-year Employment Agreement, Mr. Wanke will receive a base salary of $240,000 per year, which may be increased from time to time with the approval of the board of directors. In addition, Mr. Wanke may receive an annual bonus as determined by the board of directors. It is understood that although Mr. Wanke’s base salary will be paid by Patriot Glass, 50% of the base salary will be allocated to the expenses of Patriot Glass, and the other 50% of the base salary will be allocated to the expenses of the Company. The term of this Agreement (the “Initial Term”) shall begin as of July 21, 2021 (the “Effective Date”) and shall end on the earlier of (i) the third anniversary of the Effective Date and (ii) the time of the termination of the Executive’s employment in accordance with the Employment Agreement. This Initial Term and any Renewal Term (as defined below) shall automatically be extended for one or more additional terms of one (1) year each (each a “Renewal Term” and together with the Initial Term, the “Term”), unless either the Company or Executive provide notice to the other Party of their desire to not so renew the Initial Term or Renewal Term (as applicable) at least thirty (30) days prior to the expiration of the then-current Initial Term or Renewal Term, as applicable. All unvested shares of stock and stock options shall expire upon such termination, if any. The Executive shall be eligible for an annual bonus payment in an amount to be determined by the Board of Directors of the Company (the “Bonus”). The Bonus shall be determined and payable based on the achievement of certain performance objectives of the Company as established by the Board and communicated to and agreed to by the Executive in writing as soon as practicable after commencement of the year in respect of which the Bonus is paid. The Bonus, if earned, is payable in cash and/or restricted stock at the discretion of the Board. It is understood between the Parties that the target bonus for each year shall be up to 50% of the Base Salary.

 

29

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

On December 7, 2023, the Company’s board of directors approved a bonus to two officers in the aggregate amount of $480,000. For the bonus approved for Mr. Silverman, which amounted to $300,000, this bonus was paid 50%, or $150,000, in cash, which was paid in December 2023, and 50% in equity amounting to $150,000 which as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying unaudited consolidated balance sheet. For the bonus approved for Ms. Tomek, which amounted to $180,000, this bonus is to be paid 10% in cash of $18,000 and 90% in equity amounting to $162,000, which as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying unaudited consolidated balance sheet. On January 2, 2024, the Board of Directors of the Company agreed to satisfy the aggregate of $312,000 of the bonus owed to these executive officers (collectively, the “Management”). Management agreed to accept an aggregate of 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation (See Note 9).

        

Anti-dilution rights related to C-Bond Systems, LLC

 

Prior to the Merger, C-Bond Systems, LLC entered into certain contracts, described below, which provided certain anti-dilution protection to the counterparties to those contracts.  The Company believes that these contracts do not apply to any future issuances of equity by C-Bond Systems, Inc.

 

In 2013, pursuant to a subscription agreement, the Company’s subsidiary. C-Bond Systems, LLC issued 2,425,300 common shares. To the extent that during the term of the agreement C-Bond Systems, LLC issues any “down-round” or subsequent investments based upon an enterprise value of less than $2,000,000 (“Dilutive Transaction”) (other than an issuance pursuant to an option agreement with an employee or otherwise to compensate an employee, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units were issued to the seller of such assets) contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the investor additional common units in C-Bond Systems, LLC in an amount which would provide them with the ownership percentage interest which they would have held in C-Bond Systems, LLC represented by the common units purchased by them on this date.

 

In 2015, pursuant to a subscription agreement, C-Bond Systems, LLC issued 3,880,480 common shares to an entity at $0.77 per common share. This agreement entitled the subscriber to anti-dilution protection to the extent that C-Bond Systems, LLC issued any equity in a “down-round” based upon a value of less than $0.77 per common unit of C-Bond Systems, LLC (other than an issuance pursuant to an option agreement with an employee or consultant or otherwise to compensate an employee or consultant, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units are issued to the seller of such assets (“Dilutive Transaction”)). Contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the Subscriber additional common units in C-Bond Systems, LLC in an amount which would provide the investor with the ownership percentage interest in C-Bond Systems, LLC on a fully diluted basis which Subscriber held immediately prior to the Dilutive Transaction.

 

In 2016, pursuant to a subscription agreement, C-Bond Systems, LLC issued 1,175,902 common shares to an entity at $0.85 per common share. This agreement entitled this investor to customary broad-based weighted average anti-dilution protection to the extent that after the date of this subscription agreement C-Bond Systems, LLC issued any equity in a “down round” based upon a value of less than $0.85 per common share, including the issuance of options with an exercise price per share of less than $0.85 to compensate employees or consultants (“Dilutive Transaction”), subject to exclusions for issuances of common shares or options in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions. The agreement obligated C-Bond Systems, LLC to give to this investor written notice (an “Issuance Notice”) of any proposed issuance by C-Bond Systems, LLC of any C-Bond Systems, LLC common units, or other form of equity interest (excluding issuances of C-Bond Systems, LLC options or other equity to compensate employees or consultants and the issuance of shares in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions) at least ten business days prior to the proposed issuance date. This contract entitled the investor to purchase their pro rata portion of such shares or other equity interest of C-Bond Systems, LLC at the price and on the other terms and conditions specified in the issuance notice. 

 

Option to purchase 20% of Patriot Glass

 

In connection with the Exchange Agreement with Patriot Glass and the Patriot Glass Shareholder (See Note 1), the Company had the option to acquire the remaining 20% of Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into an amendment to the Exchange Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”).

 

30

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

If the Company exercises the Option, the Company shall acquire the Additional Units in exchange for (i) a number of shares of Company Common Stock equal to (a) the Share Value (as defined below) divided by (b) the Additional Closing Share Price (as defined below) (the “Additional Closing Exchange Shares”), and (ii) a cash payment equal to the Net Income (as below). “Total EBIT Value” shall mean the sum of (i) Patriot Glass’s net income, before income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on June 30, 2025 plus (ii) $240,000. “EBIT Value” shall mean the Total EBIT Value divided by two (2). “Share Value” shall mean (i) 300% of the EBIT Value (the “Triple EBIT Value”), minus (ii) the Net Income. “Net Income” shall mean Patriot Glass’s net income, after income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on June 30, 2025. Any salary paid by Patriot Glass, including but not limited to any salary paid to the Patriot Glass Shareholder, shall not be included in Net Income. If the Company Common Stock is quoted or listed for trading on a Trading Market on July 1, 2025, then “Additional Closing Share Price” shall mean the average of all of the closing prices of Company Common Stock on such Trading Market during the calendar month of June 2024.

 

M&A advisory agreement

 

On October 18, 2023, the Company and Maxim Group LLC (“Maxim”) entered into an engagement letter, whereby Maxim was engaged as the Company’s exclusive financial advisor to perform merger and acquisition advisory services. Either Maxim or the Company may terminate this Agreement at any time upon thirty (30) days’ prior written notice to the other party after the six (6) month anniversary of this Agreement. The Company paid Maxim a one-time non-refundable cash fee of $25,000 due promptly upon execution of the Agreement (the “Retainer”). The Retainer shall be creditable against the Success Fee. If during the term of this Agreement a Transaction is consummated or the Company enters into an agreement regarding a Transaction (which is consummated subsequent to the completion of the Term), a fee (the “Success Fee”) will be payable in U.S. dollars upon the closing of the Transaction to Maxim equal to 6.5% of the Consideration (as defined hereinafter), provided however, that if a Transaction is consummated or the company enters into an agreement regarding a Transaction with Curtis Stout Inc., such Success Fee shall be reduced to 4.0% of Consideration from Curtis Stout Inc. In the event that the Company enters into an agreement with respect to a Transaction during the term of this Agreement that is subsequently terminated, and the Company becomes entitled to a break-up, termination, topping, expense reimbursement or similar fee or payment (including any judgment for damages or amount in settlement of any dispute as a result of such termination, or any profit on any stock acquired from, or stock option granted by, any party to such transaction), a fee (the “Break-up Fee”) equal to 10.0% of all such amounts, payable promptly upon receipt of such amounts by the Company. Upon the closing of a Transaction, for a period of twelve (12) months from such closing, the Company grants Maxim the right of first refusal to act as sole managing underwriter and sole book runner, sole placement agent, or sole sales agent, for any and all future public or private equity, equity-linked or debt (excluding commercial bank debt) offerings for which the Company retains the service of an underwriter, agent, advisor, finder or other person or entity in connection with such offering period of the Company, or any successor to or any subsidiary of the Company. The Company shall not offer to retain any entity or person in connection with any such offering on terms more favorable than terms on which it offers to retain Maxim. Such offer shall be made in writing in order to be effective. Maxim shall notify the Company within ten (10) business days of its receipt of the written offer contemplated above as to whether or not it agrees to accept such retention. If Maxim should decline such retention, the Company shall have no further obligations to Maxim with respect to the offering for which it has offered to retain Maxim, except as otherwise provided for herein. As of the date of this report, no funds have been raised. In connection with this agreement, during the six months ended June 30, 2024, the Company recorded professional fees of $14,383.

 

31

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

NOTE 11 – CONCENTRATIONS

 

Concentrations Of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable and cash deposits. The Company places its cash in banks at levels that, at times, may exceed federally insured limits. On June 30, 2024, the Company had no cash in bank in excess of FDIC insured levels. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Any material loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company to move its cash to other high quality financial institutions. The Company reviews its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits. The Company has not experienced any losses in such accounts through June 30, 2024.

 

Geographic Concentrations of Sales

 

During the six months ended June 30, 2024 and 2023, all sales were in the United States.

 

Customer Concentrations

 

For the six months ended June 30, 2024, two customers accounted for approximately 41.0% of total sales (14.5% and 26.5%, respectively). For the six months ended June 30, 2023, one customer accounted for approximately 14.8% of total sales. On June 30, 2024, five customers accounted for 63.2% (11.8%, 11.0%, 13.5%, 12.7% and 14.2%, respectively) of the total accounts receivable balance. On December 31, 2023, two customers accounted for 41.8% (29.5% and 12.3%, respectively) of the total accounts receivable balance.

 

Vendor concentrations

 

Generally, the Company purchases substantially all its inventory from four suppliers. The loss of these suppliers may have a material adverse effect on the Company’s consolidated results of operations and financial condition. However, the Company believes that, if necessary, alternate vendors could supply similar products in adequate quantities to avoid material disruptions to operations.

 

NOTE 12 – SEGMENT REPORTING

 

Through May 8, 2023, the date that the Company entered into an Asset Purchase Agreement with Apex Protect GPS, LLC agreed to sell its C-Bond nanoShield™ product line (See Note 16), the Company operated in two reportable business segments - (1) the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”), and (2) the distribution and installation of window film solutions (the “Patriot Glass Segment”). The Company’s reportable segments were strategic business units that offered different products. They were managed separately based on the fundamental differences in their operations and locations. Upon the sale of the C-Bond nanoShield™ business, the legacy C-Bond business is being conducted through Patriot Glass in order to combine administrative functions and they are now being managed together.

 

32

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

Information with respect to these reportable business segments for the three and six months ended June 30, 2024 and 2023 was as follows: 

 

   For the Three Months Ended
June 30,
   For the Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Revenues:                
C-Bond  $
-
   $31,166   $
-
   $124,372 
Patriot Glass   863,533    382,889    1,800,337    804,903 
    863,533    414,055    1,800,337    929,275 
Depreciation and amortization:                    
C-Bond   
-
    132    
-
    569 
Patriot Glass   24,508    20,413    49,015    40,826 
    24,508    20,545    49,015    41,395 
Interest expense:                    
C-Bond   171    357    171    357 
Patriot Glass   18,140    6,655    27,081    11,798 
Other (a)   35,297    161,141    40,475    355,483 
    53,608    168,153    67,727    367,638 
Net income (loss):                    
C-Bond   (225,255)   3,759,343    (147,411)   3,483,967 
Patriot Glass   21,033    (93,201)   68,584    (176,813)
Other (a)   (41,747)   108,131    (474,790)   (255,968)
   $(245,969)  $3,774,273   $(553,617)  $3,051,186 

 

   June 30,
2024
   December 31,
2023
 
Identifiable long-lived tangible assets on June 30, 2024 and December 31, 2023 by segment:          
C-Bond  $
-
   $
-
 
Patriot Glass   147,842    171,606 
   $147,842   $171,606 

 

(a)The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.

 

NOTE 13 – REVENUE RECOGNITION

 

Prior to the sale of the Company’s C-Bond segment in May 2023, the revenue that the Company recognized arose from purchase requests the Company received from its customers. The Company’s performance obligations under purchase orders or by a verbal order correspond to each shipment of product that the Company makes to its customer under the purchase order or verbal order. As a result, each purchase order or verbal order generally contains more than one performance obligation based on the number of products ordered, the quantity of product to be shipped and the mode of shipment requested by the customer. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs at the later of when the customer obtains title to the product or when the customer assumes risk of loss of the product. The transfer of control generally occurs at the time of shipment from the Company’s warehouse. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue.  In connection with the Company’s C-Bond segment, when the Company receives a purchase order or verbal order from a customer, the Company is obligated to provide the product during a mutually agreed upon time period. Depending on the terms of the purchase order or verbal order, either the Company or the customer arranges delivery of the product to the customer’s intended destination. In situations where the Company has agreed to arrange delivery of the product to the customer’s intended destination and control of the product transfers upon loading of the Company’s product onto transportation equipment, the Company has elected to account for any freight income associated with the delivery of these products as freight revenue, since this activity fulfills the Company’s obligation to transfer the product to the customer. 

 

33

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

In connection with the Company’s Patriot Glass segment, the revenue that the Company recognizes arises from purchase requests the Company receives from its customers. The Company’s performance obligations under purchase order or a signed proposal correspond to each job for the distribution and installation of window film solutions. As a result, each purchase order or signed proposal generally may contain more than one performance obligation based on the specific job. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs when the job or a specific portion of the job is completed. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue.  Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output of input methods including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these methods to be the best available measure of progress on these contracts. 

 

Transaction Price

 

The Company agrees with its customers on the selling price of each transaction. This transaction price is generally based on the product, market conditions, including supply and demand balances, labor costs, and freight. In the Company’s C-Bond contracts with customers, the Company allocates the entire transaction price to the sale of product to the customer, which is the basis for the determination of the relative standalone selling price allocated to each performance obligation. Returns of the Company’s product by its customers are permitted only when the product is not to specification and were not material for the six months ended June 30, 2024 and 2023. Any sales tax, value added tax, and other tax the Company collects concurrently with its revenue-producing activities are excluded from revenue.

 

Revenue Disaggregation

 

The Company tracks its revenue by product. The following table summarizes our revenue by product for the six months ended June 30, 2024 and 2023:  

 

   For the Six Months Ended
June 30,
 
   2024   2023 
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems  $33,537   $9,709 
C-Bond nanoShield solution sales   
-
    112,413 
Window tint installation and sales recognized over time   1,766,800    804,903 
Freight and delivery   
-
    2,250 
Total  $1,800,337   $929,275 

 

NOTE 14 – OPERATING LEASE RIGHT-OF-USE (“ROU”) ASSETS AND OPERATING LEASE LIABILITIES

 

In October 2019, the Company entered into an 18-month lease agreement for the lease of office and warehouse space under a non-cancelable operating lease through May 31, 2021. From the lease commencement date of December 1, 2019 until November 30, 2020, monthly rent shall be $4,444 and from December 1, 2020 to May 31, 2021, monthly rent shall be $4,577 per month. On May 12, 2021 and effective June 1, 2021, the Company entered into an amendment to the lease which extended the lease for one year until May 31, 2022 at a monthly base rent of $5,283. On May 4, 2022 and effective June 1, 2022, the Company entered into an amendment to the lease which extended the lease for three years until May 31, 2025. On June 15, 2023, in connection with the sale of the Company’s nanoShield™ product line, the purchaser assumed the operating lease and the Company vacated the premises. 

 

In connection with the 2021 Exchange Agreement between in the Company and Patriot Glass, the Company was named as guarantor (“Guarantor”) of a Commercial Lease Agreement dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Mr. Wanke and his wife and tenant Patriot Glass d/b/a A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent of $5,600 (not including tax), with two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Patriot Glass; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Patriot Glass; or (iii) two (2) years from and after the effective date of the guaranty. During the year ended December 31, 2023, the Company’s obligation as Guarantor expired.

 

34

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

In September 2021, the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025. The monthly base rent is $365 per month. This lease has been assumed by CB NANOSHIELD LLC as part of its purchase of the nanoShield Assets (see Note 16).

 

In February 2022, the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025. The monthly base rent is $788 per month. 

 

In adopting ASC Topic 842, Leases (Topic 842) on January 1, 2019, the Company had elected the ‘package of practical expedients’, which permitted it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs (see Note 2). In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Upon signing of new leases for property and equipment, the Company analyzed the new leases and determined it is required to record a lease liability and a right of use asset on its unaudited consolidated balance sheets, at fair value.

 

During the six months ended June 30, 2024 and 2023, in connection with its property operating leases, the Company recorded rent expense of $16,800 and $40,845, respectively, which is expensed during the year and included in general and administrative expenses on the accompanying unaudited consolidated statements of operations.

 

On June 30, 2024 and December 31, 2023, right-of-use asset (“ROU”) is summarized as follows:

 

   June 30,
2024
   December 31,
2023
 
Office leases and office equipment right of use assets  $279,162   $279,162 
Less: accumulated amortization   (150,440)   (120,678)
Balance of ROU assets  $128,722   $158,484 

 

On June 30, 2024 and December 31, 2023, operating lease liabilities related to the ROU assets are summarized as follows:

 

   June 30,
2024
   December 31,
2023
 
Lease liabilities related to office leases right of use assets  $128,722   $157,752 
Less: current portion of lease liabilities   (60,773)   (60,503)
Lease liabilities – long-term  $67,949   $97,249 

  

On June 30, 2024, future minimum base lease payments due under non-cancelable operating leases are as follows:

 

Twelve months ending June 30,  Amount 
2025  $72,715 
2026   67,200 
2027   5,600 
Total minimum non-cancelable operating lease payments   145,515 
Less: discount to fair value   (16,793)
Total lease liability on June 30, 2024  $128,722 

 

35

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

NOTE 15 – RELATED PARTY TRANSACTIONS

 

Due from Related Party

 

On May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s findings, C-Bond and its Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled. As of December 31, 2023, based on the settlement offers, the Company had accrued $175,000 of settlement expense association with this matter which is included in accrued expenses on the accompany unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to the SEC and the accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024. On August 16, 2024, the Company received cash of $50,000 and reduced the amount due from related party. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled (See Note 9) and the Chief Executive Officer issued a check to the Company in the amount of $21,961, which the Company expects to deposit before year end.  The amount due of $21,961 is included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024. 

 

36

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

NOTE 16 – SALE OF NANOSHIELD PRODUCT LINE

 

On May 8, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby the Company agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023. Following the Closing, the parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company; Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee.

 

The Assets were sold and transferred to buyer by means of (i) with respect to the physical assets, a Bill of Sale; and (ii) with respect to intangible assets or intellectual property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement.

 

The APA contains customary representations, warranties, and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding under state or federal law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided the Seller a true and accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including, among other things, patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal title to, and is the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear of all liens.

 

Under the terms of the APA, the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer, among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent, for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.

 

The Parties also entered into a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive right and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass and other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles and equipment (the “Licensed Product”) in the United States and its legal territories.

 

Lastly, the Parties entered into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free, non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve, market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications of the patented technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and conditions that are mutually acceptable to both Parties.

 

Following the Closing, the Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement as agreed to by the Parties and the lessor pursuant to the Lease. 

 

37

 

 

C-BOND SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024
(UNAUDITED)

 

In connection with the APA, the Company received net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable as follows:

 

1)The Company repaid and settled the BOCO Investments, LLC Note (See Note 8) with a principal balance of $400,000 and accrued interest payable of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock (See Note 8 and 9).

 

2)The Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full (See Note 8).

 

3)The Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November 22, 2022 (collectively, the “Secured Mercer Notes”) (See Note 7).

 

4)The Company repaid Jeff Badders $875,000 for notes dated May 5, 2021, November 8, 2022, and April 4, 2023 (See Note 8).

 

5)The Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively, the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full (See Note 7).

 

6)The Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full.

 

In accordance with ASC 205-20, the sale of the C-Bond nanoShield™ product line was not reported in discontinued operations since the disposal did not represent a strategic shift that has (or will have) a major effect on the Company’s operations and financial results. The C-Bond nanoShield™ product line was only a component of the C-Bond segment which comprised of operations and cash flows that were not clearly distinguished, operationally and for financial reporting purposes, from the rest of the C-Bond segment.

 

In connection with the sale of the C-Bond nanoShield™ product line, on May 8, 2023, the Company recorded a gain from the sale of the product line of $4,051,709.

 

NOTE 17 – SUBSEQUENT EVENTS

 

Promissory Notes

 

On July 31, 2024, the Company’s subsidiary, Patriot Glass, entered into a Merchant Loan (the “July 2024 Merchant Loan”) with a lender in the principal amount of $75,000 and received net proceeds of $73,030, net of fees of $1,970, which was reflected as a debt discount to be amortized into interest expense over the term of the note. The July 2024 Merchant Loan requires a weekly payment of principal and interest of $3,022 through April 2025.

 

On August 9, 2024, the Company entered into a Promissory Note and Security Agreement (the “August 2024 Note”) with a Private investor (the “Private Investor”) in the principal amount of $990,000 in connection with the conversion of 8,000 shares Series C Preferred Stock held by the Private Investor with a stated value of $800,000 plus additional cash proceeds from the Private Investor of $190,000. The August 2024 Note consists of $800,000 stated value of Series C Preferred stock converted plus additional cash proceeds of $190,000 received from the Private Investor. The August 2024 Note shall bear interest at 6% per annum. The Company shall pay quarterly interest expense of $14,850 starting on October 1, 2024 and continuing until the maturity date, which is the earlier of August 9, 2027, or a change of control in the Company, as defined in the August 2024 Note. All outstanding principal and unpaid interest is due on the maturity date. The August 2024 Note is secured all assets of the Company.

 

On August 15, 2024, the Company entered into two amendments to its Promissory Note in favor of Diagonal dated March 1, 2024 (“March Note”) in the principal amount of $157,000 (See Note 8). The amendments to the March Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $17,877 (a total payback to the Holder of $160,893). The first payment shall be due August 30, 2024, with 8 subsequent payments due on the 30th day of each month thereafter. The amendments to the March Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the March Note remain the same.

 

On August 15, 2024, the Company entered into two amendments to its April 2024 Note in favor of Diagonal in the principal amount of $127,693 (See Note 8). The amendments to the April 2024 Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $21,980 (a total payback to the Holder of $197,820). The first payment shall be due August 13, 2024, with 8 subsequent payments due on the 15th day of each month thereafter. The amendments to the April 2024 Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the April Note remain the same.

 

On August 15, 2024, the Company entered an amendment to its June 2024 Note in favor of Diagonal in the principal amount of $67,500 (See Note 8). The amendment to the June 2024 Note changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the June Note remain the same. 

 

38

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this Report, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management and expected market growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “could,” “will,” “would,” “should,” “expect,” “plan,”, “anticipate,” “believe,” “estimate,” “intend,” “predict,” “seek,” “contemplate,” “project,” “continue,” “potential,” “ongoing” or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:

 

our ability to obtain additional funds for our operations;

 

our ability to obtain and maintain intellectual property protection for our products and our ability to operate our business without infringing the intellectual property rights of others;

  

our reliance on third party distributors;

 

the initiation, timing, progress and results of our research and development programs;

 

our dependence on current and future collaborators for developing new products;

 

the rate and degree of market acceptance of our commercial products;

 

the implementation of our business model and strategic plans for our business;

 

our estimates of our expenses, losses, future revenue and capital requirements, including our needs for additional financing;

 

our reliance on third party suppliers to supply the materials and components for our products;

 

our ability to attract and retain qualified key management and technical personnel;

 

our financial performance;

 

the impact of government regulation and developments relating to our competitors or our industry; and

 

other risks and uncertainties, including those listed under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as the same may be updated from time to time, including in this Report.

 

These statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in our SEC filings.

 

Any forward-looking statement in this Report reflects our current view with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our business, results of operations, industry, and future growth. Given these uncertainties, you should not place undue reliance on these forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Report completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

 

39

 

 

This Report also may contain estimates, projections and other information concerning our industry, our business and the markets for certain glass strengthening solutions, hydrophobic products, and window film mounting solutions, including data regarding the estimated size of those markets and their projected growth rates. Information that is based on estimates, forecasts, projections, or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained these industry, business, market and other data from reports, research surveys, studies and similar data prepared by third parties, industry, and general publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which these data are derived.

 

You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Report. Except as required by law, we do not undertake any obligation to update or release any revisions to these forward-looking statements to reflect any events or circumstances, whether as a result of new information, future events, changes in assumptions or otherwise, after the date hereof.

 

Overview

 

We are a nanotechnology company and marketer of the patented C-Bond technology. We are engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. Our present primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States. Our PGS subsidiary sells two main security products: C-Bond BRS, a ballistic-resistant window film solution and C-Bond Secure, a forced entry deterrent solution, to private enterprises, schools, government agencies, and general contractors. PGS also sells offers other types of window film for various applications, including solar, decorative, reflective, and more.

 

On May 8, 2023, we entered into an APA with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby we agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of our C-Bond nanoShield product line (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023.

 

The Assets were sold and transferred to buyer by means of (i) with respect to the physical assets, a bill of sale; and (ii) with respect to intangible assets or intellectual property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement.

 

On June 15, 2023, an Assignment and Agreement to Re-Execute was entered into by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, a Texas limited liability company (“Assignee”), whereby the Assignor assigned to the Assignee all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee.

 

The APA contains customary representations, warranties, and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding under state or federal law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided the Seller a true and accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including, among other things, patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal title to, and is the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear of all liens.

 

40

 

 

Under the terms of the APA, the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer, among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent, for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.

 

The Parties also entered into a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive right and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass and other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles and equipment (the “Licensed Product”) in the United States and its legal territories.

 

Lastly, the Parties entered into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free, non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve, market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications of the patented technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and conditions that are mutually acceptable to both Parties.

 

Following the Closing, the Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement as to be reasonably agreed to by the Parties and the lessor pursuant to the Lease.

 

On May 8, 2023, in connection with the APA, the Company received net proceeds of $1,989,755, after paying debt and accrued interest of approximately $2,053,000.

 

The following discussion highlights our results of operations and the principal factors that have affected our financial condition as well as our liquidity and capital resources for the periods described and provides information that management believes is relevant for an assessment and understanding of the statements of financial condition and results of operations presented herein. The following discussion and analysis are based on our consolidated financial statements contained in this Report, which have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). You should read the discussion and analysis together with such financial statements and the related notes thereto. 

 

Going Concern

 

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, we had a net loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, we had an accumulated deficit, shareholders’ deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. On June 30, 2024, we had cash of $196,315. These factors raise substantial doubt about our ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that we will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. We are seeking to raise capital through additional debt and/or equity financings to fund our operations in the future. Although we have historically raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that we will be able to continue to do so. If we are unable to raise additional capital or secure additional lending in the near future, management expects that we will need to curtail our operations. These unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

 

41

 

 

Critical Accounting Estimates

 

The following discussion and analysis of our consolidated financial condition and consolidated results of operations are based upon our unaudited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these unaudited consolidated financial statements require management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Management continually evaluates such estimates, including those related to critical estimates for estimates used in the calculation of percentage of completion on uncompleted jobs, assumptions used in assessing impairment of long-term assets, and the fair value of non-cash equity transactions. Management bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Any future changes to these estimates and assumptions could cause a material change to our reported amounts of revenues, expenses, assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. Management believes the following critical accounting policies affect our more significant judgments and estimates used in the preparation of the unaudited consolidated financial statements.

 

Revenue recognition

 

We follow the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.  

 

We sell our products, which include standard warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not represent a separate performance obligation.

 

Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.

 

Stock-based compensation

 

Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted under Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment

 

See Note 2 to our unaudited consolidated financial statements for a summary of significant accounting policies and recent accounting pronouncements.

 

Results of Operations

 

The following comparative analysis on results of operations was based primarily on the comparative consolidated financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the unaudited consolidated financial statements and the notes to those statements for the three and six months ended June 30, 2024 and 2023, which are included elsewhere in this quarterly report on Form 10-Q. The results discussed below are for the three and six months ended June 30, 2024 and 2023.

 

42

 

 

Comparison of Results of Operations for the Three and Six Months ended June 30, 2024 and 2023

 

Sales

 

For the three months ended June 30, 2024, sales amounted to $863,533 as compared to $414,055 for the three months ended June 30, 2023, an increase of $449,478, or 108.6%. For the six months ended June 30, 2024, sales amounted to $1,800,337 as compared to $929,275 for the six months ended June 30, 2023, an increase of $871,062, or 93.7%. These increases were attributable to an increase in sales of window tint installation and services to school districts in Texas. The Texas Education Agency (TEA) mandated that each school district and open-enrollment charter school install either entry-resistant film or fencing on ground-floor windows that would allow access, glass doors, and windows adjacent to glass doors. Additionally, we had an increase in sales from the sales of C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems. These increases were offset by a decrease in sales of our recently sold C-Bond nanoShield™ solutions product line of approximately $26,825 and $112,413 during the three and six months ended June 2024 and compared to the three and six months ended June 30, 2023, respectively, due to product line sale in May 2023, and a decrease in freight and delivery sales. 

 

Cost of Goods Sold

 

In connection with our C-Bond Solutions segment, cost of goods sold was comprised primarily of the cost of raw materials and finished inventory sold, packaging costs, and warranty costs. In connection with our Patriot Glass segment, cost of goods sold is comprised primarily of cost of raw materials such as film, labor, subcontractor costs, equipment rental, and supplies.

 

For the three months ended June 30, 2024, cost of sales amounted to $424,959 as compared to $209,071 for the three months ended June 30, 2023, an increase of $215,888, or 103.3%. For the six months ended June 30, 2024, cost of sales amounted to $886,888 as compared to $454,431 for the six months ended June 30, 2023, an increase of $432,457, or 95.2%.

 

Gross Profit

 

For the three months ended June 30, 2024, gross profit amounted to $438,574, or 50.8% of sales, as compared to $204,984, or 49.5% of sales, for the three months ended June 30, 2023, an increase of $233,590, or 114.0%. For the six months ended June 30, 2024, gross profit amounted to $913,449, or 50.7% of sales, as compared to $474,844, or 51.1% of sales, for the six months ended June 30, 2023, an increase of $438,605, or 92.4%.

 

Operating Expenses

 

For the three months ended June 30, 2024, operating expenses amounted to $630,935 as compared to $776,848 for the three months ended June 30, 2023, a decrease of $145,913, or 18.8%. For the six months ended June 30, 2024, operating expenses amounted to $1,747,329 as compared to $1,570,310 for the six months ended June 30, 2023, an increase of $177,019, or 11.3%. For the three and six months ended June 30, 2024 and 2023, operating expenses consisted of the following:

 

   Three Months ended
June 30,
   Six Months ended
June 30,
 
   2024   2023   2024   2023 
Compensation and related benefits, including stock-based compensation charges  $373,548   $441,181   $1,152,667   $868,053 
Professional fees   88,030    193,263    229,614    380,953 
General and administrative expenses   169,357    142,404    365,048    321,304 
Total  $630,935   $776,848   $1,747,329   $1,570,310 

 

43

 

 

Compensation and related benefits

 

For the three months ended June 30, 2024, compensation and related benefits decreased by $67,633, or 15.3%, as compared to the three months ended June 30, 2023. This decrease was primarily due to a decrease in stock-based compensation of $30,046 and an overall decrease in compensation and related benefits of $37,587.

 

For the six months ended June 30, 2024, compensation and related benefits increased by $284,614, or 32.8%, as compared to the six months ended June 30, 2023. This increase was primarily due to an increase in stock-based compensation of $334,785, offset by an overall decrease in compensation and related benefits of $50,171.

 

On January 2, 2024, the Board of Directors of the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers (collectively, the “Management”) as of December 31, 2023, which was included in accrued compensation on the accompanying unaudited consolidated balance sheet. Management agreed to accept 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $281,807 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. Additionally, on January 2, 2024, the Board of Directors of the Company agreed to issue 50 shares of the Company’s Series B convertible preferred stock to a director for services rendered. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $95,161, which consisted of (i) $50,000 of Series B stated value and (ii) $45,161 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock.

 

Professional fees

 

For the three months ended June 30, 2024, professional fees decreased by $105,233, or 54.4%, as compared to the three months ended June 30, 2023. This decrease was primarily related to a decrease in consulting fees of $73,487 and a decrease in legal fees of $41,553, offset by an increase in other professional fees of $9,807.

 

For the six months ended June 30, 2024, professional fees decreased by $151,339, or 39.7%, as compared to the six months ended June 30, 2023. This decrease was primarily related to a decrease in consulting fees of $134,634 and a decrease in legal fees of $37,829, offset by an increase in accounting fees of $7,175 and a net increase in other professional fees of $13,949.

 

General and administrative

 

For the three months ended June 30, 2024, general and administrative expenses increased by $26,953, or 18.9%, as compared to the three months ended June 30, 2023. The increase is primarily attributable to an increase in advertising expense of $20,029, and an increase in other selling, general and administrative expenses of $21,418, an increase in depreciation and amortization of $16,588, and an increase in shipping and handling expense of $2,863, offset by a decrease in bad debt expense of $6,889 and a decrease in rent of $27,056 associated with the sale of the C-Bond nanoShield™ product line in May 2023.

 

44

 

 

For the six months ended June 30, 2024, general and administrative expenses increased by $43,744, or 13.6%, as compared to the six months ended June 30, 2023. The increase is primarily attributable to an increase in bad debt expense of $23,094, an increase in advertising expense of $27,888, an increase in other selling, general and administrative expenses of $31,548, an increase in depreciation expense of $7,620, and an increase in shipping and handling expense of $4,695, offset by a decrease in rent of $51,101 associated with the sale of the C-Bond nanoShield™ product line in May 2023.

 

Other Operating Income

 

During the three and six months ended June 30, 2023, we reported a gain on sale of our nanoShield™ product line of $4,051,709. We did not record any other operating income during the 2024 periods.

 

(Loss) Income from Operations

 

For the three months ended June 30, 2024 and 2023, (loss) income from operations amounted to $(192,361) and $3,479,845, respectively, a negative change of $3,672,206, or 105.5%. For the six months ended June 30, 2024 and 2023, (loss) income from operations amounted to $(833,880) and $2,956,243, respectively, a negative change of $3,790,123, or 128.1%.

 

Other Income (Expenses), net

 

For the three months ended June 30, 2024, other income (expenses), net amounted to $(53,608) as compared to $294,428 for the three months ended June 30, 2023, a negative change of $348,036, or 118.2%. This change was primarily due to a decrease in gain on debt extinguishment of $462,581 related to the reversal of previously accrued compensation, offset by a decrease in interest expense of $114,545 related to a decrease in the amortization of debt discount and a decrease in interest-bearing debt.

 

For the six months ended June 30, 2024, other income (expenses), net amounted to $280,263 as compared to $94,943 for the six months ended June 30, 2023, an increase of $185,320, or 195.2%. This change was primarily due to a decrease in interest expense of $299,911 related to a decrease in the amortization of debt discount and a decrease in interest-bearing debt, offset by a decrease in gain on debt extinguishment of $114,591 related to the reversal of previously accrued compensation and settlement of debt.

 

Net (Loss) Income

 

Due to factors discussed above, for the three months ended June 30, 2024 and 2023, net (loss) income amounted to $(245,969) and $3,774,273, respectively. For the three months ended June 30, 2024, net loss attributable to common shareholders, which included dividends accrued on Series B and C preferred stock of $13,749 and the deduction of net income attributable to noncontrolling interests of $4,207, amounted to $(263,925), or $(0.00) per common share (basic and diluted). For the three months ended June 30, 2023, net income attributable to common shareholders, which included dividends accrued on Series B and C preferred stock of $13,618 and the addition of net loss attributable to noncontrolling interests of $18,640, amounted to $3,779,295, or $0.01 per basic common shares and $0.00 per diluted common share.

 

Due to factors discussed above, for the six months ended June 30, 2024 and 2023, net (loss) income amounted to $(553,617) and $3,051,186, respectively. For the six months ended June 30, 2024, net loss attributable to common shareholders, which included dividends accrued on Series B and C preferred stock of $28,098 and the deduction of net income attributable to noncontrolling interests of $13,717, amounted to $(595,432), or $(0.00) per common share (basic and diluted). For the six months ended June 30, 2023, net income attributable to common shareholders, which included dividends accrued on Series B and C preferred stock of $27,305 and the addition of net loss attributable to noncontrolling interests of $35,362, amounted to $3,059,243, or $0.01 per basic common shares and $0.00 per diluted common share.

 

45

 

 

Liquidity and Capital Resources

 

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had cash of $196,315 and $736,461 as of June 30, 2024 and December 31, 2023, respectively.

 

Our primary uses of cash have been for compensation and related benefits, fees paid to third parties for professional services, and general and administrative expenses. Historically, we have received funds from the sales of products, from various financing activities such as from the sale of our common shares, from the sale of preferred shares and from debt financings. Additionally, in May 2023, we received net proceeds from the sale of our nanoShield™ product line and related technologies of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable. The following trends are reasonably likely to result in changes in our liquidity over the near to long term:

 

  An increase in working capital requirements to finance our current business,
     
  Addition of administrative and sales personnel needed for business growth;
     
  The cost of being a public company;
     
  Marketing expense for building brand;
     
  Capital requirements for production capacity.
     
  Working capital requirements to support acquired companies.

 

As discussed elsewhere, on May 8, 2023, we entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby we sold our C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023.

 

In connection with the APA, we received net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable as follows:

 

  1) The Company repaid and settled the BOCO Investments, LLC Note with a principal balance of $400,000 and accrued interest payable of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock.
     
  2) The Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full.
     
  3) The Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November 22, 2022 (collectively, the “Secured Mercer Notes”).
     
  4) The Company repaid Jeff Badders $875,000 plus $87,868 of interest for notes dated May 5, 2021, November 8, 2022, and April 4, 2023.
     
  5) The Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively, the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full.
     
  6) The Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full.

 

46

 

 

Recent Fundings

 

On March 1, 2024, we executed a Promissory Note (“Note”) in favor of 1800 Diagonal Lending LLC (“Diagonal”) in the aggregate principal amount of $157,000 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4, 2023, in the amount of $125,000, which is net of an original issue discount of $13,000 and a one-time interest charge of $19,000. A one-time interest charge of twelve percent (12%) (the “Interest Rate”) was applied on the issuance date to the Principal. Under the terms of the Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and the Note matures on December 30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”). Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable and the Company shall pay to Diagonal, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of the Company’s Common Stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the Note be converted into shares of our common stock if such conversion would result in Diagonal and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock. On August 15, 2024, the Company entered into two amendments to its Promissory Note in favor of Diagonal dated March 1, 2024 (“March Note”) in the principal amount of $157,000 (See Note 8). The amendments to the March Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $17,877 (a total payback to the Holder of $160,893.00). The first payment shall be due August 30, 2024, with 8 subsequent payments due on the 30th day of each month thereafter. The amendments to the March Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the March Note remain the same.

 

On April 8, 2024, we executed a Promissory Note (“the April 2024 Note”) in favor of Diagonal in the aggregate principal amount of $127,963 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the April 2024 Note convertible into shares of the Company’s common stock. The Note was funded on April 10, 2024, in the amount of $100,000. A one-time interest charge of 12% (the “Interest Rate”) shall be applied on the issuance date to the Principal. Under the terms of the April 2024 Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”). Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the April 2024 Note shall become immediately due and payable and the Company shall pay to Diagonal, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this April 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this April 2024 Note to the date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount of this April 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the April 2024 Note be converted into shares of our common stock if such conversion would result in Diagonal and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock. On August 15, 2024, the Company entered into two amendments to its April 2024 Note in favor of Diagonal in the principal amount of $127,693 (See Note 8). The amendments to the April 2024 Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $21,980 (a total payback to the Holder of $197,820). The first payment shall be due August 13, 2024, with 8 subsequent payments due on the 15th day of each month thereafter. The amendments to the April 2024 Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the April Note remain the same.

 

On June 5, 2024, the Company executed a Promissory Note (the “June 2024 Note”) in favor of Diagonal in the aggregate principal amount of $67,500 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the June 2024 Note convertible into shares of the Company’s common stock. The Note was funded on June 5, 2024, in the amount of $50,000, net of original issue discount and fees of $17,500. Under the terms of the June 2024 Note, the Company is required to make nine monthly payments of principal and interest of $8,775 beginning on July 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”). Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the June 2024 Note shall become immediately due and payable and the Company shall pay to Diagonal, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this June 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this June 2024 Note to the date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right, to convert all or any part of the outstanding and unpaid amount of this June 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the June 2024 Note be converted into shares of our common stock if such conversion would result in Diagonal and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock. On August 15, 2024, the Company entered an amendment to its June 2024 Note in favor of Diagonal in the principal amount of $67,500 (See Note 8). The amendment to the June 2024 Note changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the June Note remain the same. 

 

47

 

 

Summary

 

As of June 30, 2024, we determined that there was substantial doubt about our ability to maintain operations as a going concern. Our unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. Management cannot provide assurance that we will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. We will seek to raise capital through additional debt and/or equity financings to fund operations in the future. Although we have historically raised capital from sales of common and preferred shares, from the issuance of notes payable, and from the issuance of convertible promissory notes, there is no assurance that it will be able to continue to do so. If we are unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail its operations. Our unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

Our forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement that involves risks and uncertainties, and actual results could vary materially because of a number of factors. We have based this estimate on assumptions that may prove to be wrong and could utilize our available capital resources sooner than we currently expect. Our capital requirements are difficult to forecast. Please see the section titled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC, for additional risks associated with our capital requirements.

 

Until such time as we generate substantial product revenue to offset operational expenses, we expect to finance our cash needs through a combination of public and private equity offerings and debt financings. We may be unable to raise capital or enter into such other arrangements when needed or on favorable terms or at all. Our failure to raise capital or enter into such other arrangements as and when needed would have a negative impact on our financial condition. 

 

Additional cash liquidity is generated from product sales. However, to date, we are not profitable, and we cannot provide any assurances that we will be profitable. We believe that our existing cash and cash equivalents will not be sufficient to fund our current operating plans.

 

Cash Flows

 

For the six months ended June 30, 2024 and 2023

 

The following table shows a summary of our cash flows for the six months ended June 30, 2024 and 2023.

 

   Six Months Ended
June 30,
 
   2024   2023 
Net cash used in operating activities  $(812,054)  $(912,997)
Net cash provided by investing activities   -    4,042,631 
Net cash provided by (used in) financing activities   271,908    (1,715,198)
Net (decrease) increase in cash   (540,146)   1,414,436 
Cash - beginning of the period   736,461    97,091 
Cash - end of the period  $196,315   $1,511,527 

 

48

 

 

Net Cash Used in Operating Activities:

 

Net cash flow used in operating activities was $812,054 for the six months ended June 30, 2024 as compared to net cash flow used in operating activities of $912,997 for the six months ended June 30, 2023, a decrease of $100,943.

 

Net cash flow used in operating activities for the six months ended June 30, 2024 primarily reflected a net loss of $553,617, which was then adjusted for the add-back (deduction) of non-cash items primarily consisting of depreciation and amortization of $49,015, stock-based compensation expense of $376,968, amortization of debt discount of $22,459, non-cash gain on debt extinguishment of $(347,990), non-cash compensation claw back of $(21,961), and bad debt expense of $25,833, and changes in operating assets and liabilities consisting primarily of a decrease in accounts receivable of $154,889, a decrease in inventory of $19,611, an increase in prepaid expenses of $79,304, an increase in contract liabilities of $57,456, an increase in amounts due from related party of $50,000, an increase in accounts payable of $88,605, a decrease in contract liabilities of $351,936, a decrease in accrued compensation of $3,645, and a decrease in accrued expenses of $84,257.

 

Net cash flow used in operating activities for the six months ended June 30, 2023 primarily reflected net income of $3,051,186, which was then adjusted for the add-back (deduction) of non-cash items primarily consisting of depreciation and amortization of $41,395, stock-based compensation expense of $42,183, stock-based professional fees of $97,817, amortization of debt discount of $95,922, non-cash interest expense for put premiums of $29,212, non-cash gain on debt extinguishment and inducement expense of $462,581, and gain from sale of nanoShield™ product line of $4,051,709, and changes in operating assets and liabilities consisting primarily of a decrease in accounts receivable of $188,934, an increase in inventory of $51,196, an increase in prepaid expenses of $15,434, an increase in contract assets of $52,487, a decrease in accounts payable of $50,027, an increase in accrued expenses of $8,040, an increase in contract liabilities of $157,363, an increase in accrued compensation of $49,812, and an increase in accrued interest – related party of $5,663.

 

Net Cash Provided by Investing Activities:

 

Net cash provided by investing activities was $4,042,631 for the six months ended June 30, 2023 as compared to $0 for the six months ended June 30, 2024.

 

During the six months ended June 30, 2023, we received net proceeds of $4,042,631 from the sale of our nanoShield™ product line and related technologies.

 

Net Cash Provided by (Used in) Financing Activities:

 

Net cash provided by financing activities was $271,908 for the six months ended June 30, 2024 as compared to net cash used in financing activities of $(1,715,198) for the six months ended June 30, 2023.

 

During the six months ended June 30, 2024, we received net proceeds from notes payable of $405,550. These proceeds were offset by the repayment of notes payable of $43,642 and the repayment of convertible notes payable of $90,000.

 

During the six months ended June 30, 2023, we received net proceeds from the sale of our common stock to our chief executive officer of $275,000, we received net proceeds from convertible notes payable of $50,000, and we received proceeds from notes payable of $175,000. These proceeds were offset by the repayment of notes payable of $1,792,448, the repayment of note payable – related party of $200,000, and the repayment of convertible notes payable of $222,750.

 

49

 

 

Contractual Obligations and Off-Balance Sheet Arrangements

 

Contractual Obligations

 

We have certain fixed contractual obligations and commitments that include future estimated payments. Changes in our business needs, cancellation provisions, changing interest rates, and other factors may result in actual payments differing from the estimates. We cannot provide certainty regarding the timing and amounts of payments. We have presented below a summary of the most significant assumptions used in our determination of amounts presented in the tables, to assist in the review of this information within the context of our consolidated financial position, results of operations, and cash flows.

 

The following tables summarize our contractual obligations as of June 30, 2024, and the effect these obligations are expected to have on our liquidity and cash flows in future periods.

 

   Payments Due by Period 
Contractual obligations:  Total   Less than
1 year
   1-2 years   3-5 years   5 + years 
Notes payable  $567,333   $533,856   $23,667   $9,810   $    - 
Convertible note payable   1,008,091    180,000    828,091    -    - 
Interest on notes payable   176,800    176,800    -    -    - 
Operating lease gross base rent   145,515    72,715    72,800    -    - 
Total  $1,897,739   $963,371   $924,558   $9,810   $- 

 

Off-balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements during the period presented as defined in the rules and regulations of the SEC.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as that term is defined in Rule 13a-15(e), promulgated by the SEC pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including the principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. Our management, with the participation of the principal executive officer and principal financial officer, evaluated our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of June 30, 2024, our disclosure controls and procedures were not effective.

 

As reported in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2023, our management concluded that our internal control over financial reporting was not effective as of that date because of a material weakness in our internal control over financial reporting. The ineffectiveness of our disclosure controls and procedures was due to the following material weaknesses in our internal control over financial reporting: (1) the lack of multiples levels of management review on complex business, accounting and financial reporting issues, and (2) a lack of adequate segregation of duties as a result of our limited financial resources to support hiring of personnel.

 

Until such time as we expand our staff to include additional accounting and executive personnel, it is likely we will continue to report material weaknesses in our internal control over financial reporting.

 

A material weakness is a deficiency or a combination of control deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

50

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business.

  

Except as set forth below, the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations, or cash flows. 

 

On January 20, 2022, we received an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of 1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition. On April 15, 2022, we filed an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The restatement had the cumulative effect of decreasing the Company’s reported revenue for fiscal year 2020 by $102,569 and decreasing the Company’s bad debt expense for the same period by $102,569. There was no effect on the Company’s reported net loss for fiscal year 2020 or on the financial condition of the Company on December 31, 2020. The Company received a subpoena from the SEC on April 25, 2022, requesting all documents and communications concerning the review of C-Bond’s revenue recognition practices for fiscal year 2020. In response, the Company provided the requested information and its Chief Executive Officer provided his testimony regarding this Formal Order in October 2022. The Company also filed a request to withdraw its Registration Statement on Form S-1 (“S-1”) (File No. 333-261472) (the “Registration Statement”), filed by the Company with the Securities and Exchange Commission on December 3, 2021. The S-1 related to shares of common stock underlying certain convertible promissory notes held by selling securityholders. The S-1 was not declared effective and no securities were sold in reliance thereon. The Company and our Chief Executive Officer submitted offers to settle and close the pending SEC investigation, and on May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s findings, C-Bond and its Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled and the Chief Executive Officer issued a check to the Company in the amount of $21,961, which the Company expects to deposit before year end. The amount due of $21,961 is included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024.  As of December 31, 2023, based on the settlement offers, the Company had accrued $175,000 of settlement expense association with this matter which is included in accrued expenses on the accompanying unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to the SEC and the accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024, which amount was repaid in August 2024.

 

On March 8, 2021, a former officer of the Company resigned. Both parties alleged certain claims against the other, including with respect to certain compensation claims. Neither party has filed litigation. The Company intends to vigorously defend itself against any possible claims and assert any relevant claims against the former executive and believes it will prevail. The Board of Directors of the Company have resolved and taken action in February 2024 to cause the forfeiture of equity and deferred compensation owed/outstanding by said officer. Accordingly, on February 8, 2024, the Board of Directors of the Company determined that 120 shares of Series B convertible preferred stock and 5,250,000 shares of the Company’s common stock shall be forfeited (See Note 9). Additionally, on February 8, 2024, the Company reversed accrued compensation that was outstanding to this former officer as of December 31, 2023 of $347,097 and accordingly, during the six months ended June 30, 2024, the Company recorded a gain on debt extinguishment of $347,097.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

1.On May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

The above securities were issued in reliance upon the exemptions provided by Section 4(a)(2) under the Securities Act of 1933, as amended.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

51

 

 

ITEM 5. OTHER INFORMATION

 

(a) None.

 

(b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K. 

 

(c) During the quarter ended June 30, 2024, no director or officer of the Company adopted or terminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or a non-Rule 10b5-1 trading arrangement. 

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description of Exhibit
4.1   Promissory Note, dated April 8, 2024, in favor of Investor (incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K as filed on April 12, 2024).
10.1   Securities Purchase Agreement, dated April 8, 2024, between C-Bond Systems, Inc. and Investor (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K as filed on April 12, 2024).
31.1*   Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema Document.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

  

*Filed herewith.

 

**Furnished herewith.

 

52

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  C-BOND SYSTEMS, INC.
     
Dated: August 19, 2024 By:  /s/ Scott R. Silverman
    Scott R. Silverman
   

Chief Executive Officer and

Chief Financial Officer

(principal executive officer,
principal financial officer and
principal accounting officer)

  

53

NONE false --12-31 Q2 0001421636 0001421636 2024-01-01 2024-06-30 0001421636 2024-08-14 0001421636 2024-06-30 0001421636 2023-12-31 0001421636 cbnt:SeriesBConvertiblePreferredStockMember 2024-06-30 0001421636 cbnt:SeriesBConvertiblePreferredStockMember 2023-12-31 0001421636 cbnt:SeriesCConvertiblePreferredStockMember 2024-06-30 0001421636 cbnt:SeriesCConvertiblePreferredStockMember 2023-12-31 0001421636 2024-04-01 2024-06-30 0001421636 2023-04-01 2023-06-30 0001421636 2023-01-01 2023-06-30 0001421636 us-gaap:CommonStockMember 2023-12-31 0001421636 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001421636 us-gaap:RetainedEarningsMember 2023-12-31 0001421636 us-gaap:NoncontrollingInterestMember 2023-12-31 0001421636 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001421636 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001421636 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001421636 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001421636 2024-01-01 2024-03-31 0001421636 us-gaap:CommonStockMember 2024-03-31 0001421636 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001421636 us-gaap:RetainedEarningsMember 2024-03-31 0001421636 us-gaap:NoncontrollingInterestMember 2024-03-31 0001421636 2024-03-31 0001421636 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001421636 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001421636 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001421636 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001421636 us-gaap:CommonStockMember 2024-06-30 0001421636 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001421636 us-gaap:RetainedEarningsMember 2024-06-30 0001421636 us-gaap:NoncontrollingInterestMember 2024-06-30 0001421636 us-gaap:CommonStockMember 2022-12-31 0001421636 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001421636 us-gaap:RetainedEarningsMember 2022-12-31 0001421636 us-gaap:NoncontrollingInterestMember 2022-12-31 0001421636 2022-12-31 0001421636 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001421636 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001421636 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001421636 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001421636 2023-01-01 2023-03-31 0001421636 us-gaap:CommonStockMember 2023-03-31 0001421636 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001421636 us-gaap:RetainedEarningsMember 2023-03-31 0001421636 us-gaap:NoncontrollingInterestMember 2023-03-31 0001421636 2023-03-31 0001421636 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001421636 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001421636 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001421636 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001421636 us-gaap:CommonStockMember 2023-06-30 0001421636 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001421636 us-gaap:RetainedEarningsMember 2023-06-30 0001421636 us-gaap:NoncontrollingInterestMember 2023-06-30 0001421636 2023-06-30 0001421636 2023-05-08 2023-05-08 0001421636 cbnt:ExchangeAgreementMember 2021-07-22 0001421636 us-gaap:CommonStockMember 2021-07-22 2021-07-22 0001421636 cbnt:OptionPeriodMember 2024-06-30 0001421636 cbnt:AdditionalUnitsMember 2024-06-30 0001421636 cbnt:CBondSystemsLLCMember 2024-06-30 0001421636 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentMember us-gaap:LeaseholdImprovementsMember 2024-06-30 0001421636 srt:MaximumMember us-gaap:PropertyPlantAndEquipmentMember us-gaap:LeaseholdImprovementsMember 2024-06-30 0001421636 us-gaap:PropertyPlantAndEquipmentMember 2024-06-30 0001421636 us-gaap:FiniteLivedIntangibleAssetsMember 2024-06-30 0001421636 2023-01-01 2023-12-31 0001421636 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-06-30 0001421636 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-06-30 0001421636 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-06-30 0001421636 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-06-30 0001421636 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentMember 2024-06-30 0001421636 srt:MaximumMember us-gaap:PropertyPlantAndEquipmentMember 2024-06-30 0001421636 cbnt:PropertyMember 2024-06-30 0001421636 us-gaap:ConvertibleDebtMember 2024-04-01 2024-06-30 0001421636 us-gaap:ConvertibleDebtMember 2023-04-01 2023-06-30 0001421636 us-gaap:ConvertibleDebtMember 2024-01-01 2024-06-30 0001421636 us-gaap:ConvertibleDebtMember 2023-01-01 2023-06-30 0001421636 us-gaap:SeriesBPreferredStockMember 2024-04-01 2024-06-30 0001421636 us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001421636 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-06-30 0001421636 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2024-04-01 2024-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2023-04-01 2023-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-06-30 0001421636 us-gaap:StockOptionMember 2024-01-01 2024-06-30 0001421636 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001421636 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001421636 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001421636 us-gaap:ConvertibleDebtMember 2024-01-01 2024-06-30 0001421636 us-gaap:ConvertibleDebtMember 2023-01-01 2023-06-30 0001421636 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2024-06-30 0001421636 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2024-06-30 0001421636 us-gaap:MachineryAndEquipmentMember 2024-06-30 0001421636 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001421636 srt:MinimumMember us-gaap:OfficeEquipmentMember 2024-06-30 0001421636 srt:MaximumMember us-gaap:OfficeEquipmentMember 2024-06-30 0001421636 us-gaap:OfficeEquipmentMember 2024-06-30 0001421636 us-gaap:OfficeEquipmentMember 2023-12-31 0001421636 srt:MinimumMember us-gaap:VehiclesMember 2024-06-30 0001421636 srt:MaximumMember us-gaap:VehiclesMember 2024-06-30 0001421636 us-gaap:VehiclesMember 2024-06-30 0001421636 us-gaap:VehiclesMember 2023-12-31 0001421636 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2024-06-30 0001421636 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2024-06-30 0001421636 us-gaap:LeaseholdImprovementsMember 2024-06-30 0001421636 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001421636 cbnt:CustomerRelationsMember 2024-06-30 0001421636 us-gaap:NoncompeteAgreementsMember 2024-06-30 0001421636 cbnt:CustomerRelationsMember 2023-12-31 0001421636 us-gaap:NoncompeteAgreementsMember 2023-12-31 0001421636 us-gaap:CustomerRelationshipsMember 2024-06-30 0001421636 us-gaap:CustomerRelationshipsMember 2023-12-31 0001421636 us-gaap:TradeNamesMember 2024-06-30 0001421636 us-gaap:TradeNamesMember 2023-12-31 0001421636 cbnt:MercerStreetGlobalOpportunityFundLLCMember 2021-10-15 0001421636 cbnt:SecuritiesPurchaseAgreementMember 2021-10-15 0001421636 us-gaap:WarrantMember 2021-10-15 2021-10-15 0001421636 cbnt:SecuritiesPurchaseAgreementMember 2021-10-15 2021-10-15 0001421636 cbnt:MercerStreetGlobalOpportunityFundLLCMember 2021-10-15 2021-10-15 0001421636 cbnt:MercerConvertibleDebtMember 2021-10-15 2021-10-15 0001421636 cbnt:MercerConvertibleDebtMember 2024-06-30 0001421636 cbnt:MercerConvertibleDebtMember 2024-01-01 2024-06-30 0001421636 cbnt:ExchangeAgreementMember 2022-04-20 2022-04-20 0001421636 cbnt:MercerConvertibleDebtMember 2022-04-20 0001421636 cbnt:ExchangeAgreementMember 2022-04-20 0001421636 cbnt:SecuritiesPurchaseAgreementMember 2022-04-20 0001421636 cbnt:MercerConvertibleDebtMember 2022-04-20 2022-04-20 0001421636 cbnt:OctoberFifteenTwothousandtwentytwoMember 2022-04-20 0001421636 cbnt:ExchangeAgreementMember 2024-06-30 0001421636 2022-04-20 2022-04-20 0001421636 2022-10-15 0001421636 2022-10-15 2022-10-15 0001421636 cbnt:ExchangeAgreementMember 2022-10-15 2022-10-15 0001421636 cbnt:LetterAgreementMember 2023-12-04 2023-12-04 0001421636 cbnt:LetterAgreementMember 2023-12-04 0001421636 2023-12-04 0001421636 cbnt:MercerStreetGlobalOpportunityFundLLCMember 2024-01-01 2024-06-30 0001421636 2023-12-15 2023-12-15 0001421636 srt:ScenarioForecastMember 2024-09-30 0001421636 srt:ScenarioForecastMember 2024-12-31 0001421636 cbnt:MercerConvertibleDebtMember 2023-12-31 0001421636 cbnt:MercerConvertibleDebtMember 2024-01-01 2024-06-30 0001421636 cbnt:MercerConvertibleDebtMember 2023-01-01 2023-12-31 0001421636 2022-09-06 2022-09-06 0001421636 cbnt:MercerConvertibleDebtMember 2022-04-30 0001421636 2022-04-30 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2022-11-09 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2022-11-09 2022-11-09 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2024-05-04 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2022-12-27 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2022-12-27 2022-12-27 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2024-06-27 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2023-03-17 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2023-03-17 2023-03-17 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2024-03-17 0001421636 2022-11-30 0001421636 cbnt:MercerConvertibleDebtMember 2023-03-31 0001421636 2023-05-11 0001421636 2023-05-11 2023-05-11 0001421636 cbnt:MercerConvertibleDebtMember 2023-06-30 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2024-01-01 2024-06-30 0001421636 cbnt:DiagonalLendingConvertiblesDebtMember 2023-01-01 2023-12-31 0001421636 us-gaap:ConvertibleNotesPayableMember 2024-06-30 0001421636 cbnt:MaximumLoanAmountMember 2018-11-14 0001421636 cbnt:BOCOInvestmentNoteMember 2018-11-14 0001421636 cbnt:BOCOInvestmentNoteMember 2018-11-14 2018-11-14 0001421636 cbnt:DebtExchangeAndReleaseAgreementMember cbnt:LenderMember 2023-05-31 0001421636 cbnt:DebtExchangeAndReleaseAgreementMember 2023-05-31 2023-05-31 0001421636 cbnt:DebtExchangeAndReleaseAgreementMember 2023-05-31 0001421636 cbnt:ReleaseAgreementMember 2023-05-31 2023-05-31 0001421636 cbnt:LenderMember 2023-05-31 2023-05-31 0001421636 cbnt:LenderMember 2023-05-31 0001421636 us-gaap:ConvertibleNotesPayableMember 2023-05-31 2023-05-31 0001421636 us-gaap:ConvertibleNotesPayableMember 2023-05-31 0001421636 2023-05-31 0001421636 2023-05-31 2023-05-31 0001421636 cbnt:GSCapitalNoteMember 2024-06-30 0001421636 cbnt:GSCapitalNoteMember 2023-12-31 0001421636 cbnt:March2022NoteMember 2022-03-14 0001421636 cbnt:March2022NoteMember 2022-03-14 2022-03-14 0001421636 cbnt:March2022NoteMember 2024-06-30 0001421636 cbnt:March2022NoteMember 2023-12-31 0001421636 cbnt:November2022NoteMember 2022-11-22 0001421636 cbnt:November2022NoteMember 2022-11-22 2022-11-22 0001421636 cbnt:November2022NoteMember 2024-06-30 0001421636 cbnt:November2022NoteMember 2023-12-31 0001421636 cbnt:November2022NoteMember 2023-05-31 2023-05-31 0001421636 cbnt:SecuritiesPurchaseAgreementMember cbnt:GSCapitalJuly2022NoteMember 2022-06-23 0001421636 2022-06-23 2022-06-23 0001421636 cbnt:GSCapitalJune2022Member 2022-06-23 0001421636 cbnt:March2022NoteMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001421636 cbnt:GSCapitalJune2022Member 2022-01-01 2022-12-31 0001421636 cbnt:GSCapitalJune2022Member 2023-01-01 2023-12-31 0001421636 us-gaap:CommonStockMember 2023-04-01 2023-04-01 0001421636 us-gaap:CommonStockMember 2023-05-01 2023-05-01 0001421636 cbnt:GSCapitalNoteMember us-gaap:CommonStockMember 2023-04-01 2023-04-01 0001421636 cbnt:GSCapitalNoteMember us-gaap:CommonStockMember 2023-05-01 2023-05-01 0001421636 cbnt:GSCapitalDebtMember 2023-04-01 2023-04-01 0001421636 cbnt:GSCapitalDebtMember 2023-05-01 2023-05-01 0001421636 2023-04-01 2023-04-01 0001421636 2023-05-01 2023-05-01 0001421636 cbnt:GSCapitalDebtMember 2024-06-30 0001421636 cbnt:GSCapitalDebtMember 2023-12-31 0001421636 cbnt:GSCapitalDebtMember 2022-07-26 0001421636 2022-07-26 2022-07-26 0001421636 cbnt:SecuritiesPurchaseAgreementMember 2022-07-26 0001421636 cbnt:July2022CommitmentSharesMember 2022-01-01 2022-12-31 0001421636 2022-01-01 2022-12-31 0001421636 cbnt:July2022CommitmentSharesMember cbnt:GSCapitalJuly2022NoteMember 2022-12-31 0001421636 cbnt:GSCapitalDebtMember 2022-07-26 2022-07-26 0001421636 cbnt:GSCapitalNoteMember 2023-05-31 2023-05-31 0001421636 cbnt:GSCapitalJuly2022NoteMember 2024-06-30 0001421636 cbnt:GSCapitalJuly2022NoteMember 2023-12-31 0001421636 cbnt:September2022NoteMember 2022-09-06 2022-09-06 0001421636 cbnt:September2022AgreementMember cbnt:September2022CommitmentSharesMember 2022-09-06 0001421636 cbnt:September2022CommitmentSharesMember 2022-01-01 2022-12-31 0001421636 cbnt:PlacementAgentMember 2022-01-01 2022-12-31 0001421636 cbnt:SecuritiesPurchaseAgreementMember 2022-12-31 0001421636 cbnt:GSCapitalDebtMember 2022-09-06 2022-09-06 0001421636 cbnt:GSCapitalSeptemberTwoThousanTwentyTwoMember 2024-01-01 2024-06-30 0001421636 cbnt:GSCapitalSeptemberTwoThousanTwentyTwoMember 2023-01-01 2023-12-31 0001421636 cbnt:GSCapitalDebtMember 2024-01-01 2024-06-30 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-03-01 2024-03-01 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-03-01 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-03-04 0001421636 2024-03-04 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-03-04 2024-03-04 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-04-08 2024-04-08 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-04-10 0001421636 2024-04-10 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-04-08 0001421636 2024-04-08 2024-04-08 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-01-01 2024-06-30 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2023-01-01 2023-12-31 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member 2024-06-05 2024-06-05 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member 2024-06-05 0001421636 2024-06-05 2024-06-05 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member 2024-01-01 2024-06-30 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member 2023-01-01 2023-12-31 0001421636 cbnt:PromissoryNoteMember 2021-05-10 0001421636 cbnt:VehicleAndEquipmentLoansMember 2021-07-22 0001421636 srt:MinimumMember cbnt:PatriotGlassMember 2021-07-22 0001421636 srt:MaximumMember cbnt:PatriotGlassMember 2021-07-22 0001421636 cbnt:VehicleAndEquipmentLoansMember 2024-06-30 0001421636 cbnt:VehicleAndEquipmentLoansMember 2023-12-31 0001421636 cbnt:November2022NoteMember 2022-11-08 0001421636 2022-11-08 2022-11-08 0001421636 cbnt:VehicleAndEquipmentLoansMember cbnt:OtherNotesPayableMember 2023-12-31 0001421636 srt:MinimumMember cbnt:VehicleAndEquipmentLoansMember 2023-12-31 0001421636 srt:MaximumMember cbnt:VehicleAndEquipmentLoansMember 2023-12-31 0001421636 cbnt:VehicleAndEquipmentLoansMember cbnt:OtherNotesPayableMember 2024-06-30 0001421636 cbnt:OtherNotesPayableMember 2024-06-30 0001421636 cbnt:February2024NoteMember 2024-02-21 0001421636 cbnt:February2024NoteMember 2024-02-21 2024-02-21 0001421636 cbnt:February2024NoteMember cbnt:PatriotGlassMember 2024-02-21 0001421636 cbnt:February2024NoteMember 2024-01-01 2024-06-30 0001421636 cbnt:June2024MerchantLoanMember 2024-06-17 0001421636 cbnt:June2024MerchantLoanMember 2024-06-17 2024-06-17 0001421636 cbnt:June2024MerchantLoanMember cbnt:PatriotGlassMember 2024-06-17 0001421636 cbnt:June2024MerchantLoanMember 2024-01-01 2024-06-30 0001421636 cbnt:PPPNoteMember 2020-04-28 0001421636 cbnt:PPPNoteMember 2020-04-28 2020-04-28 0001421636 cbnt:PPPNoteMember 2020-11-01 2020-11-01 0001421636 cbnt:PPPNoteMember 2021-11-04 2021-11-04 0001421636 cbnt:PPPNoteMember 2024-01-01 2024-06-30 0001421636 cbnt:PPPNoteMember 2024-06-30 0001421636 srt:MaximumMember cbnt:PPPNoteMember 2024-06-30 0001421636 srt:MinimumMember cbnt:PPPNoteMember 2023-12-31 0001421636 cbnt:PPPNoteMember 2023-12-31 0001421636 us-gaap:NotesPayableOtherPayablesMember 2024-06-30 0001421636 us-gaap:NotesPayableOtherPayablesMember 2023-12-31 0001421636 cbnt:August302024Member cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-06-30 0001421636 cbnt:September302024Member cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-06-30 0001421636 cbnt:October302024Member cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-06-30 0001421636 cbnt:November302024Member cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-06-30 0001421636 cbnt:December302024Member cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-06-30 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member 2024-06-30 0001421636 cbnt:August152024Member cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-06-30 0001421636 cbnt:September152024ThroughFebruary152025Member cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-06-30 0001421636 cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member 2024-06-30 0001421636 cbnt:PPPLoanMember 2024-06-30 0001421636 us-gaap:SeriesBPreferredStockMember 2019-12-12 0001421636 us-gaap:SeriesBPreferredStockMember 2024-06-30 0001421636 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001421636 srt:BoardOfDirectorsChairmanMember us-gaap:SeriesBPreferredStockMember 2023-01-17 0001421636 us-gaap:SeriesBPreferredStockMember 2023-01-17 0001421636 srt:BoardOfDirectorsChairmanMember us-gaap:SeriesBPreferredStockMember 2024-01-02 0001421636 us-gaap:SeriesBPreferredStockMember 2024-01-02 0001421636 us-gaap:SeriesBPreferredStockMember 2024-01-02 2024-01-02 0001421636 srt:BoardOfDirectorsChairmanMember us-gaap:SeriesBPreferredStockMember 2024-01-02 2024-01-02 0001421636 us-gaap:CommonStockMember 2024-01-02 0001421636 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember 2024-01-02 2024-01-02 0001421636 2024-01-02 0001421636 2024-01-02 2024-01-02 0001421636 us-gaap:CommonStockMember 2024-01-02 2024-01-02 0001421636 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember 2024-01-02 0001421636 srt:BoardOfDirectorsChairmanMember us-gaap:SeriesBPreferredStockMember 2024-02-08 2024-02-08 0001421636 cbnt:SeriesBConvertiblePreferredStockMember 2024-02-08 0001421636 us-gaap:SeriesBPreferredStockMember 2024-02-08 0001421636 us-gaap:SeriesBPreferredStockMember 2024-02-08 2024-02-08 0001421636 srt:ChiefExecutiveOfficerMember us-gaap:SeriesBPreferredStockMember 2024-05-20 2024-05-20 0001421636 us-gaap:SeriesBPreferredStockMember 2024-05-20 0001421636 us-gaap:SeriesBPreferredStockMember 2024-05-20 2024-05-20 0001421636 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001421636 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-12-31 0001421636 us-gaap:SeriesCPreferredStockMember 2020-08-20 0001421636 us-gaap:SeriesCPreferredStockMember 2024-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2021-04-28 2021-04-28 0001421636 us-gaap:SeriesCPreferredStockMember 2023-03-31 0001421636 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001421636 us-gaap:SeriesCPreferredStockMember 2023-06-30 0001421636 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2023-09-30 0001421636 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001421636 us-gaap:SeriesCPreferredStockMember 2024-02-01 0001421636 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-02-01 2024-02-01 0001421636 us-gaap:SeriesCPreferredStockMember 2024-03-01 0001421636 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2024-03-01 0001421636 2024-03-01 0001421636 2024-05-01 0001421636 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-05-01 2024-05-01 0001421636 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001421636 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-12-31 0001421636 cbnt:SubscriptionAgreementsMember 2023-01-17 2023-01-17 0001421636 2023-01-17 0001421636 cbnt:CommonStockIssuedForCashAndAccruedCompensationMember 2023-01-17 0001421636 2023-01-17 2023-01-17 0001421636 cbnt:MrSilvermanMember 2023-01-17 0001421636 cbnt:InvestorRelationsServicesMember 2023-01-17 2023-01-17 0001421636 cbnt:InvestorRelationsServicesMember 2023-01-17 0001421636 2023-02-06 0001421636 2023-02-06 2023-02-06 0001421636 2023-04-03 0001421636 2023-04-03 2023-04-03 0001421636 2023-06-03 0001421636 2023-06-03 2023-06-03 0001421636 cbnt:IssuanceOfCommonStockForServicesMember 2024-06-30 0001421636 cbnt:IssuanceOfCommonStockForServicesMember 2023-06-30 0001421636 us-gaap:CommonStockMember 2023-06-07 2023-06-07 0001421636 us-gaap:CommonStockMember 2023-06-07 0001421636 cbnt:CommonStockForfeitedMember 2024-02-08 2024-02-08 0001421636 cbnt:CommonStockForfeitedMember 2024-02-08 0001421636 cbnt:ReleaseAgreementMember 2023-05-01 2023-05-01 0001421636 cbnt:ReleaseAgreementMember 2023-05-31 0001421636 cbnt:LenderMember us-gaap:ConvertibleNotesPayableMember 2023-05-31 2023-05-31 0001421636 us-gaap:SeriesCPreferredStockMember 2024-05-01 0001421636 us-gaap:PreferredStockMember 2024-05-01 2024-05-01 0001421636 cbnt:TwoThousandEighteenLongTermIncentivePlanMember 2024-01-01 2024-06-30 0001421636 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001421636 us-gaap:SeriesBPreferredStockMember 2023-06-30 0001421636 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001421636 us-gaap:EmployeeStockOptionMember 2023-12-31 0001421636 us-gaap:EmployeeStockOptionMember 2023-12-31 2023-12-31 0001421636 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001421636 us-gaap:EmployeeStockOptionMember 2024-06-30 0001421636 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001421636 us-gaap:WarrantMember us-gaap:WarrantMember 2023-12-31 0001421636 us-gaap:WarrantMember us-gaap:WarrantMember 2023-12-31 2023-12-31 0001421636 us-gaap:WarrantMember us-gaap:WarrantMember 2023-12-30 0001421636 us-gaap:WarrantMember us-gaap:WarrantMember 2024-01-01 2024-06-30 0001421636 us-gaap:WarrantMember us-gaap:WarrantMember 2024-06-30 0001421636 srt:RestatementAdjustmentMember 2020-01-01 2020-12-31 0001421636 srt:MaximumMember 2024-01-01 2024-06-30 0001421636 srt:MinimumMember 2024-01-01 2024-06-30 0001421636 srt:ChiefExecutiveOfficerMember 2024-06-30 0001421636 srt:ChiefExecutiveOfficerMember us-gaap:SeriesBPreferredStockMember 2024-05-31 0001421636 srt:ChiefExecutiveOfficerMember 2024-05-31 0001421636 2024-05-31 0001421636 2024-05-31 2024-05-31 0001421636 2024-02-08 2024-02-08 0001421636 cbnt:FormerConsultantMember 2023-01-01 2023-12-31 0001421636 2017-10-18 0001421636 cbnt:SilvermanMember 2017-10-18 0001421636 cbnt:SilvermanMember cbnt:EmploymenAgreementsMember 2018-04-25 2018-04-25 0001421636 cbnt:SilvermanMember cbnt:EmploymenAgreementsMember 2024-01-01 2024-06-30 0001421636 cbnt:SilvermanMember cbnt:EmploymenAgreementsMember 2024-06-30 0001421636 2021-07-21 2021-07-21 0001421636 srt:BoardOfDirectorsChairmanMember 2023-12-07 2023-12-07 0001421636 cbnt:SilvermanMember 2023-01-01 2023-12-31 0001421636 cbnt:EquityMethodInvestmentOwnershipMember 2023-12-31 0001421636 cbnt:SilvermanMember 2023-12-31 0001421636 cbnt:EquityMethodInvestmentOwnershipMember cbnt:EmploymenAgreementsMember 2023-12-31 0001421636 srt:ChiefExecutiveOfficerMember 2023-12-31 0001421636 cbnt:MsTomekMember 2023-12-31 0001421636 us-gaap:PropertyPlantAndEquipmentMember 2023-12-31 0001421636 cbnt:EquityMethodInvestmentOwnershipMember cbnt:MsTomekMember 2023-12-31 0001421636 cbnt:SubscriptionAgreementsMember 2013-12-31 2013-12-31 0001421636 cbnt:SubscriptionAgreementsMember 2015-12-31 2015-12-31 0001421636 cbnt:CBondSystemsLLCMember cbnt:SubscriptionAgreementsMember 2015-12-31 0001421636 cbnt:SubscriptionAgreementsMember 2015-12-31 0001421636 cbnt:SubscriptionAgreementsMember 2016-12-31 2016-12-31 0001421636 cbnt:SubscriptionAgreementsMember 2016-12-31 0001421636 srt:MinimumMember cbnt:SubscriptionAgreementsMember 2016-12-31 0001421636 2016-12-31 2016-12-31 0001421636 cbnt:OptionToPurchaseTwentyPercentageOfMobileTintMember 2024-01-01 2024-06-30 0001421636 cbnt:OptionToPurchaseTwentyPercentageOfPatriotGlassMember 2023-07-01 2023-07-01 0001421636 2023-07-01 0001421636 2023-10-18 2023-10-18 0001421636 cbnt:CurtisStoutIncMember 2023-10-18 2023-10-18 0001421636 cbnt:MAAdvisoryAgreementMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerOneMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerTwoMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001421636 cbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerFiveMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001421636 cbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001421636 cbnt:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001421636 cbnt:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001421636 cbnt:CBondMember 2024-04-01 2024-06-30 0001421636 cbnt:CBondMember 2023-04-01 2023-06-30 0001421636 cbnt:CBondMember 2024-01-01 2024-06-30 0001421636 cbnt:CBondMember 2023-01-01 2023-06-30 0001421636 cbnt:PatriotGlassMember 2024-04-01 2024-06-30 0001421636 cbnt:PatriotGlassMember 2023-04-01 2023-06-30 0001421636 cbnt:PatriotGlassMember 2024-01-01 2024-06-30 0001421636 cbnt:PatriotGlassMember 2023-01-01 2023-06-30 0001421636 us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001421636 us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001421636 us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001421636 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001421636 cbnt:CBondMember 2024-06-30 0001421636 cbnt:CBondMember 2023-12-31 0001421636 cbnt:PatriotGlassMember 2024-06-30 0001421636 cbnt:PatriotGlassMember 2023-12-31 0001421636 cbnt:CBondSecureMultipurposeAndBRSBallisticResistantGlassProtectionSystemsMember 2024-01-01 2024-06-30 0001421636 cbnt:CBondSecureMultipurposeAndBRSBallisticResistantGlassProtectionSystemsMember 2023-01-01 2023-06-30 0001421636 cbnt:CBondNanoshieldSolutionSalesMember 2024-01-01 2024-06-30 0001421636 cbnt:CBondNanoshieldSolutionSalesMember 2023-01-01 2023-06-30 0001421636 cbnt:WindowTintInstallationAndSalesRecognizedOverTimeMember 2024-01-01 2024-06-30 0001421636 cbnt:WindowTintInstallationAndSalesRecognizedOverTimeMember 2023-01-01 2023-06-30 0001421636 cbnt:FreightAndDeliveryMember 2024-01-01 2024-06-30 0001421636 cbnt:FreightAndDeliveryMember 2023-01-01 2023-06-30 0001421636 2019-10-31 0001421636 2019-12-01 2020-11-30 0001421636 2020-12-01 2021-05-31 0001421636 2022-05-31 0001421636 2022-05-31 2022-05-31 0001421636 cbnt:MDWManagementLLCMember srt:MaximumMember 2024-06-30 0001421636 cbnt:MDWManagementLLCMember srt:MinimumMember 2024-06-30 0001421636 2021-09-30 2021-09-30 0001421636 2022-02-28 2022-02-28 0001421636 us-gaap:RelatedPartyMember 2024-05-08 2024-05-08 0001421636 srt:ChiefExecutiveOfficerMember us-gaap:RelatedPartyMember 2024-05-08 2024-05-08 0001421636 us-gaap:RelatedPartyMember 2024-05-08 0001421636 us-gaap:RelatedPartyMember us-gaap:SeriesBPreferredStockMember 2024-05-08 0001421636 us-gaap:RelatedPartyMember us-gaap:SeriesBPreferredStockMember 2024-05-31 2024-05-31 0001421636 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001421636 us-gaap:RelatedPartyMember 2023-03-31 0001421636 2022-05-02 2022-05-02 0001421636 us-gaap:RelatedPartyMember 2024-06-30 0001421636 us-gaap:RelatedPartyMember us-gaap:SeriesBPreferredStockMember 2024-06-30 0001421636 us-gaap:RelatedPartyMember us-gaap:SeriesBPreferredStockMember 2023-05-31 2023-05-31 0001421636 us-gaap:RelatedPartyMember 2023-05-31 0001421636 2023-03-08 2023-03-08 0001421636 cbnt:BOCOInvestmentsLLCMember 2024-06-30 0001421636 cbnt:BOCOInvestmentsLLCMember 2024-01-01 2024-06-30 0001421636 cbnt:BOCOInvestmentsLLCMember us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001421636 cbnt:GSCapitalPartnersLLCMember 2022-06-23 2022-06-23 0001421636 cbnt:GSCapitalPartnersLLCMember 2022-07-26 2022-07-26 0001421636 cbnt:GSCapitalPartnersLLCMember 2022-09-06 2022-09-06 0001421636 cbnt:MercerStreetGlobalOpportunityFundLLCMember 2022-03-14 2022-03-14 0001421636 cbnt:MercerStreetGlobalOpportunityFundLLCMember 2022-11-22 2022-11-22 0001421636 cbnt:JeffBaddersMember 2021-05-05 2021-05-05 0001421636 cbnt:JeffBaddersMember 2022-11-08 2022-11-08 0001421636 cbnt:JeffBaddersMember 2023-04-04 2023-04-04 0001421636 cbnt:DiagonalLendingLLCMember 2022-11-04 2022-11-04 0001421636 cbnt:DiagonalLendingLLCMember 2022-12-27 2022-12-27 0001421636 cbnt:DiagonalLendingLLCMember 2023-03-17 2023-03-17 0001421636 cbnt:CEOMember 2022-05-02 2022-05-02 0001421636 us-gaap:SubsequentEventMember 2024-07-31 0001421636 us-gaap:SubsequentEventMember 2024-07-31 2024-07-31 0001421636 srt:ScenarioForecastMember us-gaap:SeriesCPreferredStockMember 2024-08-31 0001421636 srt:ScenarioForecastMember us-gaap:SeriesCPreferredStockMember 2024-08-01 2024-08-31 0001421636 srt:ScenarioForecastMember 2024-08-01 2024-08-31 0001421636 srt:ScenarioForecastMember cbnt:PromissoryNoteMember 2024-08-01 2024-08-31 0001421636 cbnt:PromissoryNoteMember us-gaap:SubsequentEventMember 2024-08-31 0001421636 us-gaap:SubsequentEventMember 2024-08-01 2024-08-31 0001421636 us-gaap:SubsequentEventMember 2024-08-15 2024-08-15 0001421636 cbnt:PromissoryNoteMember 2024-01-01 2024-06-30 0001421636 cbnt:PromissoryNoteMember us-gaap:SubsequentEventMember 2024-08-15 0001421636 2024-04-01 2024-04-30 0001421636 us-gaap:SubsequentEventMember 2024-08-15 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure cbnt:segments

Exhibit 31.1

 

CERTIFICATIONS

 

I, Scott R. Silverman, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2024 of C-Bond Systems, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

  

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 19, 2024 /s/ Scott R. Silverman
  Scott R. Silverman
  Chief Executive Officer (principal executive officer)

 

Exhibit 31.2

 

CERTIFICATIONS

 

I, Scott R. Silverman, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2024 of C-Bond Systems, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

  

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 19, 2024 /s/ Scott R. Silverman
  Scott R. Silverman
  Chief Financial Officer (principal financial officer)

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of C-Bond Systems, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), and pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, as amended, I, Scott R. Silverman, Chief Executive Officer and Chief Financial Officer, certify to the best of my knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

Date: August 19, 2024 /s/ Scott R. Silverman
  Scott R. Silverman
  Chief Executive Officer and
Chief Financial Officer
(principal executive officer and
principal financial officer)

 

v3.24.2.u1
Cover - shares
6 Months Ended
Jun. 30, 2024
Aug. 14, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Entity Information [Line Items]    
Entity Registrant Name C-BOND SYSTEMS, INC.  
Entity Central Index Key 0001421636  
Entity File Number 000-53029  
Entity Tax Identification Number 26-1315585  
Entity Incorporation, State or Country Code CO  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 2029 Pat Booker Rd  
Entity Address, City or Town San Antonio  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78148  
Entity Phone Fax Numbers [Line Items]    
City Area Code 210  
Local Phone Number 490-3977  
Entity Listings [Line Items]    
Title of 12(b) Security N/A  
No Trading Symbol Flag true  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   550,503,623
v3.24.2.u1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash $ 196,315 $ 736,461
Accounts receivable, net 243,369 424,091
Inventory 162,052 181,663
Prepaid expenses and other current assets 107,807 28,503
Due from related party 71,961
Contract assets 59,856 2,400
Total Current Assets 841,360 1,373,118
OTHER ASSETS:    
Property and equipment, net 147,842 171,606
Right of use asset, net 128,722 158,484
Intangible asset, net 204,163 229,414
Goodwill 350,491 350,491
Total Other Assets 831,218 909,995
TOTAL ASSETS 1,672,578 2,283,113
CURRENT LIABILITIES:    
Convertible note payable - current portion 180,000 180,000
Notes payable, net of discount - current portion 474,014 81,908
Accounts payable 798,827 710,222
Accrued expenses 390,258 474,515
Accrued compensation 54,462 717,204
Contract liabilities 148,784 500,720
Lease liabilities, current portion 60,773 60,503
Total Current Liabilities 2,107,118 2,725,072
LONG-TERM LIABILITIES:    
Convertible notes payable, net of current portion 828,091 918,091
Notes payable, net of current portion and discount 33,477 42,109
Lease liabilities, net of current portion 67,949 97,249
Total Long-term Liabilities 929,517 1,057,449
Total Liabilities 3,036,635 3,782,521
Commitments and Contingencies (See Note 10)
SHAREHOLDERS’ DEFICIT:    
Preferred stock: $0.10 par value, 2,000,000 shares authorized; 100,000 Series B and 100,000 Series C designated, no shares issued and outstanding
Common stock: $0.001 par value, 4,998,000,000 shares authorized; 545,253,623 and 532,818,051 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 545,254 532,818
Additional paid-in capital 56,561,018 55,852,477
Accumulated deficit (61,447,146) (60,851,714)
Total C-Bond Systems, Inc. shareholders’ deficit (4,340,874) (4,466,419)
Noncontrolling interest 155,601 141,884
Total Shareholders’ Deficit (4,185,273) (4,324,535)
Total Liabilities and Shareholders’ Deficit 1,672,578 2,283,113
Series B Convertible Preferred Stock    
LONG-TERM LIABILITIES:    
Convertible preferred stock value 1,245,313 1,203,967
Series C Convertible Preferred Stock    
LONG-TERM LIABILITIES:    
Convertible preferred stock value $ 1,575,903 $ 1,621,160
v3.24.2.u1
Consolidated Balance Sheets (Parentheticals) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Preferred stock, par value (in Dollars per share) $ 0.1 $ 0.1
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares designated 100,000 100,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 4,998,000,000 4,998,000,000
Common stock, shares issued 545,253,623 532,818,051
Common stock, shares outstanding 545,253,623 532,818,051
Series B Convertible Preferred Stock    
Convertible preferred stock, par value (in Dollars per share) $ 0.1 $ 0.1
Convertible preferred stock, shares designated 100,000 100,000
Convertible preferred stock, shares issued 1,189 1,144
Convertible preferred stock, shares outstanding 1,189 1,144
Share redemption and liquidation value (in Dollars) $ 1,245,313
Series C Convertible Preferred Stock    
Convertible preferred stock, par value (in Dollars per share) $ 0.1 $ 0.1
Convertible preferred stock, shares designated 100,000 100,000
Convertible preferred stock, shares issued 14,750 15,150
Convertible preferred stock, shares outstanding 14,750 15,150
Share redemption and liquidation value (in Dollars) $ 2,363,855
v3.24.2.u1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
SALES $ 863,533 $ 414,055 $ 1,800,337 $ 929,275
COST OF SALES (excluding depreciation expense) 424,959 209,071 886,888 454,431
GROSS PROFIT 438,574 204,984 913,449 474,844
OPERATING EXPENSES:        
Compensation and related benefits (including stock-based compensation of $0 and $30,046 for the three months ended June 30, 2024 and 2023, and $376,968 and $42,183 for the six months ended June 30, 2024 and 2023, respectively) (373,548) (441,181) (1,152,667) (868,053)
Professional fees (88,030) (193,263) (229,614) (380,953)
General and administrative expenses (169,357) (142,404) (365,048) (321,304)
Total Operating Expenses (630,935) (776,848) (1,747,329) (1,570,310)
OTHER OPERATING INCOME:        
Gain on sale of product line 4,051,709 4,051,709
(LOSS) INCOME FROM OPERATIONS (192,361) 3,479,845 (833,880) 2,956,243
OTHER INCOME (EXPENSES):        
Gain on debt extinguishment, net 462,581 347,990 462,581
Interest expense (53,608) (166,189) (67,727) (361,975)
Interest expense - related party (1,964) (5,663)
Total Other Income (Expenses), net (53,608) 294,428 280,263 94,943
NET (LOSS) INCOME BEFORE NONCONTROLLING INTEREST (245,969) 3,774,273 (553,617) 3,051,186
Net (income) loss of subsidiary attributable to noncontrolling interest (4,207) 18,640 (13,717) 35,362
Preferred stock dividend (13,749) (13,618) (28,098) (27,305)
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (263,925) $ 3,779,295 $ (595,432) $ 3,059,243
NET (LOSS) INCOME PER COMMON SHARE:        
Basic (in Dollars per share) $ 0 $ 0.01 $ 0 $ 0.01
Diluted (in Dollars per share) $ 0 $ 0 $ 0 $ 0
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic (in Shares) 543,165,027 493,056,689 539,431,386 458,283,435
Diluted (in Shares) 543,165,027 2,349,380,186 539,431,386 2,314,606,932
v3.24.2.u1
Consolidated Statements of Operations (Unaudited) (Parentheticals) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Stock-based compensation $ 0 $ 30,046 $ 376,968 $ 42,183
v3.24.2.u1
Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2022 $ 350,270 $ 55,141,503 $ (62,693,184) $ 150,742 $ (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Common stock issued for cash and accrued compensation $ 54,545 245,455 300,000
Common stock issued for cash and accrued compensation (in Shares) 54,545,455        
Common stock issued for professional fees $ 6,667 33,333 40,000
Common stock issued for professional fees (in Shares) 6,666,667        
Common stock issued for accrued compensation $ 9,636 43,364 53,000
Common stock issued for accrued compensation (in Shares) 9,636,364        
Common stock issued for conversion of Series C preferred stock $ 26,586 74,814 101,400
Common stock issued for conversion of Series C preferred stock (in Shares) 26,585,614        
Preferred stock dividends and deemed dividend (13,687) (13,687)
Accretion of stock-based compensation 12,137 12,137
Net income (loss) (706,365) (16,722) (723,087)
Balance at Mar. 31, 2023 $ 447,704 55,550,606 (63,413,236) 134,020 (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272        
Balance at Dec. 31, 2022 $ 350,270 55,141,503 (62,693,184) 150,742 (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Net income (loss)         3,051,186
Balance at Jun. 30, 2023 $ 523,234 55,827,561 (59,633,941) 115,380 (3,167,766)
Balance (in Shares) at Jun. 30, 2023 523,233,675        
Balance at Mar. 31, 2023 $ 447,704 55,550,606 (63,413,236) 134,020 (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272        
Common stock issued for professional fees $ 6,500 32,950 39,450
Common stock issued for professional fees (in Shares) 6,500,000        
Common stock issued for compensation $ 2,500 23,500   26,000
Common stock issued for compensation (in Shares) 2,500,000        
Common stock issued for conversion of Series C preferred stock $ 23,158 59,442 82,600
Common stock issued for conversion of Series C preferred stock (in Shares) 23,157,922        
Common stock issued for conversion of debt, accrued interest and fees $ 43,372 157,017 200,389
Common stock issued for conversion of debt, accrued interest and fees (in Shares) 43,371,481        
Preferred stock dividends and deemed dividend (13,618) (13,618)
Accretion of stock-based compensation 4,046 4,046
Net income (loss) 3,792,913 (18,640) 3,774,273
Balance at Jun. 30, 2023 $ 523,234 55,827,561 (59,633,941) 115,380 (3,167,766)
Balance (in Shares) at Jun. 30, 2023 523,233,675        
Balance at Dec. 31, 2023 $ 532,818 55,852,477 (60,851,714) 141,884 (4,324,535)
Balance (in Shares) at Dec. 31, 2023 532,818,051        
Common stock issued for conversion of Series C preferred stock $ 11,555 28,445 40,000
Common stock issued for conversion of Series C preferred stock (in Shares) 11,554,535        
Cancellation of Series B preferred shares $ (5,250) 132,890 127,640
Cancellation of Series B preferred shares (in Shares) (5,250,000)        
Preferred stock dividends and deemed dividend (14,349) (14,349)
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 326,968 326,968
Net income (loss) (317,158) 9,510 (307,648)
Balance at Mar. 31, 2024 $ 539,123 56,340,780 (61,183,221) 151,394 (4,151,924)
Balance (in Shares) at Mar. 31, 2024 539,122,586        
Balance at Dec. 31, 2023 $ 532,818 55,852,477 (60,851,714) 141,884 (4,324,535)
Balance (in Shares) at Dec. 31, 2023 532,818,051        
Net income (loss)         (553,617)
Balance at Jun. 30, 2024 $ 545,254 56,561,018 (61,447,146) 155,601 (4,185,273)
Balance (in Shares) at Jun. 30, 2024 545,253,623        
Balance at Mar. 31, 2024 $ 539,123 56,340,780 (61,183,221) 151,394 (4,151,924)
Balance (in Shares) at Mar. 31, 2024 539,122,586        
Common stock issued for conversion of Series C preferred stock $ 6,131 13,869 20,000
Common stock issued for conversion of Series C preferred stock (in Shares) 6,131,037        
Cancellation of Series B preferred shares 206,369 206,369
Preferred stock dividends and deemed dividend (13,749) (13,749)
Net income (loss) (250,176) 4,207 (245,969)
Balance at Jun. 30, 2024 $ 545,254 $ 56,561,018 $ (61,447,146) $ 155,601 $ (4,185,273)
Balance (in Shares) at Jun. 30, 2024 545,253,623        
v3.24.2.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (553,617) $ 3,051,186
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization expense 49,015 41,395
Amortization of debt discount to interest expense 22,459 95,922
Interest expense for put premium on convertible notes 29,212
Non-cash interest expense from fees on debt conversion 2,250
Stock-based compensation 376,968 42,183
Stock-based professional fees 97,817
Non-cash gain on debt extinguishment (347,990) (462,581)
Gain from sale of nanoShield product line (4,051,709)
Lease costs 732 660
Non-cash compensation claw back (21,961)
Bad debt expense 25,833
Change in operating assets and liabilities:    
Accounts receivable 154,889 188,934
Inventory 19,611 (51,196)
Prepaid expenses and other assets (79,304) (15,434)
Contract assets (57,456) (52,487)
Due from related party (50,000)
Accounts payable 88,605 (50,027)
Accrued expenses (84,257) 8,040
Accrued interest - related party 5,663
Accrued compensation (3,645) 49,812
Contract liabilities (351,936) 157,363
NET CASH USED IN OPERATING ACTIVITIES (812,054) (912,997)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of nanoShield product line 4,042,631
NET CASH PROVIDED BY INVESTING ACTIVITIES 4,042,631
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock 275,000
Proceeds from notes payable 405,550 175,000
Repayment of notes payable (43,642) (1,792,448)
Repayment of note payable - related party (200,000)
Proceeds from convertible notes payable 50,000
Repayment of convertible notes payable (90,000) (222,750)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 271,908 (1,715,198)
NET (DECREASE) INCREASE IN CASH (540,146) 1,414,436
CASH, beginning of period 736,461 97,091
CASH, end of period 196,315 1,511,527
Cash paid for:    
Interest 26,561 199,122
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Common stock issued as prepaid for services 79,450
Common stock issued for accrued compensation 78,000
Series B preferred stock issued for accrued compensation 312,000 144,000
Preferred stock dividend accrued 28,098 27,305
Conversion of Series C preferred stock to common stock 60,000 184,000
Conversion of notes payable to common stock 194,000
Reclassification of Series B preferred stock to additional paid-in capital $ 334,009
v3.24.2.u1
Nature of Organization
6 Months Ended
Jun. 30, 2024
Nature of Organization [Abstract]  
NATURE OF ORGANIZATION

NOTE 1 – NATURE OF ORGANIZATION

 

Nature of Organization

 

C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and owner and developer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Prior to May 8, 2023, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™. Since May 8, 2023, the date that the nanoShieldTM product line and related technologies were sold (see Note 16), the Company has operated in one segment. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry-resistant system.

 

On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder. Pursuant to the Exchange Agreement, on July 22, 2021, the Company acquired 80% of Patriot Glass’s units (the “Patriot Glass Shares”). The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement (the Exchange Agreement as amended, or the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending at 5:00 P.M. EST on the date that is 30 calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions, LLC.

 

On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShieldTM division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).

v3.24.2.u1
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The Company’s unaudited consolidated financial statements include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot Glass. All significant intercompany accounts and transactions have been eliminated in consolidation. 

 

Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its financial position and the results of its operations for the periods presented. The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

 

Certain information and note disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP has been condensed or omitted from these statements pursuant to such accounting principles and, accordingly, they do not include all the information and notes necessary for comprehensive consolidated financial statements. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the year ended December 31, 2023 of the Company which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024.

 

Going Concern

 

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. On June 30, 2024, the Company had cash of $196,315. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail its operations. These unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the six months ended June 30, 2024 and 2023 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. 

 

Fair Value of Financial Instruments and Fair Value Measurements

 

The carrying amounts reported in the unaudited consolidated balance sheets for cash, accounts receivable, contract assets and liabilities, notes payable, convertible note payable, accounts payable, accrued expenses, accrued compensation, and lease liabilities approximate their fair market value based on the short-term maturity of these instruments.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company did not identify any assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 820.

 

ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

 

Cash and Cash Equivalents

 

For the purposes of the unaudited consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. The Company had no cash equivalents as of June 30, 2024 and December 31, 2023.

 

Accounts Receivable

 

The Company recognizes an allowance for losses on accounts receivable and notes receivable in an amount equal to the estimated probable losses net of recoveries under the current expected credit loss method. The allowance is based on an analysis of historical bad debt experience, current receivables aging and expected future write-offs, as well as an assessment of specific identifiable customer accounts and notes receivable considered at risk or uncollectible. On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make the required payments (current expected losses). The amount of the allowance is determined principally based on past collection experience and known financial factors regarding specific customers. The expense associated with the allowance for doubtful accounts on accounts receivable is recognized in general and administrative expenses.

 

Inventory

 

Inventory, consisting of raw materials and finished goods, are stated at lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed the expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are recorded based on estimates and included in cost of sales.

 

Property and Equipment

 

Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, which range from one to seven years. Leasehold improvements are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.

 

Goodwill and Intangible Assets

 

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over a useful life of 5 years.

 

Goodwill is not subject to amortization but is subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill by reporting unit at least annually, or when indicators of impairment are present, to determine if goodwill may be impaired. To evaluate goodwill impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of goodwill is less than its carrying value. The Company would not be required to quantitatively determine the fair value of goodwill unless it determines, based on the qualitative assessment there are indicators of impairment. Under the quantitative test of goodwill, the Company compares the fair value of the reporting unit to its carrying value, including goodwill. If the carrying value exceeds the fair value, then the goodwill is impaired by the excess amount. The Company performs its annual testing for goodwill during the fourth quarter of each fiscal year or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit.

 

Intangible assets determined to have finite lives are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset is the period over which the asset is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates both finite and indefinite lived intangible assets for impairment upon occurrence of events or changes in circumstances that indicate the carrying amount of intangible assets may not be recoverable.

 

As of December 31, 2023, the Company performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s annual impairment test indicated that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill or intangibles assets was recorded as of December 31, 2023.

 

Impairment of Long-Lived Assets

 

In accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.

 

Warranty Liability

 

The Company provides limited warranties on its products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying unaudited consolidated balance sheets and amounted to $1,000 on June 30, 2024 and December 31, 2023, respectively. During the six months ended June 30, 2024 and 2023, warranty costs were de minimis.

 

Revenue Recognition

 

The Company follows ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.

 

The Company sells its products, which include standard warranties, primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped to the customer and the title is transferred and is recorded net of any discounts or allowances. The warranty does not represent a separate performance obligation.

 

Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.

 

Cost of Sales

 

Cost of sales includes inventory costs, packaging costs and warranty expenses.

 

Cost of revenues from fixed-price contracts for the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements, are accounted for as changes in estimates in the current period. 

 

Shipping and Handling Costs

 

Shipping and handling costs incurred for product shipped to customers are included in general and administrative expenses and amounted to $10,272 and $5,577 for the six months ended June 30, 2024 and 2023, respectively. Shipping and handling costs charged to customers are included in sales.

 

Research and Development

 

Research and development costs incurred in the development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated costs incurred. For the six months ended June 30, 2024 and 2023, research and development costs incurred in the development of the Company’s products were $0.

 

Advertising Costs

 

The Company may participate in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the six months ended June 30, 2024 and 2023, advertising costs charged to operations were $38,874 and $10,986, respectively, and are included in general and administrative expenses on the accompanying unaudited consolidated statements of operations. These advertising expenses do not include cooperative advertising and sales incentives which shall been deducted from sales.

 

Federal and State Income Taxes

 

The Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

 

The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of June 30, 2024 and December 31, 2023, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. Tax years that remain subject to examination are the years ending on and after December 31, 2018. The Company recognizes interest and penalties related to uncertain income tax positions in other expense. However, no such interest and penalties were recorded as of June 30, 2024 and December 31, 2023.

 

Stock-Based Compensation

 

Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.

 

Leases

 

The Company accounts for leases in accordance with ASC 842. The lease standard requires certain leases to be reported on the consolidated balance sheets as right-of-use assets and lease liabilities. The Company has elected the practical expedients permitted under the transition guidance of this standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company does not reassess whether any contracts entered into prior to adoption are leases or contain leases.

 

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company does not have any finance leases as of June 30, 2024 and December 31, 2023. The Company’s leases generally have terms that range from three to four years for property and equipment and five years for property. The Company elected the accounting policy to include both the lease and non-lease components of our agreements as a single component and account for them as a lease.

 

Lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on the Company’s current borrowing rate. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

 

When the Company has the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that the Company will exercise the option, the Company considers these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

 

Loss Per Common Share

 

ASC 260 “Earnings Per Share”, requires dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in the future.

 

The following table presents a reconciliation of basic and diluted net income (loss) per common share:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Net (loss) income per common share - basic:                    
Net (loss) income attributable to common shareholders  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Net (loss) income per common share – basic  $(0.00)  $0.01   $(0.00)  $0.01 
                     
Net (loss) income per common share - diluted:                    
Net (loss) income attributable to common shareholders - basic  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Add: preferred stock dividends   
-
    13,618    
-
    27,305 
Add: interest of convertible debt   
-
    52,618    
-
    102,639 
Numerator for (loss) income per common share – diluted  $(263,925)  $3,845,531   $(595,432)  $3,189,187 
                     
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Add: dilutive shares related to:                    
Convertible debt   
-
    1,145,833,333    
-
    1,145,833,333 
Series B preferred   
-
    324,240,164    
-
    324,240,164 
Series C preferred   
-
    386,250,000    
-
    386,250,000 
Weighted average common shares outstanding – diluted   543,165,027    2,349,380,186    539,431,386    2,314,606,932 
Net (loss) income per common share – diluted  $(0.00)  $0.00   $(0.00)  $0.00 

 

For the three and six months ended June 30, 2023, stock options and warrants were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income. For the three and six months ended June 30, 2024, all potentially dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net losses. As of June 30, 2024 and 2023, common share equivalents and potentially dilutive securities consisted of the following: 

 

   June 30, 
   2024   2023 
Stock options   7,345,698    8,445,698 
Warrants   33,400,000    34,000,000 
Series B preferred stock   357,819,360    324,240,164 
Series C preferred stock   450,258,000    386,250,000 
Convertible debt   1,220,101,111    1,145,833,333 
    2,068,924,169    1,898,769,195 

 

Segment Reporting

 

Prior to May 8, 2023, the Company operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions. The Company’s reportable segments were strategic business units that offered different products and were managed separately based on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond nanoShield™ product line and the remaining segment (1) as described above was combined into segment (2) and is now being managed together (see Note 16).

  

Noncontrolling Interest

 

The Company accounts for noncontrolling interest in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total shareholders’ deficit on the unaudited consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest be clearly identified and presented on the face of the unaudited consolidated statements of operations.

 

Risk and Uncertainties

 

The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

 

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The adoption of this standard on January 1, 2024 had no impact on the Company’s unaudited consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

v3.24.2.u1
Accounts Receivable
6 Months Ended
Jun. 30, 2024
Accounts Receivable [Abstract]  
ACCOUNTS RECEIVABLE

NOTE 3 – ACCOUNTS RECEIVABLE

 

On June 30, 2024 and December 31, 2023, accounts receivable consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Accounts receivable  $304,525   $459,414 
Less: allowance for doubtful accounts   (61,156)   (35,323)
Accounts receivable, net  $243,369   $424,091 

 

For the six months ended June 30, 2024 and 2023, bad debt expense amounted to $23,094 (net of bad debt recovery of $2,739) and $0, respectively.

v3.24.2.u1
Inventory
6 Months Ended
Jun. 30, 2024
Inventory [Abstract]  
INVENTORY

NOTE 4 – INVENTORY

 

On June 30, 2024 and December 31, 2023, inventory consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Finished goods  $162,052   $181,663 
Total Inventory  $162,052   $181,663 

 

For the six months ended June 30, 2024 and 2023, the Company did not record any allowance for slow moving inventory.

v3.24.2.u1
Property and Equipment
6 Months Ended
Jun. 30, 2024
Property and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE 5 – PROPERTY AND EQUIPMENT

 

On June 30, 2024 and December 31, 2023, property and equipment consisted of the following: 

 

   Useful Life  June 30,
2024
   December 31,
2023
 
Machinery and equipment  5 – 7 years  $73,411   $73,411 
Furniture and office equipment  3 – 7 years   2,061    2,061 
Vehicles  1 – 5 years   68,050    68,050 
Leasehold improvements  3 – 5 years   110,645    110,645 
       254,167    254,167 
Less: accumulated depreciation      (106,325)   (82,561)
Property and equipment, net     $147,842   $171,606 

  

For the six months ended June 30, 2024 and 2023, depreciation expense was included in general and administrative expenses and amounted to $23,764 and $16,143, respectively. 

v3.24.2.u1
Intangible Assets and Goodwill
6 Months Ended
Jun. 30, 2024
Intangible Assets and Goodwill [Abstract]  
INTANGIBLE ASSETS AND GOODWILL

NOTE 6 – INTANGIBLE ASSETS AND GOODWILL

 

On June 30, 2024 and December 31, 2023, intangible assets and goodwill, which were acquired from Patriot Glass in 2021, consisted of the following:

 

   Useful life  June 30,
2024
   December 31,
2023
 
Customer relations  5 years  $212,516   $212,516 
Non-compete  5 years   40,000    40,000 
Trade name (non-amortizable) 
-
   100,000    100,000 
       352,516    352,516 
Less: accumulated amortization      (148,353)   (123,102)
Intangible assets, net     $204,163   $229,414 

 

   Useful life  June 30,
2024
   December 31,
2023
 
Goodwill  -  $350,491   $350,491 

 

For the six months ended June 30, 2024 and 2023, amortization expense of amortizable intangible assets amounted to $25,251 and $25,252, respectively. On June 30, 2024, accumulated amortization amounted to $124,853 and $23,500 for the customer relations and non-compete, respectively. On December 31, 2023, accumulated amortization amounted to $103,602 and $19,500 for the customer relations and non-compete, respectively.

 

Amortization of intangible assets with identifiable useful lives that is attributable to future periods is as follows:

 

Twelve months ending June 30:  Amount 
2025  $50,503 
2026   50,503 
2027   3,157 
Total  $104,163 
v3.24.2.u1
Convertible Notes Payable
6 Months Ended
Jun. 30, 2024
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE

NOTE 7 – CONVERTIBLE NOTES PAYABLE

 

Mercer Convertible Debt

 

On October 15, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity Fund, LLC (the “Investor”), pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000 (the “Mercer Note”) and five-year warrants to purchase up to 16,500,000 shares of the Company’s common stock at an initial exercise price of $0.05 per share, an amount equal to 50% of the conversion shares that were issued (the “Mercer Warrants”). The Company received net proceeds of $680,000, which was net of original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000. The transactions contemplated under the SPA closed on October 18, 2021.

 

The Mercer Note matured 12 months after issuance, bore interest at a rate of 4% per annum through the date of default, and was initially convertible beginning on the six-month anniversary of the original issue date into the Company’s common stock at a fixed conversion price of $0.025 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described in the Initial Note.

 

The Mercer Note and Mercer Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

Upon the occurrence of an event of default under the Mercer Note, the Investor has the right to be prepaid at 125% of the outstanding principal balance and accrued interest, and interest accrues at 18% per annum. Events of default included, among other things,

 

(i)any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days;

 

(ii)the Company or any Subsidiary shall be subject to a Bankruptcy Event;

 

(iii)the SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor;

 

(iv)the Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);

 

(v)the Company incurs any Indebtedness other than Permitted Indebtedness;

 

  (vi) the Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following Trading Day. The Company filed a Report on Form 8-K announcing the restatement of its financial statements for the year ended December 31, 2020. Following the first public announcement or disclosure that a restatement occurred, the VWAP on the next Trading Day was not 20% less than the VWAP on the prior Trading Day and accordingly, the default provisions were not triggered.

 

The Company has also granted the investor a 12-month (or until the Notes are no longer outstanding) right to participate in specified future financings, up to a level of 30%.

 

On April 20, 2022, the Company and the Investor entered into an Exchange Agreement (the “Exchange Agreement”). The original SPA remains in effect. Per the terms of the Exchange Agreement, the Parties agreed to exchange (i) the Mercer Note for a new Convertible Promissory Note (the “New Note”) and (ii) the Mercer Warrant for a new five-year warrant to purchase, in the aggregate, 33,000,000 shares of the Company’s common stock at an exercise price of $0.025 per share (the “New Warrant” and together with the New Note, the “New Securities”), according to the terms and conditions of the Exchange Agreement. On April 20, 2022, pursuant to the terms of the Exchange Agreement, the Investor surrendered the Prior Securities in exchange for the New Securities. Other than the surrender of the Prior Securities, no consideration of any kind whatsoever was given by the Investor to the Company in connection with the Exchange Agreement. The terms of the New Securities are the same as the Prior Securities except for the pricing of the shares issuable under the New Note and the shares issuable upon exercise of the New Warrant. The New Securities are composed of the New Note, which is a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000, and the New Warrant. The New Note matured on October 15, 2022, bore interest at a rate of 4% per annum through the date of default, and was initially convertible into the Company’s common stock at a fixed conversion price of $0.0125 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described in the New Note. If the average Closing Price during any 10 consecutive Trading Day period beginning and ending during the 60 Day Effectiveness Period (the “Average Closing Price”) is below the Conversion Price than the conversion price will be reduced to such Average Closing Price but in no event less than $0.00875.

 

On October 15, 2022, the due date of the New Note, the New Note defaulted due to non-payment. Accordingly, the Company added a default penalty of $206,250, or 25%, to the principal balance and recorded interest expense of $206,250, and interest shall accrue at 18% per annum.

 

On December 4, 2023, the Company entered into a letter agreement (the “Agreement”) with the Investor to eliminate the convertible features and implement a standstill on the interest due under the Convertible Promissory Note Dated October 15, 2021 (the “Note”). This Note is the only remaining convertible note on the Company’s balance sheet. Per the terms of the Agreement, provided that the Company continues making the Payments as outlined in the Agreement and meets its obligations under the Agreement, the Investor shall not have the right to convert the Note into the Company’s common stock. The Company shall make the Payments on the 15th of every month. “Payments” shall mean $15,000 per month for 35 months with a balloon payment of $588,091 on the 36th month, for aggregate payments of $1,113,091.

 

Additionally, the Company shall pay Mercer 20% of the gross proceeds from capital raised by the Company through the issuance of securities or incurrence of any Debt (regardless of whether the incurrence of debt includes of the sale of any securities) (“Capital Raise Payments”). Capital Raise Payments shall only be required for capital raises resulting in the Company receiving gross proceeds of at least $500,000. By way example, if the Company receives $600,000 from the issuance of Debt, the Company shall make a Capital Raise Payment of $120,000 to Mercer. Any Capital Raise Payments shall be first be applied to the then outstanding Balloon Payment and thereafter to the last Payments (35th, 34th and so on). “Debt” means borrowed money including the sale of any existing and future receivables. The Capital Raise Payments shall be made within two business days of the receipt of the funds under such raise. Any failure to make the Payments within the cure period or from the Capital Raise Payments by the required date shall make this Agreement null and void.

 

Additionally, provided that the Company is in compliance with this Agreement, Mercer agrees to a standstill on the interest due under the Note beginning with the date that the first $15,000 Payment is made which the Company paid on December 15, 2023 as required by the Note. Further, if the Company pays off the entire principal and accrued interest by the dates detailed below, the Investor agrees to reduce the total amount due on the Note (principal and interest) by the percentages as follows: 20% if fully paid by March 31, 2024, 15% if fully paid by June 30, 2024, 10% if fully paid by September 30, 2024, and 5% if fully paid by December 31, 2024. All rights and obligations under the original Note shall remain the same. Mercer is not waiving any of its rights under the original Note, including but not limited to, rights available prior to this Agreement.

 

As of June 30, 2024 and December 31, 2023, the principal balance of the New Note was $1,008,091 and $1,098,091, respectively. Additionally, as of June 30, 2024 and December 31, 2023, accrued interest payable amounted to $176,184 and $176,184, respectively, which is reflected in accrued expenses on the accompanying unaudited consolidated statements of operations. Under the terms of the Agreement, $176,184 of accrued interest is subject to forgiveness if the Company complies with the terms of the Agreement. As of the date of this report, the Company has made all required payments.

 

At any time this Note or any amounts accrued and payable thereunder remain outstanding, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any common stock or common stock equivalents entitling any Person to acquire shares of the Company’s common stock at an effective price per share that is lower than the conversion price then in effect (such lower price, the “Base Conversion Price” and each such issuance or announcement a “Dilutive Issuance”), then the conversion price shall be immediately reduced to equal the Base Conversion Price. Such adjustment shall be made whenever such common stock or common stock equivalents are issued. On September 6, 2022, the Company issued common stock equivalents with an initial conversion price of $0.009 per share and accordingly, the conversion price and warrant down-round provisions were triggered. As a result, the conversion price of the New April 2022 Note was reduced to $0.009 per share and the exercise price of the New April 2022 Warrant was lowered to $0.009.

 

Pursuant to the provisions of ASC 815-40 – Derivatives and Hedging – Contracts in an Entity’s Own Stock, the convertible note and related warrants issued in connection with the Mercer convertible note was analyzed and it was determined that the terms of the convertible note and warrants contained terms that were not considered derivatives.

 

1800 Diagonal Lending Convertible Debt

 

On November 9, 2022, the Company closed a Securities Purchase Agreement dated November 4, 2022, with 1800 DIAGONAL LENDING LLC (“Diagonal”), pursuant to which a Promissory Note (the “November 2022 Diagonal Note”) dated November 4, 2022, was made to Diagonal in the aggregate principal amount of $104,250 and the Company received net proceeds of $100,000 which was net of fees of $4,250. The November 2022 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on May 4, 2024. In May 2023, the November 2022 Diagonal Note and any interest due was repaid in full (See Note 16).

 

On December 27, 2022, the Company closed a Securities Purchase Agreement dated December 27, 2022, with 1800 Diagonal pursuant to which a Promissory Note (“December 2022 Diagonal Note”) dated December 27, 2022, was made to Diagonal in the aggregate principal amount of $64,250 and the Company received net proceeds of $60,000 which was net of fees of $4,250. The December 2022 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on June 27, 2024. In May 2023, the December 2022 Diagonal Note and any interest due was repaid in full (See Note 16).

 

On March 17, 2023, the Company closed a Securities Purchase Agreement dated November 4, 2022, with Diagonal pursuant to which a Promissory Note (the “March 2023 Diagonal Note”) dated March 17, 2023, was made to Diagonal in the aggregate principal amount of $54,250 and the Company received net proceeds of $50,000 which was net of fees of $4,250. The March 2023 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on March 17, 2024. In May 2023, the March 2023 Diagonal Note and any interest due was repaid in full (See Note 16).

 

The Company accounted for the November 2022 and December 2022 Diagonal Notes as stock settled debt under ASC 480 and recorded an aggregate debt premium of $90,731 with a charge to interest expense. The Company has accounted for the March 2023 Diagonal Note as stock settled debt under ASC 480 and recorded an aggregate debt premium of $29,212 with a charge to interest expense. On May 11, 2023, upon repayment of the November 2022, December 2022 and March 2023 Diagonal Notes, the Company reversed the debt premium of $119,943 and recorded a gain on debt extinguishment of $119,943 on the accompanying unaudited consolidated statement of operations.

 

For the six months ended June 30, 2024 and 2023, amortization of debt discounts related to the convertible notes payable amounted to $0 and $2,627, respectively, which has been included in interest expense on the accompanying unaudited consolidated statements of operations.

 

On June 30, 2024 and December 31, 2023, accrued interest payable under all outstanding convertible notes discussed above amounted to $176,184 and $176,184, respectively, and was included in accrued expenses on the accompanying unaudited consolidated balance sheets.

 

On June 30, 2024 and December 31, 2023, convertible notes payable consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Convertible note payable  $1,008,091   $1,098,091 
Convertible note payable, net   1,008,091    1,098,091 
Less: current portion of convertible note payable   (180,000)   (180,000)
Convertible note payable – long-term  $828,091   $918,091 

  

On June 30, 2024, future annual maturities of convertible note payable are as follows:

 

June 30,  Amount 
2025  $180,000 
2026   180,000 
2027   648,091 
Total convertible note payable on June 30, 2024  $1,008,091 
v3.24.2.u1
Notes Payable
6 Months Ended
Jun. 30, 2024
Notes Payable [Abstract]  
NOTES PAYABLE

NOTE 8 – NOTES PAYABLE

 

On June 30, 2024 and December 31, 2023, notes payable consisted of the following:

 

   June 30,
2024
   December 31,
2023
 
Notes payable  $553,469   $105,958 
Note payable – PPP note   13,864    18,823 
Total notes payable   567,333    124,781 
Less: unamortized debt discount   (59,842)   (764)
Note payable, net   507,491    124,017 
Less: current portion of notes payable, net of discount   (474,014)   (81,908)
Notes payable – long-term  $33,477   $42,109 

 

Notes Payable

 

BOCO Investment Note

 

On November 14, 2018, the Company entered into a Revolving Credit Facility Loan and Security Agreement (“Loan Agreement”) and a Secured Promissory Note (the “Note”) with BOCO Investments, LLC (the “Lender”). Subject to and in accordance with the terms and conditions of the Loan Agreement and the Note, the Lender agreed to lend to the Company up to $400,000 (the “Maximum Loan Amount”) against the issuance and delivery by the Company of the Note for use as working capital and to assist in inventory acquisition. In 2018, the Lender loaned $400,000 to the Company, the Maximum Loan Amount. The outstanding principal advanced to Company pursuant to the Loan Agreement initially bore interest at the rate of 12% per annum, compounded annually. Upon the occurrence of an Event of Default under the Loan Agreement and Note, all amounts then outstanding (including principal and interest) bore interest at the rate of 18% per annum, compounded annually until the Event of Default is cured.

 

In May 2023, the Company and the Lender entered into a Debt Exchange and Release Agreement in regard to the $400,000 Note discussed above, whereby the Company paid the Lender cash of $200,000 and issued the Lender 22,000,000 shares of Common Stock of the Company (see Note 9) in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 16). The 22,000,000 shares issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with the repayment and settlement of this debt, in May 2023, the Company recorded a gain from debt extinguishment of $385,293 consisting of a) $68,000 calculated as the difference in the principal amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000, and b) the forgiveness of interest due of $317,293.

 

On June 30, 2024 and December 31, 2023, the principal amount due and accrued interest payable under this Note amounted to $0.

 

Mercer Street Global Opportunity Fund Notes

 

On March 14, 2022, the Company entered into an Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”) in the principal amount of $197,500 with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note was funded on March 14, 2022 and the Company received net proceeds of $175,000 which is net of an original issue discount and investor legal fees of $22,500. The original issue discount was recorded as a debt discount to be amortized over the life of the March 2022 note. On June 30, 2024 and December 31, 2023, the principal balance due and accrued interest payable on the March 2022 Note amounted to $0. In May 2023, the March 2022 Note and all accrued interest due was paid in full (See Note 16). 

 

On November 22, 2022, the Company entered into a Promissory Note and Security Agreement (the “November 2022 Note”) with a principal amount of $65,000 with the Investor. The November 2022 Note was funded on November 22, 2022 and the Company received net proceeds of $62,500 which is net of Investor legal fees of $2,500. The legal fees were recorded as a debt discount to be amortized over the life of the November 2022 note. The November 2022 Note was to mature on August 22, 2023 and bore interest at a rate of 8% per annum. On June 30, 2024 and December 31, 2023, the principal balance due and accrued interest payable on the November 2022 Note amounted to $0. In May 2023, the November 2022 Note and all accrued interest due was paid in full and the Company recorded a gain on debt extinguishment of approximately $18,900 (See Note 16).

 

GS Capital Debt

 

On June 23, 2022, the Company entered into a Securities Purchase Agreement (“Agreement”) with GS Capital Partners, LLC (“GS Capital”), pursuant to which a Promissory Note (the “GS Capital June 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital June 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on June 24, 2022 (less legal and other administrative fees). The Company received net proceeds of $148,420. In 2022, the Company issued GS Capital a total of 1,750,000 commitment shares (“Commitment Shares”) as additional consideration for the purchase of this Note. Through December 31, 2022, the Company paid $53,512 of principal balance and during the year ended December 31, 2023, paid principal balance of $79,488. During April and May 2023, the Company issued 21,371,481 shares of its common stock upon the conversion of the remaining principal amount of $62,000, accrued interest of $4,139, and fees of $2,250 (See Note 9). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital Note and accrued interest payable amounted to $0 (See Note 16). 

 

On July 26, 2022, the Company closed a Securities Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“GS Capital July 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital July 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on July 28, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. In 2022, the Company issued GS Capital a total of 2,600,000 commitment shares (“July 2022 Commitment Shares”) as additional consideration for the purchase of the July 2022 Note. In addition, in 2022, the Company issued 998,008 of its common stock to the placement agent as a fee for the capital raise, respectively. The July Commitment Shares and the placement agent shares were recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the Note. Principal and interest payments were payable in 10 installments of $21,060 each beginning on the 90th-day anniversary following the issue date and continuing thereafter each 30 days for nine months. The GS Capital July 2022 Note was to mature 12 months after issuance and bore interest at a rate of 8% per annum. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital July 2022 note by 60 days. Specifically, the maturity date of the GS Capital July 2022 note was extended to September 26, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid $34,120 of principal balance and in May 2023, the Company paid the remaining principal balance of $160,880 and all accrued interest due in full (See Note 16). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital July 2022 Note and accrued interest payable amounted to $0.

 

On September 6, 2022, the Company closed a Securities Purchase Agreement (“September 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“September 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The September 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on September 6, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. In 2022, the Company issued GS Capital a total of 3,300,000 commitment shares (“September 2022 Commitment Shares”) as additional consideration for the purchase of the September 2022 Note. In addition, in 2022, the Company issued 773,626 of its common stock to the placement agent as fee for the capital raise, respectively. The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the Note. Principal and interest payments were payable in 9 installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note was to mature 12 months after issuance and bore interest at a rate of 8% per annum. In the event that following the Issue Date the closing trading price of the Company’s common stock was then being traded below $0.009 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. In May 2023, the GS Capital September 2022 Note and all accrued interest due was paid in full (See Note 16). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital September 2022 Note and accrued interest payable amounted to $0. 

 

In May 2023, the GS Capital June 2022 Note, the GS Capital July 2022 Note, and the September 2022 Note were paid in full without any default penalty and the Company recorded a gain on debt extinguishment of approximately $25,400 (see Note 16).

 

1800 Diagonal Lending Note Payable - March 2024

 

On March 1, 2024, the Company executed a Promissory Note (the “Note”) in favor of Diagonal in the aggregate principal amount of $157,000 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4, 2024, in the amount of $125,000, which is net of an original issue discount of $13,000 and a one-time interest charge at 12% (the “Interest Rate”) of approximately $19,000 was applied on the issuance date to the Principal. Under the terms of the Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and the Note matures on December 30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”). Monthly payments of principal and interest was as follows:

 

Payment Date:  Amount 
August 30, 2024  $87,920 
September 30, 2024   21,980 
October 30, 2024   21,980 
November 30, 2024   21,980 
December 30, 2024   21,980 
Total  $175,840 

  

Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of the Company’s Common Stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the Note be converted into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock.

 

On June 30, 2024 and December 31, 2023, the principal balance due on the March 2024 Note amounted to $157,000 and $0, respectively. 

 

On August 15, 2024, The Company and Diagonal amended this Note to change the payment schedule and change the conversion terms (See Note 17).

 

1800 Diagonal Lending Note Payable – April 2024

 

On April 8, 2024, the Company executed a Promissory Note (the “April 2024 Note”) in favor of Diagonal in the aggregate principal amount of $127,693 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the April 2024 Note convertible into shares of the Company’s common stock. The Note was funded on April 10, 2024, in the amount of $100,000. A one-time interest charge of 12% (the “Interest Rate”) shall be applied on the issuance date to the Principal. Under the terms of the April 2024 Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).

 

Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the April 2024 Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this April 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this April 2024 Note to the date of payment plus Default Interest, if any.

 

At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount of this April 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the April 2024 Note be converted into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock.

 

Monthly payments of principal and interest on the April 2024 Note was as follows:

 

Payment Date:  Amount 
August 15, 2024  $85,810 
September 15, 2024 through February 15, 2025 (6 monthly payments)   57,206 
Total  $143,016 

 

On June 30, 2024 and December 31, 2023, the principal balance due on the April 2024 Note amounted to $127,693 and $0, respectively.

 

On August 15, 2024, the Company and Diagonal amended the April 2024 Note to change the payment schedule and change the conversion terms (See Note 17).

 

1800 Diagonal Lending Note Payable – June 2024

 

On June 5, 2024, the Company executed a Promissory Note (the “June 2024 Note”) in favor of Diagonal in the aggregate principal amount of $67,500 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the June 2024 Note convertible into shares of the Company’s common stock. The Note was funded on June 5, 2024, in the amount of $50,000, net of original issue discount and fees of $17,500. Under the terms of the June 2024 Note, the Company is required to make nine monthly payments of principal and interest of $8,775 beginning on July 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).

 

Among other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the June 2024 Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal amount of this June 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this June 2024 Note to the date of payment plus Default Interest, if any.

 

At any time following an Event of Default, the Holder shall have the right, to convert all or any part of the outstanding and unpaid amount of this June 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the June 2024 Note be converted into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock.

 

On June 30, 2024 and December 31, 2023, the principal balance due on the June 2024 Note amounted to $67,500 and $0, respectively. 

 

On August 15, 2024, the Company and Diagonal amended the June 2024 Note to change the conversion terms (See Note 17).

 

Other Notes Payable

 

On May 10, 2021, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) and a Secured Promissory Note (the “Promissory Note”) in the amount of $500,000 with a lender. The Promissory Note accrued interest at 8% per annum, compounded annually, and all outstanding principal and accrued interest was due and payable on May 10, 2023. In May 2023, this Promissory Note and all accrued interest was paid in full (See Note 16).

 

On July 22, 2021, in connection with the acquisition of Patriot Glass, the Company’s subsidiary, Patriot Glass, assumed vehicle and equipment loans in the amount of $95,013. These loans bear interest at rates ranging from 6.79% to 8.24% and are payable monthly through April 2025. On June 30, 2024 and December 31, 2023, notes payable related to these vehicle and equipment loans amounted to $5,526 and $8,250, respectively.

 

On November 8, 2022, the Company entered into a Promissory Note (the “November 2022 Note”) with a lender investor (the “Private Investor”) in the principal amount of $200,000 and received net proceeds of $200,000. The November 2022 Note bore interest at a rate of 8% per annum and all outstanding principal and accrued and unpaid interest was due on November 8, 2024. In May 2023, the November 2022 Note and all unpaid interest was paid in full (See Note 16). 

 

During the year ended December 31, 2023, in connection with the acquisition of a vehicle and an air conditioner unit, the Company’s subsidiary, Patriot Glass, entered into three vehicle and equipment loans in the amount of $117,721. These loans bear interest at rates ranging from 10.0% to 35.1% and are payable monthly through September 2028. On June 30, 2024 and December 31, 2023, notes payable related to the vehicle and equipment loans amounted to $71,006 and $97,708, respectively. The net book value on June 30, 2024 relating to the collateralized assets was $98,573.

 

On February 21, 2024, the Company’s subsidiary, Patriot Glass, entered into a Promissory Note (the “February 2024 Note”) with a lender in the principal amount of $50,000 and received net proceeds of $49,000, net of original issue discount of $1,000, which was reflected as a debt discount to be amortized into interest expense over the term of the note. The February 2024 Note bears interest at an effective rate of 33.4% per annum and all outstanding principal and accrued and unpaid interest is due on August 21, 2025. On June 30, 2024, the principal amount due on the February 2024 Note is $40,920. 

 

On June 17, 2024, the Company’s subsidiary, Patriot Glass, entered into a Merchant Loan (the “June 2024 Merchant Loan”) with a lender in the principal amount of $85,000 and received net proceeds of $81,550, net of fees of $3,450, which was reflected as a debt discount to be amortized into interest expense over the term of the note. The June 2024 Merchant Loan requires a weekly payment of principal and interest of $2,988 through March 19, 2025 for an effective interest rate of 85.9%. On June 30, 2024, the principal amount due on the June 2024 Merchant Loan is $83,824. 

 

For the six months ended June 30, 2024 and 2023, amortization of debt discounts related to all the above notes payable amounted to $22,459 and $93,295, respectively, which has been included in interest expense on the accompanying unaudited consolidated statements of operations.

 

PPP Loan

 

On April 28, 2020, the Company entered into a Paycheck Protection Program Promissory Note (the “PPP Note”) with respect to a loan of $156,200 (the “PPP Loan”) from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES act”) administered by the U.S. Small Business Administration (“SBA”). The PPP Loan matured on April 28, 2022 and bears interest at a rate of 1.00% per annum. The PPP Loan was payable in 18 equal monthly payments of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Company applied for forgiveness of its PPP Loan, and on November 4, 2021, the Company was notified that the Small Business Administration forgave $95,000 of the principal loan amount and $1,442 of interest. On February 29, 2029, the Company entered into a payment plan arrangement with the SBA and agreed to pay the remaining balance of $17,824 by making 17 monthly payments of $990 and a final payment of $994. On June 30, 2024 and December 31, 2023, the principal amount due under the PPP Loan amounted to $13,864 and $18,823, respectively. As of June 30, 2024 and December 31, 2023, accrued interest payable amounted to $0 and $358, respectively.

 

On June 30, 2024, future annual maturities of notes payable are as follows:

 

June 30,  Amount 
2025  $533,856 
2026   16,654 
2027   7,013 
2028   7,751 
2029   2,059 
Total notes payable on June 30, 2024  $567,333 
v3.24.2.u1
Shareholders' Deficit
6 Months Ended
Jun. 30, 2024
Shareholders  
SHAREHOLDERS’ DEFICIT

NOTE 9 – SHAREHOLDERS’ DEFICIT

 

Preferred Stock

 

Series B Preferred Stock

 

On December 12, 2019, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series B Convertible Preferred Stock (the “Series B”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series B, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing.

 

The Series B ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The Series B has a stated value per share of $1,000, subject to adjustment as provided in the Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value.

 

The Series B is subject to redemption (at Stated Value, plus any accrued, but unpaid dividends (the “Liquidation Value”) by the Company no later than three years after a Deemed Liquidation Event and at the Company’s option after one year from the issuance date of the Series B, subject to a ten-day notice (to allow holder conversion). A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.

 

The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).

 

In the event of a conversion of any Series B, the Company shall issue to the holder a number of shares of common stock equal to the sum of the Stated Value plus accrued but unpaid dividends multiplied by the number of shares of Series B Preferred Stock being converted divided by the Conversion Price.

 

Upon liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders of any preferred stock ranking senior to the Series B but prior to any distribution to the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series B, the holders of Series B will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series B equal to the Liquidation Value.

 

The Series B has voting rights per Series B Share equal to the Liquidation Value per share, divided by the Conversion Price, multiplied by fifty (50). Subject to applicable Colorado law, the holders of Series B will have functional voting control in situations requiring shareholder vote.

 

These Series B preferred share issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the issuer, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of the Series B preferred stock agreements, Series B preferred stock is redeemable for cash and other assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since Series B preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series B preferred stock is classified as temporary equity.

 

The Company concluded that the Series B Preferred Stock represented an equity host and, therefore, the redemption feature of the Series B Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the conversion rights under the Series B Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the conversion rights feature on the Series B Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.

 

On January 17, 2023, the Board of Directors of the Company agreed to satisfy $144,000 of accrued compensation owed to its executive officers (collectively, the “Management”) which, as of December 31, 2022 was included in accrued compensation on the accompanying unaudited consolidated balance sheet. Management agreed to accept 144 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The beneficial conversion feature of the Series B Preferred Stock at the time of issuance was determined to be deminimis on the commitment date. 

 

On January 2, 2024, the Board of Directors of the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers (collectively, the “Management”) as of December 31, 2023, which was included in accrued compensation on the accompanying unaudited consolidated balance sheet. Management agreed to accept 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $281,807 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. The beneficial conversion feature amount of $281,807 was determined by calculating the number of excess common shares to be received upon conversion of the accrued compensation of $312,000 on the grant date based on (i) the quoted closing price of the Company’s common stock on the grant date of $0.059 and (ii) the initial conversion of the Series B Preferred Stock of $0.0031, multiplied by the quoted closing price of the Company’s common stock on the grant date of $0.059.

 

On January 2, 2024, the Board of Directors of the Company agreed to issue 50 shares of the Company’s Series B convertible preferred stock to a director for services rendered. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $95,161, which consisted of (i) $50,000 of Series B stated value and (ii) $45,161 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. The beneficial conversion feature amount of $45,161 was determined by calculating the number of excess common shares to be received upon conversion of the $50,000 of Series B stated value on the grant date based on (i) the quoted closing price of the Company’s common stock on the grant date of $0.059 and (ii) the initial conversion of the Series B Preferred Stock of $0.0031, multiplied by the quoted closing price of the Company’s common stock on the grant date of $0.059.

 

On February 8, 2024, 120 shares of Series B Preferred Stock were forfeited. In connection with this forfeiture, the Company reclassified an aggregate amount of $127,640 from Series B convertible preferred stock to additional paid-in capital, which consisted of (i) stated value of $120,000, and (ii) $7,640 of accrued dividends.

 

On May 20, 2024, the Company’s chief executive officer returned 197 shares of Series B Preferred Stock to the Company granted to him in January 2022, per the terms of the Securities and Exchange Commissions’ Order issued to the Company on May 8, 2024 (See Note 10). In connection with this forfeiture, the Company reclassified an aggregate amount of $206,369 from Series B convertible preferred stock to additional paid-in capital, which consisted of (i) stated value of $197,000, and (ii) $9,369 of accrued dividends.

 

During the six months ended June 30, 2024 and 2023, the Company accrued dividends of $13,355 and $11,226, respectively, which was included in Series B convertible preferred stock on the accompanying unaudited consolidated balance sheets.

 

As of June 30, 2024, the net Series B Preferred Stock balance was $1,245,313, which includes stated value of $1,189,623 and accrued dividends payable of $55,690 As of December 31, 2023, the net Series B Preferred Stock balance was $1,203,967, which includes stated value of $1,144,624 and accrued dividends payable of $59,343. The net Series B Preferred Stock balance is included on the accompanying unaudited consolidated balance sheets.

 

During the six months ended June 30, 2024 and 2023, Series B preferred stock activity is as follows:

 

   For the Six Months Ended
June 30, 2024
   For the Six Months Ended
June 30, 2023
 
   Number of
Shares
   Amount   Number of
Shares
   Amount 
Balance at beginning of period   1,144   $1,203,967    1,000   $1,037,201 
Shares issued for accrued compensation   312    312,000    144    144,000 
Shares issued for compensation   50    50,000    
-
    
-
 
Shares and accrued dividends forfeited   (317)   (334,009)   
-
    
-
 
Dividends accrued   
-
    13,355    
-
    11,226 
Balance at end of period   1,189   $1,245,313    1,144   $1,192,427 

 

Series C Preferred Stock

 

On August 20, 2020, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series C Convertible Preferred Stock (the “Series C”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series C, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing.

 

The Series C ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The Series C has a stated value per share of $100, subject to adjustment as provided in the Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value.

 

The Company has no option to redeem the Series C Preferred Stock. If the Company determines to liquidate, dissolve or wind-up its business and affairs, or effect any Deemed Liquidation Event as defined below, each of which has been approved by the holders of a majority of the shares of Series C Preferred Stock then outstanding, the Company will redeem all of the shares of Series C Preferred Stock outstanding immediately prior to such mandatory redemption event at a price per share of Series C Preferred Stock equal to the aggregate Series C Liquidation Value, which is 150% of the sum of the Stated Value plus accrued and unpaid dividends, for the shares of Series C Preferred Stock being redeemed.

 

The Company will deliver ten-day advance written notice prior to the consummation of any mandatory redemption event via email or overnight courier (“Notice of Mandatory Redemption”) to each Holder whose shares are to be redeemed. The Series C is subject to redemption at liquidation Value noted above by the Company. Upon receipt by any Holder of a Notice of Mandatory Redemption, if Holder does not choose to convert, such Holder will promptly submit to the Company such Holder’s Series C Preferred Stock certificates on the Redemption Payment Date. Upon receipt of such Holder’s Series C Preferred Stock certificates, the Company will pay the applicable redemption price to such Holder in cash. A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company. Since the Company has determined that a deemed liquidation event is not probable, the Series C is stated at the Stated Value plus accrued and unpaid dividends rather than redemption value, which is liquidation value.

 

The Series C is convertible at the option of a holder at any time following the issuance date. In the event of a conversion of any Series C Preferred Stock, the Company shall issue to such Holder a number of Conversion Shares equal to (x) the sum of (1) the Stated Value per share of Series C Preferred Stock plus (2) any accrued but unpaid dividends thereon multiplied by (y) the number of shares of Series C Preferred Stock held by such Holder and subject to the Holder Conversion Notice, divided by (z) the Conversion Price with respect to such Series C Preferred Stock. Conversion Price means a price per share of the common stock equal to the lowest daily volume weighted average price of the common stock for any trading day during the two years preceding the date of delivery of the conversion notice, subject to adjustment as otherwise provided in the Series C Certificate of Designation.

 

Upon liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders of any preferred stock ranking senior to the Series C but prior to any distribution to the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series C, the holders of Series C will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series C equal to the Liquidation Value.

 

On April 28, 2021, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights, and Limitations of Series C Convertible Preferred Stock (the “Amended Certificate”). The Amended Certificate changed the voting rights of the Series C Preferred Stock on any matters requiring shareholder approval or any matters on which the common shareholders are permitted to vote. Series C Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the common shareholders (or other preferred stock of the Company which may vote with the common shareholders) are permitted to vote. With respect to any voting rights of the Series C Preferred Stock set forth herein, the Series C Preferred Stock shall vote as a class, each share of Series C Preferred Stock shall have one vote on any such matter, and any such approval may be given via a written consent in lieu of a meeting of the Holders of the Series C Preferred Stock. Any reference herein to a determination, decision or election being made by the “Majority Holders” shall mean the determination, decision or election as made by Holders holding a majority of the issued and outstanding shares of Series C Preferred Stock at such time. It also adjusts the conversion feature of the Series C Preferred Stock so that any Holder of Series C Preferred Stock cannot convert any portion of the Series C in excess of that number of Series C Preferred Stock that upon conversion would result in beneficial ownership by the Holder of more than 4.99% of the outstanding shares of common stock of the Company.

 

These Series C preferred stock issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the holder, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of the Series C preferred stock agreements, Series C preferred stock is redeemable for cash and other assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since Series C preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series C preferred stock is classified as temporary equity.

 

The Company concluded that the Series C Preferred Stock represented an equity host and, therefore, the redemption feature of the Series C Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the conversion rights under the Series C Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the conversion rights feature on the Series C Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.

 

During the three months ended March 31, 2023, the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.

 

During the three months ended June 30, 2023, the Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.

 

During the three months ended September 30, 2023, the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares of Series C preferred with a stated redemption value of $30,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On February 1, 2024, the Company issued 5,772,973 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On March 1, 2024, the Company issued 5,781,562 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares. 

 

During the six months ended June 30, 2024 and 2023, the Company accrued dividends of $14,743 and $16,079, respectively, which was included in Series C convertible preferred stock on the accompanying unaudited consolidated balance sheets.

 

As of June 30, 2024, the net Series C Preferred Stock balance was $1,575,903, which includes stated liquidation value of $1,455,000 and accrued dividends payable of $120,903. As of December 31, 2023, the net Series C Preferred Stock balance was $1,621,160, which includes stated liquidation value of $1,515,000 and accrued dividends payable of $106,160. The net Series C Preferred Stock balance is included on the accompanying unaudited consolidated balance sheets.

 

During the six months ended June 30, 2024 and 2023, Series C preferred stock activity is as follows:

 

   For the Six Months Ended
June 30, 2024
   For the Six Months Ended
June 30, 2023
 
   Number of Shares   Amount   Number of Shares   Amount 
Balance at beginning of period   15,150   $1,621,160    17,290   $1,803,731 
Conversion of Series C shares to common shares   (600)   (60,000)   (1,840)   (184,000)
Dividends accrued   
-
    14,743    
-
    16,079 
Balance at end of period   14,550   $1,575,903    15,450   $1,635,810 

 

Common Stock

 

Common Stock Issued for Cash and Accrued Compensation

 

On January 17, 2023, the Company entered into a Subscription Agreement with its Chairman and Chief Executive Officer, Scott R. Silverman (the “Subscription Agreement”), whereby Mr. Silverman purchased 54,545,455 shares (the “Subscription Shares”) of the Company’s common stock for $300,000, or $0.0055 per share, based on the quoted closing price of the Company’s common stock on the measurement date (the “Consideration”). The Consideration consisted of a cash payment of $275,000 the conversion of $25,000 of accrued compensation owed to Mr. Silverman. 

 

On January 17, 2023, Barry Edelstein, a member of the Company’s Board of Directors, elected to convert $53,000 of accrued compensation into 9,636,364 shares of unregistered common stock of the Company. The shares were valued at $53,000, or $0.0055, based on the quoted closing price of the Company’s common stock on the measurement date.

 

Issuance of Common Stock for Services

 

Issuance of Common Stock for Professional Fees

 

2023

 

On February 6, 2023, the Company issued 6,666,667 shares of its common stock for public relations services to be rendered. These shares were valued at $40,000, or $0.006 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, during the six months ended June 30, 2023, the Company recorded stock-based professional fees of $11,667 and prepaid expense of $28,333, which was amortized into professional fees over the remaining term of the agreement.

 

On April 3, 2023, the Company issued 5,000,000 shares of its common stock for investor relations services to be rendered. These shares were valued at $22,500, or $0.0045 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company recorded stock-based professional fees of $22,500, which was amortized into professional fees over the term of the agreement.

 

On June 3, 2023, the Company issued 1,500,000 shares of its common stock for investor relations services to be rendered. These shares were valued at $16,950, or $0.0011 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company recorded stock-based professional fees of $5,650 and prepaid expenses of $11,300, which will be amortized into professional fees over the remaining term of the agreement.

 

During the six months ended June 30, 2024 and 2023, the Company recorded stock-based professional fees of $0 and $38,000 in connection with the amortization to prepaid expenses related to common shares previously issued, respectively.

 

Issuance of Common Stock for Stock-Based Compensation

 

On June 7, 2023, the Company issued 2,500,000 shares of its common stock to employees for services for services rendered. These shares were valued at $26,000, or $0.0104 per common share, based on the quoted closing price of the Company’s common stock on the measurement date.

 

During the six months ended June 30, 2024 and 2023, aggregate accretion of stock-based compensation expense on granted common shares amounted to $0 and $42,183, respectively. Total unrecognized compensation expense related to these unvested common shares on June 30, 2024 and December 31, 2023 amounted to $0. By mutual agreement between the parties, the vesting date of previously granted shares was extended through May 2025.

 

The following table summarizes activity related to non-vested shares:

 

   Number of
Non-Vested
Shares
   Weighted
Average
Grant Date
Fair Value
 
Non-vested, December 31, 2023   14,970,120   $0.132 
Shares vested   
-
    
-
 
Non-vested, June 30, 2024   14,970,120   $0.132 

 

Common Stock Forfeited

 

On February 8, 2024, 5,250,000 shares of the Company’s common stock were forfeited. In connection with this forfeiture, the Company reclassified the amount of $5,250 from common stock, par value to additional paid-in capital.

 

Common Stock Issued in Connection with Notes Payable

 

During April and May 2023, the Company issued 21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest of $4,139, and fees of $2,250.

 

In May 2023, the Company issued the Lender 22,000,000 shares of common stock of the Company in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 8 - BOCO Investment Note). The 22,000,000 shares issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with the issuance of these shares, the Company recorded a gain from debt extinguishment of $68,000 calculated as the different in the principal amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000.

 

Common Stock Issued for Conversion of Series C Preferred Stock

 

2023

 

During the three months ended March 31, 2023, the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.

 

During the three months ended June 30, 2023, the Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.

 

2024

 

On February 1, 2024, the Company issued 5,772,973 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On March 1, 2024, the Company issued 5,781,562 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.

 

On May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares. 

 

Stock Options

 

For the six months ended June 30, 2024 and 2023, the Company recorded no compensation expense related to stock options. Total unrecognized compensation expense related to unvested stock options on June 30, 2024 and December 31, 2023 amounted to $0.

 

Stock option activities for the six months ended June 30, 2024 are summarized as follows:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Balance Outstanding, December 31, 2023   8,445,698   $0.40    2.43    
       -
 
Expired   (1,100,000)   
-
    
-
    
-
 
Balance Outstanding, June 30, 2024   7,345,698   $0.44    2.25   $
-
 
Exercisable, June 30, 2024   7,345,698   $0.44    2.25   $
-
 

  

Warrants

 

Warrant activities for the six months ended June 30, 2024 are summarized as follows:

 

   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Balance Outstanding December 31, 2023   34,000,000   $0.011    2.73   $
      -
 
Expired   (600,000)   
-
    
-
    
-
 
Balance Outstanding June 30, 2024   33,400,000   $0.01    2.28   $
-
 
Exercisable, June 30, 2024   33,400,000   $0.01    2.28   $
-
 

 

2018 Long-Term Incentive Plan

 

On June 7, 2018, a majority of the Company’s shareholders and its board approved the adoption of a 2018 Long-Term Incentive Plan (the “2018 Plan”). The purpose of the 2018 Plan is to advance the interests of the Company, its affiliates and its stockholders and promote the long-term growth of the Company by providing employees, non-employee directors and third-party service providers with incentives to maximize stockholder value and to otherwise contribute to the success of the Company and its affiliates, thereby aligning the interests of such individuals with the interests of the Company’s stockholders and providing them additional incentives to continue in their employment or affiliation with the Company. The Plan was adopted on June 7, 2018 and effective on August 2, 2018. Under the 2018 Plan, the Plan Administrator may grant:

 

options to acquire the Company’s common stock, both incentive stock options that are intended to satisfy the requirements of Section 422 of the Internal Revenue Code and nonqualified stock options which are not intended to satisfy such requirements. The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.

 

stock appreciation rights, or SARs, which allow the recipient to receive the appreciation in the fair market value of the Company’s common stock between the date of grant and the exercise date. The amount payable under the stock appreciation right may be paid in cash or with shares of the Company’s common stock, or a combination thereof, as determined by the Administrator.

 

restricted stock awards, which are awards of the Company’s shares of common stock that vest in accordance with terms and conditions established by the Administrator.

 

restricted stock units, which are awards that are based on the value of the Company’s common stock and may be paid in cash or in shares of the Company’s common stock.

 

other types of stock-based or stock-related awards not otherwise described by the terms and provision of the 2018 Plan, including the grant or offer for sale of unrestricted shares of the Company’s common stock, and which may involve the transfer of actual shares of the Company’s common stock or payment in cash or otherwise of amounts based on the value of shares of the Company’s common stock and may be designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.

 

other cash-based awards to eligible persons in such amounts and upon such terms as the Administrator shall determine.

 

An award granted under the 2018 Plan must include a minimum vesting period of at least one year, provided, however, that an award may provide that the award will vest before the completion of such one-year period upon the death or qualifying disability of the grantee of the award or a change of control of the Company and awards covering, in the aggregate, 25,000,000 shares of our common stock may be issued without any minimum vesting period.

 

The aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted stock have been issued as of June 30, 2024. All shares underlying grants are expected to be issued from the Company’s unissued authorized shares available.

v3.24.2.u1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, the Company may be involved in litigation related to claims arising out of its operations in the normal course of business. As of June 30, 2024, other than discussed below, the Company is not involved in any other pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations, or cash flows.

 

On January 20, 2022, we received an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of 1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition. On April 15, 2022, the Company filed an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The restatement had the cumulative effect of decreasing the Company’s reported revenue for fiscal year 2020 by $102,569 and decreasing the Company’s bad debt expense for the same period by $102,569. There was no effect on the Company’s reported net loss for fiscal year 2020 or on the financial condition of the Company on December 31, 2020. The Company received a subpoena from the SEC on April 25, 2022, requesting all documents and communications concerning the review of C-Bond’s revenue recognition practices for fiscal year 2020. In response, the Company provided the requested information and its Chief Executive Officer provided his testimony regarding this Formal Order in October 2022. The Company also filed a request to withdraw its Registration Statement on Form S-1 (“S-1”) (File No. 333-261472) (the “Registration Statement”), filed by the Company with the SEC on December 3, 2021. The S-1 related to shares of common stock underlying certain convertible promissory notes held by selling securityholders. The S-1 was not declared effective and no securities were sold in reliance thereon. The Company and its Chief Executive Officer submitted offers to settle and close the pending SEC investigation, and on May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s findings, C-Bond and its Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled (See Note 9) and the Chief Executive Officer issued a check to the Company in the amount of $21,961, which the Company expects to deposit before year end. The amount due of $21,961 is included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024.  As of December 31, 2023, based on the settlement offers, the Company had accrued $175,000 of settlement expense associated with this matter which was included in accrued expenses on the accompany unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to the SEC and accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024, which amount was repaid in August 2024.

 

On March 8, 2021, a former officer of the Company resigned. Both parties alleged certain claims against the other, including with respect to certain compensation claims. Neither party has filed litigation. The Company intends to vigorously defend itself against any possible claims and assert any relevant claims against the former executive and believes it will prevail. The Board of Directors of the Company has resolved and taken action in February 2024 to cause the forfeiture of equity and deferred compensation owed/outstanding by said officer. Accordingly, on February 8, 2024, the Board of Directors of the Company determined that 120 shares of Series B convertible preferred stock and 5,250,000 shares of the Company’s common stock shall be forfeited (See Note 9). Additionally, on February 8, 2024, the Company reversed accrued compensation that was outstanding to this former officer as of December 31, 2023 of $347,097 and accordingly, during the six months ended June 30, 2024, the Company recorded a gain on debt extinguishment of $347,097.

 

Employment Agreements

 

On October 18, 2017, the Company entered into an employment agreement with Mr. Scott Silverman, pursuant to which he serves as the Chief Executive Officer of the Company for an initial term of three years that extends for successive one-year renewal terms unless either party gives 30-days’ advance notice of non-renewal. As consideration for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits: 

  

  An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward.
     
  After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company.
     
  Annual cash performance bonus opportunity as determined by the Board.
     
  An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives.
     
  Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits.

 

The receipt of $1,240,000 in connection with the April 25, 2018 financing triggered the right of the employee to receive the deferred salary and the 5% bonus provision disclosed above.

 

Mr. Silverman’s employment agreement provides that, in the event that his employment is terminated by the Company without “cause” (as defined in his employment agreement), or if Mr. Silverman resigned for “good reasons” (as defined in his new employment agreement), subject to a complete release of claims, he will be entitled to (i) retain all stock options previously granted; and (ii) receive any benefits then owed or accrued along with one year of base salary and any unreimbursed expenses incurred by him. All amounts shall be paid on the termination date. In the event that Mr. Silverman’s employment is terminated by the Company for “cause” (as defined in his employment agreement), or if Mr. Silverman resigned without “good reasons” (as defined in his employment agreement), subject to a complete release of claims, he will be entitled to receive any unpaid base salary and benefits then owed or accrued and any unreimbursed expenses incurred by him. Additionally, if a change of control (as defined in his employment agreement) occurs during the term of this agreement, all unvested stock options will vest in full and if the valuation of the Company in the change of control transaction is greater than $0.85 per common share, then Mr. Silverman shall be paid a bonus equal to two times his minimum base salary and minimum target bonus. Pursuant to the employment agreement, Mr. Silverman will be subject to a confidentiality covenant, a two-year post-termination non-competition covenant and a two-year post-termination non-solicitation covenant. On June 30, 2020, the Company amended the employment agreement of Mr. Silverman to provide for successive one-year extensions until either the executive or the Board of Directors of the Company gives notice to terminate the employment agreement per its terms. This employment agreement amendment also includes an allowance of up to $10,000 per year to cover uncovered medical/dental expenses for Mr. Silverman and his family.

 

On July 21, 2021, the Company entered into the Employment Agreement with Mr. Wanke, the President of Patriot Glass, to serve as the President of C-Bond’s Safety Solutions Group. Under the three-year Employment Agreement, Mr. Wanke will receive a base salary of $240,000 per year, which may be increased from time to time with the approval of the board of directors. In addition, Mr. Wanke may receive an annual bonus as determined by the board of directors. It is understood that although Mr. Wanke’s base salary will be paid by Patriot Glass, 50% of the base salary will be allocated to the expenses of Patriot Glass, and the other 50% of the base salary will be allocated to the expenses of the Company. The term of this Agreement (the “Initial Term”) shall begin as of July 21, 2021 (the “Effective Date”) and shall end on the earlier of (i) the third anniversary of the Effective Date and (ii) the time of the termination of the Executive’s employment in accordance with the Employment Agreement. This Initial Term and any Renewal Term (as defined below) shall automatically be extended for one or more additional terms of one (1) year each (each a “Renewal Term” and together with the Initial Term, the “Term”), unless either the Company or Executive provide notice to the other Party of their desire to not so renew the Initial Term or Renewal Term (as applicable) at least thirty (30) days prior to the expiration of the then-current Initial Term or Renewal Term, as applicable. All unvested shares of stock and stock options shall expire upon such termination, if any. The Executive shall be eligible for an annual bonus payment in an amount to be determined by the Board of Directors of the Company (the “Bonus”). The Bonus shall be determined and payable based on the achievement of certain performance objectives of the Company as established by the Board and communicated to and agreed to by the Executive in writing as soon as practicable after commencement of the year in respect of which the Bonus is paid. The Bonus, if earned, is payable in cash and/or restricted stock at the discretion of the Board. It is understood between the Parties that the target bonus for each year shall be up to 50% of the Base Salary.

 

On December 7, 2023, the Company’s board of directors approved a bonus to two officers in the aggregate amount of $480,000. For the bonus approved for Mr. Silverman, which amounted to $300,000, this bonus was paid 50%, or $150,000, in cash, which was paid in December 2023, and 50% in equity amounting to $150,000 which as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying unaudited consolidated balance sheet. For the bonus approved for Ms. Tomek, which amounted to $180,000, this bonus is to be paid 10% in cash of $18,000 and 90% in equity amounting to $162,000, which as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying unaudited consolidated balance sheet. On January 2, 2024, the Board of Directors of the Company agreed to satisfy the aggregate of $312,000 of the bonus owed to these executive officers (collectively, the “Management”). Management agreed to accept an aggregate of 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation (See Note 9).

        

Anti-dilution rights related to C-Bond Systems, LLC

 

Prior to the Merger, C-Bond Systems, LLC entered into certain contracts, described below, which provided certain anti-dilution protection to the counterparties to those contracts.  The Company believes that these contracts do not apply to any future issuances of equity by C-Bond Systems, Inc.

 

In 2013, pursuant to a subscription agreement, the Company’s subsidiary. C-Bond Systems, LLC issued 2,425,300 common shares. To the extent that during the term of the agreement C-Bond Systems, LLC issues any “down-round” or subsequent investments based upon an enterprise value of less than $2,000,000 (“Dilutive Transaction”) (other than an issuance pursuant to an option agreement with an employee or otherwise to compensate an employee, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units were issued to the seller of such assets) contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the investor additional common units in C-Bond Systems, LLC in an amount which would provide them with the ownership percentage interest which they would have held in C-Bond Systems, LLC represented by the common units purchased by them on this date.

 

In 2015, pursuant to a subscription agreement, C-Bond Systems, LLC issued 3,880,480 common shares to an entity at $0.77 per common share. This agreement entitled the subscriber to anti-dilution protection to the extent that C-Bond Systems, LLC issued any equity in a “down-round” based upon a value of less than $0.77 per common unit of C-Bond Systems, LLC (other than an issuance pursuant to an option agreement with an employee or consultant or otherwise to compensate an employee or consultant, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units are issued to the seller of such assets (“Dilutive Transaction”)). Contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the Subscriber additional common units in C-Bond Systems, LLC in an amount which would provide the investor with the ownership percentage interest in C-Bond Systems, LLC on a fully diluted basis which Subscriber held immediately prior to the Dilutive Transaction.

 

In 2016, pursuant to a subscription agreement, C-Bond Systems, LLC issued 1,175,902 common shares to an entity at $0.85 per common share. This agreement entitled this investor to customary broad-based weighted average anti-dilution protection to the extent that after the date of this subscription agreement C-Bond Systems, LLC issued any equity in a “down round” based upon a value of less than $0.85 per common share, including the issuance of options with an exercise price per share of less than $0.85 to compensate employees or consultants (“Dilutive Transaction”), subject to exclusions for issuances of common shares or options in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions. The agreement obligated C-Bond Systems, LLC to give to this investor written notice (an “Issuance Notice”) of any proposed issuance by C-Bond Systems, LLC of any C-Bond Systems, LLC common units, or other form of equity interest (excluding issuances of C-Bond Systems, LLC options or other equity to compensate employees or consultants and the issuance of shares in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions) at least ten business days prior to the proposed issuance date. This contract entitled the investor to purchase their pro rata portion of such shares or other equity interest of C-Bond Systems, LLC at the price and on the other terms and conditions specified in the issuance notice. 

 

Option to purchase 20% of Patriot Glass

 

In connection with the Exchange Agreement with Patriot Glass and the Patriot Glass Shareholder (See Note 1), the Company had the option to acquire the remaining 20% of Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into an amendment to the Exchange Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”).

 

If the Company exercises the Option, the Company shall acquire the Additional Units in exchange for (i) a number of shares of Company Common Stock equal to (a) the Share Value (as defined below) divided by (b) the Additional Closing Share Price (as defined below) (the “Additional Closing Exchange Shares”), and (ii) a cash payment equal to the Net Income (as below). “Total EBIT Value” shall mean the sum of (i) Patriot Glass’s net income, before income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on June 30, 2025 plus (ii) $240,000. “EBIT Value” shall mean the Total EBIT Value divided by two (2). “Share Value” shall mean (i) 300% of the EBIT Value (the “Triple EBIT Value”), minus (ii) the Net Income. “Net Income” shall mean Patriot Glass’s net income, after income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on June 30, 2025. Any salary paid by Patriot Glass, including but not limited to any salary paid to the Patriot Glass Shareholder, shall not be included in Net Income. If the Company Common Stock is quoted or listed for trading on a Trading Market on July 1, 2025, then “Additional Closing Share Price” shall mean the average of all of the closing prices of Company Common Stock on such Trading Market during the calendar month of June 2024.

 

M&A advisory agreement

 

On October 18, 2023, the Company and Maxim Group LLC (“Maxim”) entered into an engagement letter, whereby Maxim was engaged as the Company’s exclusive financial advisor to perform merger and acquisition advisory services. Either Maxim or the Company may terminate this Agreement at any time upon thirty (30) days’ prior written notice to the other party after the six (6) month anniversary of this Agreement. The Company paid Maxim a one-time non-refundable cash fee of $25,000 due promptly upon execution of the Agreement (the “Retainer”). The Retainer shall be creditable against the Success Fee. If during the term of this Agreement a Transaction is consummated or the Company enters into an agreement regarding a Transaction (which is consummated subsequent to the completion of the Term), a fee (the “Success Fee”) will be payable in U.S. dollars upon the closing of the Transaction to Maxim equal to 6.5% of the Consideration (as defined hereinafter), provided however, that if a Transaction is consummated or the company enters into an agreement regarding a Transaction with Curtis Stout Inc., such Success Fee shall be reduced to 4.0% of Consideration from Curtis Stout Inc. In the event that the Company enters into an agreement with respect to a Transaction during the term of this Agreement that is subsequently terminated, and the Company becomes entitled to a break-up, termination, topping, expense reimbursement or similar fee or payment (including any judgment for damages or amount in settlement of any dispute as a result of such termination, or any profit on any stock acquired from, or stock option granted by, any party to such transaction), a fee (the “Break-up Fee”) equal to 10.0% of all such amounts, payable promptly upon receipt of such amounts by the Company. Upon the closing of a Transaction, for a period of twelve (12) months from such closing, the Company grants Maxim the right of first refusal to act as sole managing underwriter and sole book runner, sole placement agent, or sole sales agent, for any and all future public or private equity, equity-linked or debt (excluding commercial bank debt) offerings for which the Company retains the service of an underwriter, agent, advisor, finder or other person or entity in connection with such offering period of the Company, or any successor to or any subsidiary of the Company. The Company shall not offer to retain any entity or person in connection with any such offering on terms more favorable than terms on which it offers to retain Maxim. Such offer shall be made in writing in order to be effective. Maxim shall notify the Company within ten (10) business days of its receipt of the written offer contemplated above as to whether or not it agrees to accept such retention. If Maxim should decline such retention, the Company shall have no further obligations to Maxim with respect to the offering for which it has offered to retain Maxim, except as otherwise provided for herein. As of the date of this report, no funds have been raised. In connection with this agreement, during the six months ended June 30, 2024, the Company recorded professional fees of $14,383.

v3.24.2.u1
Concentrations
6 Months Ended
Jun. 30, 2024
Concentrations [Abstract]  
CONCENTRATIONS

NOTE 11 – CONCENTRATIONS

 

Concentrations Of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable and cash deposits. The Company places its cash in banks at levels that, at times, may exceed federally insured limits. On June 30, 2024, the Company had no cash in bank in excess of FDIC insured levels. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Any material loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company to move its cash to other high quality financial institutions. The Company reviews its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits. The Company has not experienced any losses in such accounts through June 30, 2024.

 

Geographic Concentrations of Sales

 

During the six months ended June 30, 2024 and 2023, all sales were in the United States.

 

Customer Concentrations

 

For the six months ended June 30, 2024, two customers accounted for approximately 41.0% of total sales (14.5% and 26.5%, respectively). For the six months ended June 30, 2023, one customer accounted for approximately 14.8% of total sales. On June 30, 2024, five customers accounted for 63.2% (11.8%, 11.0%, 13.5%, 12.7% and 14.2%, respectively) of the total accounts receivable balance. On December 31, 2023, two customers accounted for 41.8% (29.5% and 12.3%, respectively) of the total accounts receivable balance.

 

Vendor concentrations

 

Generally, the Company purchases substantially all its inventory from four suppliers. The loss of these suppliers may have a material adverse effect on the Company’s consolidated results of operations and financial condition. However, the Company believes that, if necessary, alternate vendors could supply similar products in adequate quantities to avoid material disruptions to operations.

v3.24.2.u1
Segment Reporting
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 12 – SEGMENT REPORTING

 

Through May 8, 2023, the date that the Company entered into an Asset Purchase Agreement with Apex Protect GPS, LLC agreed to sell its C-Bond nanoShield™ product line (See Note 16), the Company operated in two reportable business segments - (1) the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”), and (2) the distribution and installation of window film solutions (the “Patriot Glass Segment”). The Company’s reportable segments were strategic business units that offered different products. They were managed separately based on the fundamental differences in their operations and locations. Upon the sale of the C-Bond nanoShield™ business, the legacy C-Bond business is being conducted through Patriot Glass in order to combine administrative functions and they are now being managed together.

 

Information with respect to these reportable business segments for the three and six months ended June 30, 2024 and 2023 was as follows: 

 

   For the Three Months Ended
June 30,
   For the Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Revenues:                
C-Bond  $
-
   $31,166   $
-
   $124,372 
Patriot Glass   863,533    382,889    1,800,337    804,903 
    863,533    414,055    1,800,337    929,275 
Depreciation and amortization:                    
C-Bond   
-
    132    
-
    569 
Patriot Glass   24,508    20,413    49,015    40,826 
    24,508    20,545    49,015    41,395 
Interest expense:                    
C-Bond   171    357    171    357 
Patriot Glass   18,140    6,655    27,081    11,798 
Other (a)   35,297    161,141    40,475    355,483 
    53,608    168,153    67,727    367,638 
Net income (loss):                    
C-Bond   (225,255)   3,759,343    (147,411)   3,483,967 
Patriot Glass   21,033    (93,201)   68,584    (176,813)
Other (a)   (41,747)   108,131    (474,790)   (255,968)
   $(245,969)  $3,774,273   $(553,617)  $3,051,186 

 

   June 30,
2024
   December 31,
2023
 
Identifiable long-lived tangible assets on June 30, 2024 and December 31, 2023 by segment:          
C-Bond  $
-
   $
-
 
Patriot Glass   147,842    171,606 
   $147,842   $171,606 

 

(a)The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
v3.24.2.u1
Revenue Recognition
6 Months Ended
Jun. 30, 2024
Revenue Recognition [Abstract]  
REVENUE RECOGNITION

NOTE 13 – REVENUE RECOGNITION

 

Prior to the sale of the Company’s C-Bond segment in May 2023, the revenue that the Company recognized arose from purchase requests the Company received from its customers. The Company’s performance obligations under purchase orders or by a verbal order correspond to each shipment of product that the Company makes to its customer under the purchase order or verbal order. As a result, each purchase order or verbal order generally contains more than one performance obligation based on the number of products ordered, the quantity of product to be shipped and the mode of shipment requested by the customer. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs at the later of when the customer obtains title to the product or when the customer assumes risk of loss of the product. The transfer of control generally occurs at the time of shipment from the Company’s warehouse. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue.  In connection with the Company’s C-Bond segment, when the Company receives a purchase order or verbal order from a customer, the Company is obligated to provide the product during a mutually agreed upon time period. Depending on the terms of the purchase order or verbal order, either the Company or the customer arranges delivery of the product to the customer’s intended destination. In situations where the Company has agreed to arrange delivery of the product to the customer’s intended destination and control of the product transfers upon loading of the Company’s product onto transportation equipment, the Company has elected to account for any freight income associated with the delivery of these products as freight revenue, since this activity fulfills the Company’s obligation to transfer the product to the customer. 

 

In connection with the Company’s Patriot Glass segment, the revenue that the Company recognizes arises from purchase requests the Company receives from its customers. The Company’s performance obligations under purchase order or a signed proposal correspond to each job for the distribution and installation of window film solutions. As a result, each purchase order or signed proposal generally may contain more than one performance obligation based on the specific job. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs when the job or a specific portion of the job is completed. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue.  Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output of input methods including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these methods to be the best available measure of progress on these contracts. 

 

Transaction Price

 

The Company agrees with its customers on the selling price of each transaction. This transaction price is generally based on the product, market conditions, including supply and demand balances, labor costs, and freight. In the Company’s C-Bond contracts with customers, the Company allocates the entire transaction price to the sale of product to the customer, which is the basis for the determination of the relative standalone selling price allocated to each performance obligation. Returns of the Company’s product by its customers are permitted only when the product is not to specification and were not material for the six months ended June 30, 2024 and 2023. Any sales tax, value added tax, and other tax the Company collects concurrently with its revenue-producing activities are excluded from revenue.

 

Revenue Disaggregation

 

The Company tracks its revenue by product. The following table summarizes our revenue by product for the six months ended June 30, 2024 and 2023:  

 

   For the Six Months Ended
June 30,
 
   2024   2023 
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems  $33,537   $9,709 
C-Bond nanoShield solution sales   
-
    112,413 
Window tint installation and sales recognized over time   1,766,800    804,903 
Freight and delivery   
-
    2,250 
Total  $1,800,337   $929,275 
v3.24.2.u1
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities
6 Months Ended
Jun. 30, 2024
Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities [Abstract]  
OPERATING LEASE RIGHT-OF-USE (“ROU”) ASSETS AND OPERATING LEASE LIABILITIES

NOTE 14 – OPERATING LEASE RIGHT-OF-USE (“ROU”) ASSETS AND OPERATING LEASE LIABILITIES

 

In October 2019, the Company entered into an 18-month lease agreement for the lease of office and warehouse space under a non-cancelable operating lease through May 31, 2021. From the lease commencement date of December 1, 2019 until November 30, 2020, monthly rent shall be $4,444 and from December 1, 2020 to May 31, 2021, monthly rent shall be $4,577 per month. On May 12, 2021 and effective June 1, 2021, the Company entered into an amendment to the lease which extended the lease for one year until May 31, 2022 at a monthly base rent of $5,283. On May 4, 2022 and effective June 1, 2022, the Company entered into an amendment to the lease which extended the lease for three years until May 31, 2025. On June 15, 2023, in connection with the sale of the Company’s nanoShield™ product line, the purchaser assumed the operating lease and the Company vacated the premises. 

 

In connection with the 2021 Exchange Agreement between in the Company and Patriot Glass, the Company was named as guarantor (“Guarantor”) of a Commercial Lease Agreement dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Mr. Wanke and his wife and tenant Patriot Glass d/b/a A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent of $5,600 (not including tax), with two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Patriot Glass; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Patriot Glass; or (iii) two (2) years from and after the effective date of the guaranty. During the year ended December 31, 2023, the Company’s obligation as Guarantor expired.

 

In September 2021, the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025. The monthly base rent is $365 per month. This lease has been assumed by CB NANOSHIELD LLC as part of its purchase of the nanoShield Assets (see Note 16).

 

In February 2022, the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025. The monthly base rent is $788 per month. 

 

In adopting ASC Topic 842, Leases (Topic 842) on January 1, 2019, the Company had elected the ‘package of practical expedients’, which permitted it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs (see Note 2). In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Upon signing of new leases for property and equipment, the Company analyzed the new leases and determined it is required to record a lease liability and a right of use asset on its unaudited consolidated balance sheets, at fair value.

 

During the six months ended June 30, 2024 and 2023, in connection with its property operating leases, the Company recorded rent expense of $16,800 and $40,845, respectively, which is expensed during the year and included in general and administrative expenses on the accompanying unaudited consolidated statements of operations.

 

On June 30, 2024 and December 31, 2023, right-of-use asset (“ROU”) is summarized as follows:

 

   June 30,
2024
   December 31,
2023
 
Office leases and office equipment right of use assets  $279,162   $279,162 
Less: accumulated amortization   (150,440)   (120,678)
Balance of ROU assets  $128,722   $158,484 

 

On June 30, 2024 and December 31, 2023, operating lease liabilities related to the ROU assets are summarized as follows:

 

   June 30,
2024
   December 31,
2023
 
Lease liabilities related to office leases right of use assets  $128,722   $157,752 
Less: current portion of lease liabilities   (60,773)   (60,503)
Lease liabilities – long-term  $67,949   $97,249 

  

On June 30, 2024, future minimum base lease payments due under non-cancelable operating leases are as follows:

 

Twelve months ending June 30,  Amount 
2025  $72,715 
2026   67,200 
2027   5,600 
Total minimum non-cancelable operating lease payments   145,515 
Less: discount to fair value   (16,793)
Total lease liability on June 30, 2024  $128,722 
v3.24.2.u1
Related Party Transactions
6 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 15 – RELATED PARTY TRANSACTIONS

 

Due from Related Party

 

On May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s findings, C-Bond and its Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled. As of December 31, 2023, based on the settlement offers, the Company had accrued $175,000 of settlement expense association with this matter which is included in accrued expenses on the accompany unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to the SEC and the accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024. On August 16, 2024, the Company received cash of $50,000 and reduced the amount due from related party. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197 Series B preferred shares were cancelled (See Note 9) and the Chief Executive Officer issued a check to the Company in the amount of $21,961, which the Company expects to deposit before year end.  The amount due of $21,961 is included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024. 

v3.24.2.u1
Sale of Nanoshield Product Line
6 Months Ended
Jun. 30, 2024
Sale of Nanoshield Product Line [Abstract]  
SALE OF NANOSHIELD PRODUCT LINE

NOTE 16 – SALE OF NANOSHIELD PRODUCT LINE

 

On May 8, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby the Company agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023. Following the Closing, the parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company; Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee.

 

The Assets were sold and transferred to buyer by means of (i) with respect to the physical assets, a Bill of Sale; and (ii) with respect to intangible assets or intellectual property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement.

 

The APA contains customary representations, warranties, and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding under state or federal law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided the Seller a true and accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including, among other things, patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal title to, and is the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear of all liens.

 

Under the terms of the APA, the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer, among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent, for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.

 

The Parties also entered into a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive right and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass and other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles and equipment (the “Licensed Product”) in the United States and its legal territories.

 

Lastly, the Parties entered into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free, non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve, market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications of the patented technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and conditions that are mutually acceptable to both Parties.

 

Following the Closing, the Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement as agreed to by the Parties and the lessor pursuant to the Lease. 

 

In connection with the APA, the Company received net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable as follows:

 

1)The Company repaid and settled the BOCO Investments, LLC Note (See Note 8) with a principal balance of $400,000 and accrued interest payable of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock (See Note 8 and 9).

 

2)The Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full (See Note 8).

 

3)The Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November 22, 2022 (collectively, the “Secured Mercer Notes”) (See Note 7).

 

4)The Company repaid Jeff Badders $875,000 for notes dated May 5, 2021, November 8, 2022, and April 4, 2023 (See Note 8).

 

5)The Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively, the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full (See Note 7).

 

6)The Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full.

 

In accordance with ASC 205-20, the sale of the C-Bond nanoShield™ product line was not reported in discontinued operations since the disposal did not represent a strategic shift that has (or will have) a major effect on the Company’s operations and financial results. The C-Bond nanoShield™ product line was only a component of the C-Bond segment which comprised of operations and cash flows that were not clearly distinguished, operationally and for financial reporting purposes, from the rest of the C-Bond segment.

 

In connection with the sale of the C-Bond nanoShield™ product line, on May 8, 2023, the Company recorded a gain from the sale of the product line of $4,051,709.

v3.24.2.u1
Subsequent Events
6 Months Ended
Jun. 30, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 17 – SUBSEQUENT EVENTS

 

Promissory Notes

 

On July 31, 2024, the Company’s subsidiary, Patriot Glass, entered into a Merchant Loan (the “July 2024 Merchant Loan”) with a lender in the principal amount of $75,000 and received net proceeds of $73,030, net of fees of $1,970, which was reflected as a debt discount to be amortized into interest expense over the term of the note. The July 2024 Merchant Loan requires a weekly payment of principal and interest of $3,022 through April 2025.

 

On August 9, 2024, the Company entered into a Promissory Note and Security Agreement (the “August 2024 Note”) with a Private investor (the “Private Investor”) in the principal amount of $990,000 in connection with the conversion of 8,000 shares Series C Preferred Stock held by the Private Investor with a stated value of $800,000 plus additional cash proceeds from the Private Investor of $190,000. The August 2024 Note consists of $800,000 stated value of Series C Preferred stock converted plus additional cash proceeds of $190,000 received from the Private Investor. The August 2024 Note shall bear interest at 6% per annum. The Company shall pay quarterly interest expense of $14,850 starting on October 1, 2024 and continuing until the maturity date, which is the earlier of August 9, 2027, or a change of control in the Company, as defined in the August 2024 Note. All outstanding principal and unpaid interest is due on the maturity date. The August 2024 Note is secured all assets of the Company.

 

On August 15, 2024, the Company entered into two amendments to its Promissory Note in favor of Diagonal dated March 1, 2024 (“March Note”) in the principal amount of $157,000 (See Note 8). The amendments to the March Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $17,877 (a total payback to the Holder of $160,893). The first payment shall be due August 30, 2024, with 8 subsequent payments due on the 30th day of each month thereafter. The amendments to the March Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the March Note remain the same.

 

On August 15, 2024, the Company entered into two amendments to its April 2024 Note in favor of Diagonal in the principal amount of $127,693 (See Note 8). The amendments to the April 2024 Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $21,980 (a total payback to the Holder of $197,820). The first payment shall be due August 13, 2024, with 8 subsequent payments due on the 15th day of each month thereafter. The amendments to the April 2024 Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the April Note remain the same.

 

On August 15, 2024, the Company entered an amendment to its June 2024 Note in favor of Diagonal in the principal amount of $67,500 (See Note 8). The amendment to the June 2024 Note changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the June Note remain the same. 

v3.24.2.u1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2.u1
Accounting Policies, by Policy (Policies)
6 Months Ended
Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The Company’s unaudited consolidated financial statements include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot Glass. All significant intercompany accounts and transactions have been eliminated in consolidation. 

Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its financial position and the results of its operations for the periods presented. The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

 

Certain information and note disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP has been condensed or omitted from these statements pursuant to such accounting principles and, accordingly, they do not include all the information and notes necessary for comprehensive consolidated financial statements. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the year ended December 31, 2023 of the Company which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024.

Going Concern

Going Concern

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. On June 30, 2024, the Company had cash of $196,315. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail its operations. These unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the six months ended June 30, 2024 and 2023 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. 

Fair Value of Financial Instruments and Fair Value Measurements

Fair Value of Financial Instruments and Fair Value Measurements

The carrying amounts reported in the unaudited consolidated balance sheets for cash, accounts receivable, contract assets and liabilities, notes payable, convertible note payable, accounts payable, accrued expenses, accrued compensation, and lease liabilities approximate their fair market value based on the short-term maturity of these instruments.

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company did not identify any assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 820.

ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

Cash and Cash Equivalents

Cash and Cash Equivalents

For the purposes of the unaudited consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. The Company had no cash equivalents as of June 30, 2024 and December 31, 2023.

 

Accounts Receivable

Accounts Receivable

The Company recognizes an allowance for losses on accounts receivable and notes receivable in an amount equal to the estimated probable losses net of recoveries under the current expected credit loss method. The allowance is based on an analysis of historical bad debt experience, current receivables aging and expected future write-offs, as well as an assessment of specific identifiable customer accounts and notes receivable considered at risk or uncollectible. On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make the required payments (current expected losses). The amount of the allowance is determined principally based on past collection experience and known financial factors regarding specific customers. The expense associated with the allowance for doubtful accounts on accounts receivable is recognized in general and administrative expenses.

Inventory

Inventory

Inventory, consisting of raw materials and finished goods, are stated at lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed the expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are recorded based on estimates and included in cost of sales.

Property and Equipment

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, which range from one to seven years. Leasehold improvements are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over a useful life of 5 years.

Goodwill is not subject to amortization but is subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill by reporting unit at least annually, or when indicators of impairment are present, to determine if goodwill may be impaired. To evaluate goodwill impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of goodwill is less than its carrying value. The Company would not be required to quantitatively determine the fair value of goodwill unless it determines, based on the qualitative assessment there are indicators of impairment. Under the quantitative test of goodwill, the Company compares the fair value of the reporting unit to its carrying value, including goodwill. If the carrying value exceeds the fair value, then the goodwill is impaired by the excess amount. The Company performs its annual testing for goodwill during the fourth quarter of each fiscal year or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit.

Intangible assets determined to have finite lives are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset is the period over which the asset is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates both finite and indefinite lived intangible assets for impairment upon occurrence of events or changes in circumstances that indicate the carrying amount of intangible assets may not be recoverable.

As of December 31, 2023, the Company performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s annual impairment test indicated that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill or intangibles assets was recorded as of December 31, 2023.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

In accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.

 

Warranty Liability

Warranty Liability

The Company provides limited warranties on its products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying unaudited consolidated balance sheets and amounted to $1,000 on June 30, 2024 and December 31, 2023, respectively. During the six months ended June 30, 2024 and 2023, warranty costs were de minimis.

Revenue Recognition

Revenue Recognition

The Company follows ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.

The Company sells its products, which include standard warranties, primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped to the customer and the title is transferred and is recorded net of any discounts or allowances. The warranty does not represent a separate performance obligation.

Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.

Cost of Sales

Cost of Sales

Cost of sales includes inventory costs, packaging costs and warranty expenses.

Cost of revenues from fixed-price contracts for the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements, are accounted for as changes in estimates in the current period. 

Shipping and Handling Costs

Shipping and Handling Costs

Shipping and handling costs incurred for product shipped to customers are included in general and administrative expenses and amounted to $10,272 and $5,577 for the six months ended June 30, 2024 and 2023, respectively. Shipping and handling costs charged to customers are included in sales.

 

Research and Development

Research and Development

Research and development costs incurred in the development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated costs incurred. For the six months ended June 30, 2024 and 2023, research and development costs incurred in the development of the Company’s products were $0.

Advertising Costs

Advertising Costs

The Company may participate in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the six months ended June 30, 2024 and 2023, advertising costs charged to operations were $38,874 and $10,986, respectively, and are included in general and administrative expenses on the accompanying unaudited consolidated statements of operations. These advertising expenses do not include cooperative advertising and sales incentives which shall been deducted from sales.

Federal and State Income Taxes

Federal and State Income Taxes

The Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of June 30, 2024 and December 31, 2023, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. Tax years that remain subject to examination are the years ending on and after December 31, 2018. The Company recognizes interest and penalties related to uncertain income tax positions in other expense. However, no such interest and penalties were recorded as of June 30, 2024 and December 31, 2023.

Stock-Based Compensation

Stock-Based Compensation

Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.

Leases

Leases

The Company accounts for leases in accordance with ASC 842. The lease standard requires certain leases to be reported on the consolidated balance sheets as right-of-use assets and lease liabilities. The Company has elected the practical expedients permitted under the transition guidance of this standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company does not reassess whether any contracts entered into prior to adoption are leases or contain leases.

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company does not have any finance leases as of June 30, 2024 and December 31, 2023. The Company’s leases generally have terms that range from three to four years for property and equipment and five years for property. The Company elected the accounting policy to include both the lease and non-lease components of our agreements as a single component and account for them as a lease.

 

Lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on the Company’s current borrowing rate. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

When the Company has the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that the Company will exercise the option, the Company considers these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

Loss Per Common Share

Loss Per Common Share

ASC 260 “Earnings Per Share”, requires dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in the future.

The following table presents a reconciliation of basic and diluted net income (loss) per common share:

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Net (loss) income per common share - basic:                    
Net (loss) income attributable to common shareholders  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Net (loss) income per common share – basic  $(0.00)  $0.01   $(0.00)  $0.01 
                     
Net (loss) income per common share - diluted:                    
Net (loss) income attributable to common shareholders - basic  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Add: preferred stock dividends   
-
    13,618    
-
    27,305 
Add: interest of convertible debt   
-
    52,618    
-
    102,639 
Numerator for (loss) income per common share – diluted  $(263,925)  $3,845,531   $(595,432)  $3,189,187 
                     
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Add: dilutive shares related to:                    
Convertible debt   
-
    1,145,833,333    
-
    1,145,833,333 
Series B preferred   
-
    324,240,164    
-
    324,240,164 
Series C preferred   
-
    386,250,000    
-
    386,250,000 
Weighted average common shares outstanding – diluted   543,165,027    2,349,380,186    539,431,386    2,314,606,932 
Net (loss) income per common share – diluted  $(0.00)  $0.00   $(0.00)  $0.00 

For the three and six months ended June 30, 2023, stock options and warrants were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income. For the three and six months ended June 30, 2024, all potentially dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net losses. As of June 30, 2024 and 2023, common share equivalents and potentially dilutive securities consisted of the following: 

   June 30, 
   2024   2023 
Stock options   7,345,698    8,445,698 
Warrants   33,400,000    34,000,000 
Series B preferred stock   357,819,360    324,240,164 
Series C preferred stock   450,258,000    386,250,000 
Convertible debt   1,220,101,111    1,145,833,333 
    2,068,924,169    1,898,769,195 

 

Segment Reporting

Segment Reporting

Prior to May 8, 2023, the Company operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions. The Company’s reportable segments were strategic business units that offered different products and were managed separately based on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond nanoShield™ product line and the remaining segment (1) as described above was combined into segment (2) and is now being managed together (see Note 16).

Noncontrolling Interest

Noncontrolling Interest

The Company accounts for noncontrolling interest in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total shareholders’ deficit on the unaudited consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest be clearly identified and presented on the face of the unaudited consolidated statements of operations.

Risk and Uncertainties

Risk and Uncertainties

The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The adoption of this standard on January 1, 2024 had no impact on the Company’s unaudited consolidated financial statements.

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

v3.24.2.u1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Common Share The following table presents a reconciliation of basic and diluted net income (loss) per common share:
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Net (loss) income per common share - basic:                    
Net (loss) income attributable to common shareholders  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Net (loss) income per common share – basic  $(0.00)  $0.01   $(0.00)  $0.01 
                     
Net (loss) income per common share - diluted:                    
Net (loss) income attributable to common shareholders - basic  $(263,925)  $3,779,295   $(595,432)  $3,059,243 
Add: preferred stock dividends   
-
    13,618    
-
    27,305 
Add: interest of convertible debt   
-
    52,618    
-
    102,639 
Numerator for (loss) income per common share – diluted  $(263,925)  $3,845,531   $(595,432)  $3,189,187 
                     
Weighted average common shares outstanding – basic   543,165,027    493,056,689    539,431,386    458,283,435 
Add: dilutive shares related to:                    
Convertible debt   
-
    1,145,833,333    
-
    1,145,833,333 
Series B preferred   
-
    324,240,164    
-
    324,240,164 
Series C preferred   
-
    386,250,000    
-
    386,250,000 
Weighted average common shares outstanding – diluted   543,165,027    2,349,380,186    539,431,386    2,314,606,932 
Net (loss) income per common share – diluted  $(0.00)  $0.00   $(0.00)  $0.00 
Schedule of Common Share Equivalents and Potentially Dilutive Securities As of June 30, 2024 and 2023, common share equivalents and potentially dilutive securities consisted of the following:
   June 30, 
   2024   2023 
Stock options   7,345,698    8,445,698 
Warrants   33,400,000    34,000,000 
Series B preferred stock   357,819,360    324,240,164 
Series C preferred stock   450,258,000    386,250,000 
Convertible debt   1,220,101,111    1,145,833,333 
    2,068,924,169    1,898,769,195 

 

v3.24.2.u1
Accounts Receivable (Tables)
6 Months Ended
Jun. 30, 2024
Accounts Receivable [Abstract]  
Schedule of Accounts Receivable On June 30, 2024 and December 31, 2023, accounts receivable consisted of the following:
   June 30,
2024
   December 31,
2023
 
Accounts receivable  $304,525   $459,414 
Less: allowance for doubtful accounts   (61,156)   (35,323)
Accounts receivable, net  $243,369   $424,091 
v3.24.2.u1
Inventory (Tables)
6 Months Ended
Jun. 30, 2024
Inventory [Abstract]  
Schedule of Inventory On June 30, 2024 and December 31, 2023, inventory consisted of the following:
   June 30,
2024
   December 31,
2023
 
Finished goods  $162,052   $181,663 
Total Inventory  $162,052   $181,663 
v3.24.2.u1
Property and Equipment (Tables)
6 Months Ended
Jun. 30, 2024
Property and Equipment [Abstract]  
Schedule of Property and Equipment On June 30, 2024 and December 31, 2023, property and equipment consisted of the following:
   Useful Life  June 30,
2024
   December 31,
2023
 
Machinery and equipment  5 – 7 years  $73,411   $73,411 
Furniture and office equipment  3 – 7 years   2,061    2,061 
Vehicles  1 – 5 years   68,050    68,050 
Leasehold improvements  3 – 5 years   110,645    110,645 
       254,167    254,167 
Less: accumulated depreciation      (106,325)   (82,561)
Property and equipment, net     $147,842   $171,606 
v3.24.2.u1
Intangible Assets and Goodwill (Tables)
6 Months Ended
Jun. 30, 2024
Intangible Assets and Goodwill [Abstract]  
Schedule of Intangible Assets and Goodwill On June 30, 2024 and December 31, 2023, intangible assets and goodwill, which were acquired from Patriot Glass in 2021, consisted of the following:
   Useful life  June 30,
2024
   December 31,
2023
 
Customer relations  5 years  $212,516   $212,516 
Non-compete  5 years   40,000    40,000 
Trade name (non-amortizable) 
-
   100,000    100,000 
       352,516    352,516 
Less: accumulated amortization      (148,353)   (123,102)
Intangible assets, net     $204,163   $229,414 
   Useful life  June 30,
2024
   December 31,
2023
 
Goodwill  -  $350,491   $350,491 

 

Schedule of Amortization of Intangible Assets Amortization of intangible assets with identifiable useful lives that is attributable to future periods is as follows:
Twelve months ending June 30:  Amount 
2025  $50,503 
2026   50,503 
2027   3,157 
Total  $104,163 
v3.24.2.u1
Convertible Notes Payable (Tables)
6 Months Ended
Jun. 30, 2024
Convertible Note Payable [Abstract]  
Schedule of Convertible Notes Payable On June 30, 2024 and December 31, 2023, convertible notes payable consisted of the following:
   June 30,
2024
   December 31,
2023
 
Convertible note payable  $1,008,091   $1,098,091 
Convertible note payable, net   1,008,091    1,098,091 
Less: current portion of convertible note payable   (180,000)   (180,000)
Convertible note payable – long-term  $828,091   $918,091 
Schedule of Future Annual Maturities of Convertible Note Payable On June 30, 2024, future annual maturities of convertible note payable are as follows:
June 30,  Amount 
2025  $180,000 
2026   180,000 
2027   648,091 
Total convertible note payable on June 30, 2024  $1,008,091 
v3.24.2.u1
Notes Payable (Tables)
6 Months Ended
Jun. 30, 2024
Notes Payable [Abstract]  
Schedule of Notes Payable On June 30, 2024 and December 31, 2023, notes payable consisted of the following:
   June 30,
2024
   December 31,
2023
 
Notes payable  $553,469   $105,958 
Note payable – PPP note   13,864    18,823 
Total notes payable   567,333    124,781 
Less: unamortized debt discount   (59,842)   (764)
Note payable, net   507,491    124,017 
Less: current portion of notes payable, net of discount   (474,014)   (81,908)
Notes payable – long-term  $33,477   $42,109 
Schedule of Notes Payable Monthly Payment Monthly payments of principal and interest was as follows:
Payment Date:  Amount 
August 30, 2024  $87,920 
September 30, 2024   21,980 
October 30, 2024   21,980 
November 30, 2024   21,980 
December 30, 2024   21,980 
Total  $175,840 
Monthly payments of principal and interest on the April 2024 Note was as follows:
Payment Date:  Amount 
August 15, 2024  $85,810 
September 15, 2024 through February 15, 2025 (6 monthly payments)   57,206 
Total  $143,016 
Schedule of Future Annual Maturities of Notes Payable On June 30, 2024, future annual maturities of notes payable are as follows:
June 30,  Amount 
2025  $533,856 
2026   16,654 
2027   7,013 
2028   7,751 
2029   2,059 
Total notes payable on June 30, 2024  $567,333 
v3.24.2.u1
Shareholders' Deficit (Tables)
6 Months Ended
Jun. 30, 2024
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock Option Activities During the six months ended June 30, 2024 and 2023, Series B preferred stock activity is as follows:
   For the Six Months Ended
June 30, 2024
   For the Six Months Ended
June 30, 2023
 
   Number of
Shares
   Amount   Number of
Shares
   Amount 
Balance at beginning of period   1,144   $1,203,967    1,000   $1,037,201 
Shares issued for accrued compensation   312    312,000    144    144,000 
Shares issued for compensation   50    50,000    
-
    
-
 
Shares and accrued dividends forfeited   (317)   (334,009)   
-
    
-
 
Dividends accrued   
-
    13,355    
-
    11,226 
Balance at end of period   1,189   $1,245,313    1,144   $1,192,427 

 

During the six months ended June 30, 2024 and 2023, Series C preferred stock activity is as follows:
   For the Six Months Ended
June 30, 2024
   For the Six Months Ended
June 30, 2023
 
   Number of Shares   Amount   Number of Shares   Amount 
Balance at beginning of period   15,150   $1,621,160    17,290   $1,803,731 
Conversion of Series C shares to common shares   (600)   (60,000)   (1,840)   (184,000)
Dividends accrued   
-
    14,743    
-
    16,079 
Balance at end of period   14,550   $1,575,903    15,450   $1,635,810 
Schedule of Activity Related to Non-Vested Shares The following table summarizes activity related to non-vested shares:
   Number of
Non-Vested
Shares
   Weighted
Average
Grant Date
Fair Value
 
Non-vested, December 31, 2023   14,970,120   $0.132 
Shares vested   
-
    
-
 
Non-vested, June 30, 2024   14,970,120   $0.132 
Warrant [Member]  
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock Option Activities Warrant activities for the six months ended June 30, 2024 are summarized as follows:
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Balance Outstanding December 31, 2023   34,000,000   $0.011    2.73   $
      -
 
Expired   (600,000)   
-
    
-
    
-
 
Balance Outstanding June 30, 2024   33,400,000   $0.01    2.28   $
-
 
Exercisable, June 30, 2024   33,400,000   $0.01    2.28   $
-
 

 

Stock Options [Member]  
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock Option Activities Stock option activities for the six months ended June 30, 2024 are summarized as follows:
   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Balance Outstanding, December 31, 2023   8,445,698   $0.40    2.43    
       -
 
Expired   (1,100,000)   
-
    
-
    
-
 
Balance Outstanding, June 30, 2024   7,345,698   $0.44    2.25   $
-
 
Exercisable, June 30, 2024   7,345,698   $0.44    2.25   $
-
 
v3.24.2.u1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Schedule of Reportable Business Segments Information with respect to these reportable business segments for the three and six months ended June 30, 2024 and 2023 was as follows:
   For the Three Months Ended
June 30,
   For the Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Revenues:                
C-Bond  $
-
   $31,166   $
-
   $124,372 
Patriot Glass   863,533    382,889    1,800,337    804,903 
    863,533    414,055    1,800,337    929,275 
Depreciation and amortization:                    
C-Bond   
-
    132    
-
    569 
Patriot Glass   24,508    20,413    49,015    40,826 
    24,508    20,545    49,015    41,395 
Interest expense:                    
C-Bond   171    357    171    357 
Patriot Glass   18,140    6,655    27,081    11,798 
Other (a)   35,297    161,141    40,475    355,483 
    53,608    168,153    67,727    367,638 
Net income (loss):                    
C-Bond   (225,255)   3,759,343    (147,411)   3,483,967 
Patriot Glass   21,033    (93,201)   68,584    (176,813)
Other (a)   (41,747)   108,131    (474,790)   (255,968)
   $(245,969)  $3,774,273   $(553,617)  $3,051,186 
(a)The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
Schedule of Identifiable Long-Lived Tangible Assets
   June 30,
2024
   December 31,
2023
 
Identifiable long-lived tangible assets on June 30, 2024 and December 31, 2023 by segment:          
C-Bond  $
-
   $
-
 
Patriot Glass   147,842    171,606 
   $147,842   $171,606 
(a)The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
v3.24.2.u1
Revenue Recognition (Tables)
6 Months Ended
Jun. 30, 2024
Revenue Recognition [Abstract]  
Schedule of Revenue by Product The Company tracks its revenue by product. The following table summarizes our revenue by product for the six months ended June 30, 2024 and 2023:
   For the Six Months Ended
June 30,
 
   2024   2023 
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems  $33,537   $9,709 
C-Bond nanoShield solution sales   
-
    112,413 
Window tint installation and sales recognized over time   1,766,800    804,903 
Freight and delivery   
-
    2,250 
Total  $1,800,337   $929,275 
v3.24.2.u1
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Tables)
6 Months Ended
Jun. 30, 2024
Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities [Abstract]  
Schedule of Right-of-Use Asset On June 30, 2024 and December 31, 2023, right-of-use asset (“ROU”) is summarized as follows:
   June 30,
2024
   December 31,
2023
 
Office leases and office equipment right of use assets  $279,162   $279,162 
Less: accumulated amortization   (150,440)   (120,678)
Balance of ROU assets  $128,722   $158,484 
Schedule of Operating Lease Liabilities Related to the ROU Assets On June 30, 2024 and December 31, 2023, operating lease liabilities related to the ROU assets are summarized as follows:
   June 30,
2024
   December 31,
2023
 
Lease liabilities related to office leases right of use assets  $128,722   $157,752 
Less: current portion of lease liabilities   (60,773)   (60,503)
Lease liabilities – long-term  $67,949   $97,249 
Schedule of Future Minimum Base Lease Payments Due Under Non-Cancelable Operating Leases On June 30, 2024, future minimum base lease payments due under non-cancelable operating leases are as follows:
Twelve months ending June 30,  Amount 
2025  $72,715 
2026   67,200 
2027   5,600 
Total minimum non-cancelable operating lease payments   145,515 
Less: discount to fair value   (16,793)
Total lease liability on June 30, 2024  $128,722 
v3.24.2.u1
Nature of Organization (Details)
6 Months Ended
May 08, 2023
Jul. 22, 2021
USD ($)
shares
Jun. 30, 2024
Nature of Organization [Line Items]      
Number of operating segments 1   2
Exchange Agreement [Member]      
Nature of Organization [Line Items]      
Ownership percentage   80.00%  
Option Period [Member]      
Nature of Organization [Line Items]      
Ownership percentage     20.00%
Additional Units [Member]      
Nature of Organization [Line Items]      
Ownership percentage     20.00%
Common Stock [Member]      
Nature of Organization [Line Items]      
Restricted shares exchanged (in Shares) | shares   28,021,016  
Average closing price (in Dollars) | $   $ 800,000  
v3.24.2.u1
Summary of Significant Accounting Policies (Details)
3 Months Ended 6 Months Ended 12 Months Ended
May 08, 2023
segments
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Jun. 30, 2024
USD ($)
segments
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
May 31, 2024
USD ($)
Dec. 31, 2022
USD ($)
Summary of Significant Accounting Policies [Line Items]                    
Net loss   $ (245,969) $ (307,648) $ 3,774,273 $ (723,087) $ (553,617) $ 3,051,186      
Net cash used in operations           (812,054) (912,997)      
Accumulated deficit   (61,447,146)       (61,447,146)   $ (60,851,714)    
Shareholders’ deficit   (4,185,273) $ (4,151,924) (3,167,766) $ (7,280,906) (4,185,273) (3,167,766) $ (4,324,535)   $ (7,050,669)
Working capital deficit   1,265,758       1,265,758        
Cash   196,315       196,315        
Number of reporting unit               1    
Accrued expenses   1,000       1,000   $ 1,000 $ 175,000  
General and administrative expenses   $ 169,357   $ 142,404   365,048 321,304      
Research and development costs incurred           $ 0 0      
Number of reportable segments (in segments) | segments 2         2        
Finite-Lived Intangible Assets [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   5 years       5 years        
C-Bond Systems, LLC [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Ownership percentage   80.00%       80.00%        
Shipping and Handling [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
General and administrative expenses           $ 10,272 5,577      
Leasehold Improvements [Member] | Minimum [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   3 years       3 years        
Leasehold Improvements [Member] | Maximum [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   5 years       5 years        
Leasehold Improvements [Member] | Property, Plant and Equipment [Member] | Minimum [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   1 year       1 year        
Leasehold Improvements [Member] | Property, Plant and Equipment [Member] | Maximum [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   7 years       7 years        
Property, Plant and Equipment [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   5 years       5 years        
Property, Plant and Equipment [Member] | Minimum [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   3 years       3 years        
Property, Plant and Equipment [Member] | Maximum [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   4 years       4 years        
Property [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Useful life   5 years       5 years        
General and Administrative Expense [Member]                    
Summary of Significant Accounting Policies [Line Items]                    
Advertising cost           $ 38,874 $ 10,986      
v3.24.2.u1
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Common Share - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Net (loss) income per common share - basic:        
Net (loss) income attributable to common shareholders (in Dollars) $ (263,925) $ 3,779,295 $ (595,432) $ 3,059,243
Weighted average common shares outstanding – basic 543,165,027 493,056,689 539,431,386 458,283,435
Net (loss) income per common share – basic (in Dollars per share) $ 0 $ 0.01 $ 0 $ 0.01
Net (loss) income per common share - diluted:        
Net (loss) income attributable to common shareholders - basic (in Dollars) $ (263,925) $ 3,779,295 $ (595,432) $ 3,059,243
Add: preferred stock dividends (in Dollars) 13,618 27,305
Add: interest of convertible debt (in Dollars) 52,618 102,639
Numerator for (loss) income per common share – diluted (in Dollars) $ (263,925) $ 3,845,531 $ (595,432) $ 3,189,187
Weighted average common shares outstanding – basic 543,165,027 493,056,689 539,431,386 458,283,435
Add: dilutive shares related to:        
Dilutive shares 543,165,027 2,349,380,186 539,431,386 2,314,606,932
Net (loss) income per common share – diluted (in Dollars per share) $ 0 $ 0 $ 0 $ 0
Convertible Debt [Member]        
Add: dilutive shares related to:        
Dilutive shares 1,145,833,333 1,145,833,333
Series B Preferred [Member]        
Add: dilutive shares related to:        
Dilutive shares 324,240,164 324,240,164
Series A Preferred [Member]        
Add: dilutive shares related to:        
Dilutive shares 386,250,000 386,250,000
v3.24.2.u1
Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities - shares
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 2,068,924,169 1,898,769,195
Warrants [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 33,400,000 34,000,000
Series B preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 357,819,360 324,240,164
Series C preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 450,258,000 386,250,000
Convertible debt [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 1,220,101,111 1,145,833,333
Stock options [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 7,345,698 8,445,698
v3.24.2.u1
Accounts Receivable (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Accounts Receivable [Abstract]    
Bad debt expense $ 23,094
Bad debt recovery $ 2,739  
v3.24.2.u1
Accounts Receivable (Details) - Schedule of Accounts Receivable - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Accounts Receivable [Abstract]    
Accounts receivable $ 304,525 $ 459,414
Less: allowance for doubtful accounts (61,156) (35,323)
Accounts receivable, net $ 243,369 $ 424,091
v3.24.2.u1
Inventory (Details) - Schedule of Inventory - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Inventory [Abstract]    
Finished goods $ 162,052 $ 181,663
Total Inventory $ 162,052 $ 181,663
v3.24.2.u1
Property and Equipment (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
General and Administrative Expense [Member]    
Property and Equipment [Abstract]    
Depreciation expense $ 23,764 $ 16,143
v3.24.2.u1
Property and Equipment (Details) - Schedule of Property and Equipment - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross $ 254,167 $ 254,167
Less: accumulated depreciation (106,325) (82,561)
Property and equipment, net 147,842 171,606
Machinery and equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 73,411 73,411
Furniture and office equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 2,061 2,061
Vehicles [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 68,050 68,050
Leasehold improvements [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross $ 110,645 $ 110,645
Minimum [Member] | Machinery and equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 5 years  
Minimum [Member] | Furniture and office equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 3 years  
Minimum [Member] | Vehicles [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 1 year  
Minimum [Member] | Leasehold improvements [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 3 years  
Maximum [Member] | Machinery and equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 7 years  
Maximum [Member] | Furniture and office equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 7 years  
Maximum [Member] | Vehicles [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 5 years  
Maximum [Member] | Leasehold improvements [Member]    
Schedule of Property and Equipment [Line Items]    
Estimated Useful Life 5 years  
v3.24.2.u1
Intangible Assets and Goodwill (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Intangible Assets and Goodwill [Line Items]      
Amortizable intangible assets $ 25,251 $ 25,252  
Customer Relations [Member]      
Intangible Assets and Goodwill [Line Items]      
Accumulated amortization 124,853   $ 103,602
Non-compete [Member]      
Intangible Assets and Goodwill [Line Items]      
Accumulated amortization $ 23,500   $ 19,500
v3.24.2.u1
Intangible Assets and Goodwill (Details) - Schedule of Intangible Assets and Goodwill - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Intangible Assets and Goodwill [Line Items]    
Intangible assets, Gross $ 352,516 $ 352,516
Less: accumulated amortization (148,353) (123,102)
Intangible assets, net 204,163 229,414
Goodwill $ 350,491 350,491
Customer relations [Member]    
Schedule of Intangible Assets and Goodwill [Line Items]    
Intangible asset, Useful life 5 years  
Intangible assets, Gross $ 212,516 212,516
Non-compete [Member]    
Schedule of Intangible Assets and Goodwill [Line Items]    
Intangible asset, Useful life 5 years  
Intangible assets, Gross $ 40,000 40,000
Trade name (non-amortizable) [Member]    
Schedule of Intangible Assets and Goodwill [Line Items]    
Intangible asset, Useful life  
Intangible assets, Gross $ 100,000 $ 100,000
v3.24.2.u1
Intangible Assets and Goodwill (Details) - Schedule of Amortization of Intangible Assets
Jun. 30, 2024
USD ($)
Schedule of Amortization of Intangible Assets [Abstract]  
2025 $ 50,503
2026 50,503
2027 3,157
Total $ 104,163
v3.24.2.u1
Convertible Notes Payable (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 15, 2023
Dec. 04, 2023
May 11, 2023
May 01, 2023
Apr. 01, 2023
Mar. 17, 2023
Dec. 27, 2022
Nov. 09, 2022
Oct. 15, 2022
Sep. 06, 2022
Jul. 26, 2022
Jun. 23, 2022
Apr. 20, 2022
Oct. 15, 2021
Apr. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2024
Sep. 30, 2024
Jun. 27, 2024
May 04, 2024
Mar. 31, 2024
Mar. 17, 2024
May 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Nov. 30, 2022
Apr. 30, 2022
Convertible Notes Payable [Line Items]                                                              
Exercise price of per share (in Dollars per share)                                                             $ 0.009
Interest rate                             35.00%     35.00%                          
Purchase of promissory notes                   $ 176,000 $ 176,000 $ 176,000                                      
Legal fees       $ 2,250 $ 2,250                                                    
Outstanding principal balance rate                               125.00%   125.00%                          
Accrued interest rate per annum                               18.00%   18.00%                          
Debt instrument trading days                                   10 days                          
Percentage of excess assets                               50.00%   50.00%                          
Future financings percentage                                   30.00%                          
Conversion price per share (in Dollars per share)                   $ 0.009     $ 0.00875                                    
Penalty                 $ 206,250                                            
Principal amount percentage                 25.00%                                            
Interest expense                               $ 53,608 $ 168,153 $ 67,727 $ 367,638                        
Accrued interest of percentage                 18.00%                                            
Payments                                   $ 17,877                          
Aggregate payment   $ 1,113,091                                                          
Capital Raise Payments                                   20.00%                          
Net proceeds of company                   $ 158,920 158,920 $ 148,420                                      
Capital raise payment                                   $ 120,000                          
Payment amount $ 15,000                                                            
Accrued interest percentage                               15.00%   15.00%             20.00%            
Accrued interest due                               $ 176,184   $ 176,184                 $ 160,880        
Debt premium     $ 119,943                                                   $ 90,731 $ 90,731  
Loss on debt extinguishment     $ 119,943                         462,581 347,990 462,581                        
Debt discount                                   22,459 95,922                        
Diagonal Lending Convertible Debt [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Principal amount           $ 54,250 $ 64,250 $ 104,250                                              
Purchase of promissory notes           50,000 60,000 100,000                                              
Net fees           $ 4,250 $ 4,250 $ 4,250                                              
Mercer Street Global Opportunity Fund, LLC [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Original issue discount percentage                           10.00%                                  
Original issue discounts                           $ 75,000                                  
Receiving gross proceeds                                   500,000                          
Net proceeds of company                                   $ 600,000                          
Securities Purchase Agreement [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Principal amount                     $ 19,000   $ 825,000 $ 825,000                                  
Exercise price of per share (in Dollars per share)                           $ 0.05                                  
Interest rate                           50.00%                                  
Purchase of promissory notes                           $ 680,000                                  
Mercer Convertible Debt [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Placement fees                           60,000                                  
Legal fees                           $ 10,000                                  
Interest rate percentage                               4.00%   4.00%                          
Conversion price per share (in Dollars per share)                               $ 0.025   $ 0.025                         $ 0.009
Matured date                         Oct. 15, 2022                                    
Principal balance                               $ 1,008,091   $ 1,008,091   $ 1,098,091                      
Accrued interest payable                                   176,184   176,184                      
Amortization of debt discounts                               $ 0 $ 2,627 $ 0 $ 2,627                        
Exchange Agreement [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Original issue discount percentage                         10.00%                                    
Conversion price per share (in Dollars per share)                               $ 0.0125   $ 0.0125                          
Aggregate shares (in Shares)                         33,000,000                                    
Interest expense                 $ 206,250                                            
October 15, 2022 [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Interest rate percentage                         4.00%                                    
Letter Agreement [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Payments   15,000                                                          
Balloon payment   $ 588,091                                                          
Diagonal Lending Convertible Debt [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Interest rate percentage                                             12.00% 12.00%   12.00%          
Debt discount                                   $ 176,184   $ 176,184                      
Mercer Convertible Debt [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Exercise price of per share (in Dollars per share)                         $ 0.025                                    
Excess outstanding shares percentage                                   4.99%                          
Limitation exceeds                                   9.99%                          
Debt instrument trading days                                   5 days                          
Debt premium                                                       $ 29,212      
Warrant [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Purchase of warrant issued (in Shares)                           16,500,000                                  
Forecast [Member]                                                              
Convertible Notes Payable [Line Items]                                                              
Accrued interest percentage                                         5.00% 10.00%                  
v3.24.2.u1
Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Convertible Notes Payable [Abstract]    
Convertible note payable $ 1,008,091 $ 1,098,091
Convertible note payable, net 1,008,091 1,098,091
Less: current portion of convertible note payable (180,000) (180,000)
Convertible note payable – long-term $ 828,091 $ 918,091
v3.24.2.u1
Convertible Notes Payable (Details) - Schedule of Future Annual Maturities of Convertible Note Payable - Convertible Notes Payable [Member]
Jun. 30, 2024
USD ($)
Schedule of Future Annual Maturities of Convertible Note Payable [Abstract]  
2025 $ 180,000
2026 180,000
2027 648,091
Total notes payable on June 30, 2024 $ 1,008,091
v3.24.2.u1
Notes Payable (Details) - Part-2 - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 05, 2024
Apr. 08, 2024
Mar. 04, 2024
Mar. 01, 2024
Feb. 08, 2024
Jan. 02, 2024
Jun. 03, 2023
May 31, 2023
May 11, 2023
May 01, 2023
Apr. 03, 2023
Apr. 01, 2023
Feb. 06, 2023
Nov. 22, 2022
Sep. 06, 2022
Jul. 26, 2022
Jun. 23, 2022
Apr. 20, 2022
Mar. 14, 2022
Oct. 15, 2021
Nov. 14, 2018
Apr. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Apr. 10, 2024
Jun. 07, 2023
Nov. 08, 2022
Note Payable [Line Items]                                                                
Paid principal balance                                                   $ 160,893            
Shares issued (in Shares)                                                         998,008      
Settlement amount                                             $ 567,333     567,333   $ 124,781        
Issued value amount             $ 16,950       $ 22,500   $ 40,000                                      
Shares issued, price (in Dollars per share)             $ 0.0011       $ 0.0045   $ 0.006                                      
Debt extinguishment                                                   347,097            
Fair value disclosure measurement               $ 132,000                                                
Forgiveness of interest due               317,293                                                
Net proceeds of company                             $ 158,920 $ 158,920 $ 148,420                              
Fees expenses                   $ 2,250   $ 2,250                                        
Loss on debt extinguishment                 $ 119,943                           $ 462,581   347,990 $ 462,581          
Purchase of promissory notes                             $ 176,000 176,000 176,000                              
Conversion of common stock shares issued (in Shares)         120 312                                                    
Conversion of common stock amount issued                   $ 62,000   62,000                                        
Original issuance discount                                             59,842     59,842   764        
Loan payments                                                   17,877            
Accrued interest due               $ 160,880                             176,184     $ 176,184            
Maturity term                             12 months                                  
Interest rate                                           35.00%       35.00%            
Common stock trading price per share (in Dollars per share)                             $ 0.009                                  
Conversion price per share (in Dollars per share)                             $ 0.009     $ 0.00875                            
Interest rate percentage     12.00%                                                     12.00%    
One-time interest charge amount $ 8,775                                                              
Discount rate 35.00% 35.00%                                                            
Percentage of outstanding shares of common stock 4.99% 4.99%                                                            
Principal amount due                                                   $ 157,000   0        
Monthly payments of principal and interest 9 months                                                              
Lender [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)               22,000,000                                                
Issued value amount               $ 132,000                                                
Shares issued, price (in Dollars per share)               $ 0.006                                                
Maximum Loan Amount [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                         $ 400,000                      
BOCO Investment Note [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                         $ 400,000                      
Interest rate percentage                                         12.00%                      
Bear interest rate during the period                                         18.00%                      
Debt Exchange and Release Agreement [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount               $ 68,000                                                
Paid principal balance               $ 200,000                                                
Shares issued (in Shares)               22,000,000                                                
Settlement amount               $ 200,000                                                
Debt Exchange and Release Agreement [Member] | Lender [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount               400,000                                                
Release Agreement [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)                   22,000,000                                            
Settlement amount               200,000                                                
Accrued interest               317,293                                                
GS Capital Note [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                             0     0   0        
Paid principal balance               34,120                                                
Securities Purchase Agreement [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                               19,000   $ 825,000   $ 825,000                        
Purchase of promissory notes                                       $ 680,000                        
Debt discount                                                         $ 30,326      
Interest rate                                       50.00%                        
GS Capital June 2022 [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                 19,000                              
Paid principal balance                                                       79,488 $ 53,512      
GS Capital Debt [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                               $ 195,000                                
Interest rate percentage                               8.00%                                
Accrued interest                   $ 4,139   $ 4,139                                        
Loss on debt extinguishment                                                   25,400            
Accrued expenses                                             0     0   0        
Loan payments                             $ 23,400 $ 21,060                                
Interest rate                             8.00%                                  
Conversion price per share (in Dollars per share)                             $ 0.0032                                  
July 2022 Commitment Shares [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)                                                         2,600,000      
GS Capital July 2022 Note [Member]                                                                
Note Payable [Line Items]                                                                
Accrued expenses                                             0     0            
September 2022 Note [Member]                                                                
Note Payable [Line Items]                                                                
Paid principal balance                             $ 195,000                                  
Placement Agent [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)                                                         773,626      
GS Capital September 2022 [Member]                                                                
Note Payable [Line Items]                                                                
Accrued interest                                                   0   0        
1800 Diagonal Lending Note Payable - March 2024 [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount       $ 125,000                                                        
Interest rate percentage     220.00%                                                          
Bear interest rate during the period     22.00%                                                          
Interest rate       65.00%                                                        
Aggregate principal amount       $ 157,000                                                        
Original issue discount     $ 13,000                                                          
One-time interest charge amount     $ 19,000                                                          
Conversion price per share (in Dollars per share)     $ 0.0025                                                          
Trading days       10 days                                                        
Discount rate       35.00%                                                        
Percentage of outstanding shares of common stock       4.99%                                                        
1800 Diagonal Lending Note Payable – April 2024 [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                                           $ 100,000    
Interest rate percentage   220.00%                                                            
Bear interest rate during the period   22.00%                                                            
Interest rate   65.00%                                                            
Aggregate principal amount   $ 127,693                                                            
Conversion price per share (in Dollars per share)   $ 0.0025                                                            
Trading days   10 days                                                            
Principal amount due                                                   127,693   0        
1800 Diagonal Lending Note Payable – June 2024 [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount $ 50,000                                                              
Interest rate percentage 220.00%                                                              
Bear interest rate during the period 22.00%                                                              
Interest rate 65.00%                                                              
Aggregate principal amount $ 67,500                                                              
Original issue discount $ 17,500                                                              
Conversion price per share (in Dollars per share) $ 0.0025                                                              
Trading days 10 days                                                              
Principal amount due                                                   67,500   0        
Notes Payable [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount               200,000                                                
Debt extinguishment               385,293                                                
Notes Payable [Member] | Lender [Member]                                                                
Note Payable [Line Items]                                                                
Debt extinguishment               68,000                                                
March 2022 Note [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                     $ 197,500       0     0   0        
Net proceeds of company                                     175,000                          
Fees expenses                                     $ 22,500                          
November 2022 Note [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                           $ 65,000                 $ 0     $ 0   0       $ 200,000
Bear interest rate during the period                           8.00%                                    
Net proceeds of company                           $ 62,500                                    
Fees expenses                           $ 2,500                                    
Loss on debt extinguishment               $ 18,900                                                
GS Capital July 2022 Note [Member]                                                                
Note Payable [Line Items]                                                                
Accrued expenses                                                       $ 0        
GS Capital July 2022 Note [Member] | Securities Purchase Agreement [Member]                                                                
Note Payable [Line Items]                                                                
Principal amount                                 $ 195,000                              
GS Capital July 2022 Note [Member] | July 2022 Commitment Shares [Member]                                                                
Note Payable [Line Items]                                                                
Original issuance discount                                                         $ 34,606      
September 2022 Commitment Shares [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)                                                         3,300,000      
September 2022 Commitment Shares [Member] | September 2022 Agreement [Member]                                                                
Note Payable [Line Items]                                                                
Original issuance discount                             $ 19,000                                  
Common Stock [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)                                                 9,636,364              
Shares issued, price (in Dollars per share)                                                             $ 0.0104  
Conversion of common stock shares issued (in Shares)                   21,371,481   21,371,481                                        
Conversion of common stock amount issued           $ 45,161                                                    
Common Stock [Member] | GS Capital Note [Member]                                                                
Note Payable [Line Items]                                                                
Conversion of common stock amount issued                   $ 62,000   $ 62,000                                        
Common Stock [Member] | March 2022 Note [Member]                                                                
Note Payable [Line Items]                                                                
Shares issued (in Shares)                                                         1,750,000      
v3.24.2.u1
Notes Payable (Details) - Part-3 - USD ($)
6 Months Ended 12 Months Ended
Jun. 17, 2024
Feb. 21, 2024
Nov. 22, 2022
Nov. 08, 2022
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jul. 22, 2021
May 10, 2021
Note Payable [Line Items]                  
Net proceeds       $ 200,000          
Bear interest percentage       8.00%          
Original issuance discount         $ 59,842   $ 764    
Principal amount due         157,000   0    
Debt discounts         22,459 $ 93,295      
Other Notes Payable [Member] | Vehicle and Equipment Loans [Member]                  
Note Payable [Line Items]                  
Principal amount             117,721    
Principal amount due         71,006   97,708    
Other Notes Payable [Member]                  
Note Payable [Line Items]                  
Collateralized assets         98,573        
February 2024 Note [Member]                  
Note Payable [Line Items]                  
Principal amount   $ 50,000              
Net proceeds   $ 49,000              
Bear interest rate during the period   33.40%              
Principal amount due         40,920        
February 2024 Note [Member] | Patriot Glass [Member]                  
Note Payable [Line Items]                  
Original issuance discount   $ 1,000              
June 2024 Merchant Loan [Member]                  
Note Payable [Line Items]                  
Principal amount $ 85,000                
Net proceeds $ 81,550                
Bear interest rate during the period 85.90%                
Principal amount due         83,824        
Weekly payment $ 2,988                
June 2024 Merchant Loan [Member] | Patriot Glass [Member]                  
Note Payable [Line Items]                  
Original issuance discount $ 3,450                
Promissory Note [Member]                  
Note Payable [Line Items]                  
Principal amount                 $ 500,000
Interest rate percentage                 8.00%
Vehicle and Equipment Loans [Member]                  
Note Payable [Line Items]                  
Principal amount               $ 95,013  
Principal amount due         5,526   8,250    
November 2022 Note [Member]                  
Note Payable [Line Items]                  
Principal amount     $ 65,000 $ 200,000 $ 0   $ 0    
Bear interest rate during the period     8.00%            
Minimum [Member] | Vehicle and Equipment Loans [Member]                  
Note Payable [Line Items]                  
Interest rate percentage             10.00%    
Minimum [Member] | Patriot Glass [Member]                  
Note Payable [Line Items]                  
Interest rate percentage               6.79%  
Maximum [Member] | Vehicle and Equipment Loans [Member]                  
Note Payable [Line Items]                  
Interest rate percentage             35.10%    
Maximum [Member] | Patriot Glass [Member]                  
Note Payable [Line Items]                  
Interest rate percentage               8.24%  
v3.24.2.u1
Notes Payable (Details) - Part-4 - PPP Loan [Member] - USD ($)
6 Months Ended
Nov. 04, 2021
Nov. 01, 2020
Apr. 28, 2020
Jun. 30, 2024
Dec. 31, 2023
Note Payable [Line Items]          
Loan payable     $ 156,200    
Maturity date     Apr. 28, 2022    
Interest rate percentage     1.00%    
Loan payments   $ 8,900      
Administration forgave $ 95,000        
Debt instrument forgiveness of interest $ 1,442        
Remaining balance       $ 17,824  
Monthly payments       990  
Final payment       994  
Accrued expenses       0 $ 358
Maximum [Member]          
Note Payable [Line Items]          
Principal amount due       $ 13,864  
Minimum [Member]          
Note Payable [Line Items]          
Principal amount due         $ 18,823
v3.24.2.u1
Notes Payable (Details) - Schedule of Notes Payable - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Note Payable [Line Items]    
Total notes payable $ 567,333 $ 124,781
Less: unamortized debt discount (59,842) (764)
Note payable, net 507,491 124,017
Less: current portion of notes payable, net of discount (474,014) (81,908)
Notes payable – long-term 33,477 42,109
PPP Note [Member]    
Note Payable [Line Items]    
Total notes payable 13,864 18,823
Notes payable [Member]    
Note Payable [Line Items]    
Total notes payable $ 553,469 $ 105,958
v3.24.2.u1
Notes Payable (Details) - Schedule of Notes Payable Monthly Payment
Jun. 30, 2024
USD ($)
1800 Diagonal Lending Note Payable - March 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment $ 175,840
1800 Diagonal Lending Note Payable – April 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 143,016
August 30, 2024 [Member] | 1800 Diagonal Lending Note Payable - March 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 87,920
September 30, 2024 [Member] | 1800 Diagonal Lending Note Payable - March 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 21,980
October 30, 2024 [Member] | 1800 Diagonal Lending Note Payable - March 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 21,980
November 30, 2024 [Member] | 1800 Diagonal Lending Note Payable - March 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 21,980
December 30, 2024 [Member] | 1800 Diagonal Lending Note Payable - March 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 21,980
August 15, 2024 [Member] | 1800 Diagonal Lending Note Payable – April 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment 85,810
September 15, 2024 through February 15, 2025 (6 monthly payments) [Member] | 1800 Diagonal Lending Note Payable – April 2024 [Member]  
Schedule of Notes Payable Monthly Payment [Line Items]  
Total Monthly payment $ 57,206
v3.24.2.u1
Notes Payable (Details) - Schedule of Future Annual Maturities of Notes Payable - PPP Loan [Member]
Jun. 30, 2024
USD ($)
Debt Instrument [Line Items]  
2025 $ 533,856
2026 16,654
2027 7,013
2028 7,751
2029 2,059
Total notes payable on June 30, 2024 $ 567,333
v3.24.2.u1
Shareholders' Deficit (Details) - Part-1 - USD ($)
6 Months Ended 12 Months Ended
May 20, 2024
Feb. 08, 2024
Jan. 02, 2024
May 01, 2023
Apr. 01, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jan. 17, 2023
Dec. 12, 2019
Shareholders' Deficit [Line Items]                    
Preferred stock shares authorized (in Shares)           2,000,000   2,000,000    
Preferred stock par value (in Dollars per share)           $ 0.1   $ 0.1    
Preferred stock convertible percentage           100.00%        
Accrued compensation           $ 54,462   $ 717,204    
Stock-based compensation expense           $ 0 $ 42,183      
Conversion of common stock amount issued       $ 62,000 $ 62,000          
Issuance of grant date value (in Dollars per share)     $ 0.059     $ 0.132   $ 0.132    
Initial conversion closing price (in Dollars per share)     $ 0.0031              
Forfeited shares (in Shares)   5,250,000                
Non-cash stock-based compensation     $ 95,161              
Compensation stated value     $ 50,000              
Closing price per share (in Dollars per share)     $ 0.059              
Accrued dividends payable           $ 120,903        
Preferred stock value issued           1,575,903        
Stated liquidation value           1,455,000        
Dividend payable           $ 55,690        
Series B Convertible Preferred Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Aggregate amount   $ 127,640                
Series B Preferred Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Preferred stock shares authorized (in Shares)                   100,000
Preferred stock par value (in Dollars per share)           $ 1,000       $ 0.1
Preferred stock dividend rate           2.00%        
Acceptance of shares (in Shares)     312           144  
Stock-based compensation expense     $ 281,807              
Accrued compensation     312,000              
Forfeited shares (in Shares)           317      
Compensation stated value     50,000              
Conversion issue amount     45,161              
Aggregate amount $ 206,369                  
Additional paid in capital 197,000 120,000                
Accrued dividends $ 9,369 $ 7,640                
Accrued dividends payable           $ 13,355 $ 11,226      
Preferred stock value issued           1,245,313   $ 1,203,967    
Stated liquidation value           $ 1,189,623   1,144,624    
Dividend payable               $ 59,343    
Series B Preferred Stock [Member] | Board of Directors [Member]                    
Shareholders' Deficit [Line Items]                    
Accrued compensation     312,000           $ 144,000  
Conversion of common stock amount issued     $ 281,807              
Forfeited shares (in Shares)   120 50              
Series B Preferred Stock [Member] | Chief Executive Officer [Member]                    
Shareholders' Deficit [Line Items]                    
Forfeited shares (in Shares) 197                  
Common Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Preferred stock convertible percentage           400.00%        
Common Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Conversion of common stock amount issued     $ 45,161              
Issuance of grant date value (in Dollars per share)     $ 0.059              
Common Stock [Member] | Series B Preferred Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Issuance of grant date value (in Dollars per share)     0.059              
Initial conversion closing price (in Dollars per share)     $ 0.0031              
v3.24.2.u1
Shareholders' Deficit (Details) - Part-2 - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 01, 2024
Mar. 01, 2024
Feb. 08, 2024
Feb. 01, 2024
Jan. 02, 2024
Apr. 28, 2021
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Dec. 31, 2023
Aug. 20, 2020
Shareholders' Deficit [Line Items]                        
Preferred stock shares authorized (in Shares)                   2,000,000 2,000,000  
Preferred stock par value (in Dollars per share)                   $ 0.1 $ 0.1  
Preferred stock convertible percentage                   100.00%    
Shares issued upon conversion (in Shares) 6,131,037                      
Common shares conversion shares (in Shares)     120   312              
Preferred stock redemption amount $ 20,000 $ 20,000           $ 82,600        
Accrued dividends               $ 16,079   $ 14,743    
Preferred stock value issued                   1,575,903    
Stated liquidation value                   1,455,000    
Accrued dividends payable                   $ 120,903    
Stated liquidation value                     $ 1,515,000  
Series C Preferred Stock [Member]                        
Shareholders' Deficit [Line Items]                        
Preferred stock shares authorized (in Shares)                       100,000
Preferred stock par value (in Dollars per share)                   $ 100   $ 0.1
Preferred stock dividend rate                   2.00%    
Preferred stock liquidation value percentage                   150.00%    
Preferred stock convertible percentage           4.99%            
Shares issued upon conversion (in Shares) 6,131,037 5,781,562   5,772,973     8,584,376 23,157,922 26,585,614      
Preferred stock redemption amount $ 20,000 $ 20,000   $ 20,000     $ 30,000 $ 82,600 $ 101,400      
Preferred stock value issued                     1,621,160  
Accrued dividends payable                     $ 106,160  
Preferred Stock [Member]                        
Shareholders' Deficit [Line Items]                        
Common shares conversion shares (in Shares) 200                      
Preferred Stock [Member] | Series C Preferred Stock [Member]                        
Shareholders' Deficit [Line Items]                        
Common shares conversion shares (in Shares) 200 200   200     300 826 1,014      
v3.24.2.u1
Shareholders' Deficit (Details) - Part-3 - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 01, 2024
Mar. 01, 2024
Feb. 08, 2024
Feb. 01, 2024
Jan. 02, 2024
Jun. 07, 2023
Jun. 03, 2023
May 31, 2023
May 01, 2023
Apr. 03, 2023
Apr. 01, 2023
Feb. 06, 2023
Jan. 17, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Jul. 26, 2022
Shareholders' Deficit [Line Items]                                          
Purchased shares (in Shares)                         275,000                
Common stock par value (in Dollars per share)                         $ 300,000       $ 0.001   $ 0.001    
Accrued compensation                                 $ 54,462   $ 717,204    
Accrued compensation value                         $ 53,000                
Accrued compensation shares (in Shares)                         9,636,364                
Common stock value issued             $ 16,950     $ 22,500   $ 40,000                  
Common shares per share (in Dollars per share)             $ 0.0011     $ 0.0045   $ 0.006                  
Common shares issued (in Shares)             1,500,000     5,000,000   6,666,667         545,253,623   532,818,051    
Stock-based professional fees             $ 5,650     $ 22,500             $ 11,667        
Prepaid expense             $ 11,300                   28,333        
Shares value                             $ 26,000            
Stock-based compensation expense                                 0 $ 42,183      
Unrecognized compensation expense                                 0   $ 0    
Forfeited shares (in Shares)     5,250,000                                    
Common shares conversion shares (in Shares)     120   312                                
Conversion of common stock amount issued                 $ 62,000   $ 62,000                    
Legal fees                 2,250   2,250                    
Shares issued (in Shares)                                       998,008  
Settlement amount                                 567,333   $ 124,781    
Debt extinguishment                                 347,097        
Fair value disclosure measurement               $ 132,000                          
Shares issued upon conversion (in Shares) 6,131,037                                        
Preferred stock redemption amount $ 20,000 $ 20,000                         $ 82,600     82,600      
GS Capital Debt [Member]                                          
Shareholders' Deficit [Line Items]                                          
Accrued interest                 $ 4,139   $ 4,139                    
Principal amount                                         $ 195,000
Release Agreement [Member]                                          
Shareholders' Deficit [Line Items]                                          
Accrued interest               317,293                          
Shares issued (in Shares)                 22,000,000                        
Settlement amount               200,000                          
Common Stock [Member]                                          
Shareholders' Deficit [Line Items]                                          
Purchased shares (in Shares)                               54,545,455          
Common shares per share (in Dollars per share)           $ 0.0104                              
Shares issued to employees (in Shares)           2,500,000                 2,500,000            
Shares value           $ 26,000                 $ 2,500            
Common shares conversion shares (in Shares)                 21,371,481   21,371,481                    
Conversion of common stock amount issued         $ 45,161                                
Shares issued (in Shares)                               9,636,364          
Preferred Stock [Member]                                          
Shareholders' Deficit [Line Items]                                          
Common shares conversion shares (in Shares) 200                                        
Lender [Member]                                          
Shareholders' Deficit [Line Items]                                          
Common stock value issued               $ 132,000                          
Common shares per share (in Dollars per share)               $ 0.006                          
Shares issued (in Shares)               22,000,000                          
Investor Relations Services [Member]                                          
Shareholders' Deficit [Line Items]                                          
Common stock value issued                         $ 53,000                
Common shares per share (in Dollars per share)                         $ 0.0055                
Mr. Silverman [Member]                                          
Shareholders' Deficit [Line Items]                                          
Accrued compensation                         $ 25,000                
Convertible Notes Payable [Member]                                          
Shareholders' Deficit [Line Items]                                          
Debt extinguishment               $ 385,293                          
Principal amount               200,000                          
Convertible Notes Payable [Member] | Lender [Member]                                          
Shareholders' Deficit [Line Items]                                          
Debt extinguishment               $ 68,000                          
Subscription Agreements [Member]                                          
Shareholders' Deficit [Line Items]                                          
Purchased shares (in Shares)                         54,545,455                
Common Stock Issued for Cash and Accrued Compensation [Member]                                          
Shareholders' Deficit [Line Items]                                          
Common stock par value (in Dollars per share)                         $ 0.0055                
Issuance of Common Stock for Services [Member]                                          
Shareholders' Deficit [Line Items]                                          
Professional fees                             $ 38,000   0 38,000      
Common Stock Forfeited [Member]                                          
Shareholders' Deficit [Line Items]                                          
Forfeited shares (in Shares)     5,250,000                                    
Additional paid amount     $ 5,250                                    
Series C Preferred Stock [Member]                                          
Shareholders' Deficit [Line Items]                                          
Conversion of common stock amount issued                                 $ 60,000 $ 184,000      
Shares issued upon conversion (in Shares) 6,131,037 5,781,562   5,772,973                   8,584,376 23,157,922 26,585,614   23,157,922      
Preferred stock redemption amount $ 20,000 $ 20,000   $ 20,000                   $ 30,000 $ 82,600 $ 101,400   $ 82,600      
Series C Preferred Stock [Member] | Preferred Stock [Member]                                          
Shareholders' Deficit [Line Items]                                          
Common shares conversion shares (in Shares) 200 200   200                   300 826 1,014          
v3.24.2.u1
Shareholders' Deficit (Details) - Part-5 - USD ($)
3 Months Ended 6 Months Ended
May 01, 2024
Mar. 01, 2024
Feb. 08, 2024
Feb. 01, 2024
Jan. 02, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Dec. 31, 2023
Shareholders' Deficit [Line Items]                    
Shares issued upon conversion (in Shares) 6,131,037                  
Common shares conversion shares (in Shares)     120   312          
Preferred stock redemption amount $ 20,000 $ 20,000         $ 82,600      
Total unrecognized compensation expense                 $ 0 $ 0
Voting percentage                 10.00%  
Fair market percentage                 110.00%  
Options granted shares (in Shares)                 50,000,000  
Issued or granted under incentive stock options (in Shares)                 11,445,698  
Shares of restricted stock (in Shares)                 29,451,070  
Series C Preferred Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Shares issued upon conversion (in Shares) 6,131,037 5,781,562   5,772,973   8,584,376 23,157,922 26,585,614    
Preferred stock redemption amount $ 20,000 $ 20,000   $ 20,000   $ 30,000 $ 82,600 $ 101,400    
2018 Long-Term Incentive Plan [Member]                    
Shareholders' Deficit [Line Items]                    
Aggregate shares of common stock (in Shares)                 25,000,000  
Preferred Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Common shares conversion shares (in Shares) 200                  
Preferred Stock [Member] | Series C Preferred Stock [Member]                    
Shareholders' Deficit [Line Items]                    
Common shares conversion shares (in Shares) 200 200   200   300 826 1,014    
v3.24.2.u1
Shareholders' Deficit (Details) - Schedule of Stock Option Activities - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Series B Preferred Stock [Member]    
Schedule of Stock Option Activities [Line Items]    
Number of Shares, Balance at beginning of period 1,144 1,000
Amount, Balance at beginning of period $ 1,203,967 $ 1,037,201
Number of Shares, Shares issued for accrued compensation 312 144
Amount, Shares issued for accrued compensation $ 312,000 $ 144,000
Number of Shares, Shares issued for compensation 50
Amount, Shares issued for compensation $ 50,000
Number of Shares, Shares and accrued dividends forfeited (317)
Amount, Shares and accrued dividends forfeited $ (334,009)
Number of Shares, Dividends accrued
Amount, Dividends accrued $ 13,355 $ 11,226
Number of Shares, Balance at end of period 1,189 1,144
Amount, Balance at end of period $ 1,245,313 $ 1,192,427
Series C Preferred Stock [Member]    
Schedule of Stock Option Activities [Line Items]    
Number of Shares, Balance at beginning of period 15,150 17,290
Amount, Balance at beginning of period $ 1,621,160 $ 1,803,731
Number of Shares, Conversion of Series C shares to common shares (600) (1,840)
Amount, Conversion of Series C shares to common shares $ (60,000) $ (184,000)
Number of Shares, Dividends accrued
Amount, Dividends accrued $ 14,743 $ 16,079
Number of Shares, Balance at end of period 14,550 15,450
Amount, Balance at end of period $ 1,575,903 $ 1,635,810
v3.24.2.u1
Shareholders' Deficit (Details) - Schedule of Activity Related to Non-Vested Shares
6 Months Ended
Jun. 30, 2024
$ / shares
shares
Schedule of Activity Related to Non-Vested Shares [Abstract]  
Number of Non-Vested Shares, beginning balance | shares 14,970,120
Weighted Average Grant Date Fair Value, beginning balance | $ / shares $ 0.132
Number of Non-Vested Shares, Shares vested | shares
Weighted Average Grant Date Fair Value, Shares vested | $ / shares
Number of Non-Vested Shares, ending balance | shares 14,970,120
Weighted Average Grant Date Fair Value, ending balance | $ / shares $ 0.132
v3.24.2.u1
Shareholders' Deficit (Details) - Schedule of Stock Option Activities - Stock options [Member] - USD ($)
6 Months Ended
Dec. 31, 2023
Jun. 30, 2024
Schedule of Stock Option Activities [Line Items]    
Number of Options, Balance Outstanding, ending 8,445,698 7,345,698
Weighted Average Exercise Price, Balance Outstanding, ending $ 0.4 $ 0.44
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, ending 2 years 5 months 4 days 2 years 3 months
Aggregate Intrinsic Value, Balance Outstanding, ending
Number of Options, Exercisable   7,345,698
Weighted Average Exercise Price, Exercisable   $ 0.44
Weighted Average Remaining Contractual Term (Years), Exercisable   2 years 3 months
Aggregate Intrinsic Value, Exercisable  
Number of Options, Expired   (1,100,000)
Weighted Average Exercise Price, Expired  
Weighted Average Remaining Contractual Term (Years), Expired  
Aggregate Intrinsic Value, Expired  
v3.24.2.u1
Shareholders' Deficit (Details) - Schedule of Stock Option Activities - Warrant [Member] - Warrant [Member] - USD ($)
6 Months Ended
Dec. 31, 2023
Jun. 30, 2024
Schedule of Warrant Activities [Line Items]    
Number of Warrants, Balance Outstanding, ending 34,000,000 33,400,000
Weighted Average Exercise Price, Balance Outstanding, ending $ 0.011 $ 0.01
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, ending 2 years 8 months 23 days 2 years 3 months 10 days
Aggregate Intrinsic Value, Balance Outstanding, ending
Number of Warrants, Exercisable   33,400,000
Weighted Average Exercise Price, Exercisable   $ 0.01
Weighted Average Remaining Contractual Term (Years), Exercisable   2 years 3 months 10 days
Aggregate Intrinsic Value, Exercisable  
Number of Warrants, Expired   (600,000)
Weighted Average Exercise Price, Expired  
Weighted Average Remaining Contractual Term (Years), Expired  
Aggregate Intrinsic Value, Expired  
v3.24.2.u1
Commitments and Contingencies (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 31, 2024
May 20, 2024
Feb. 08, 2024
Jan. 02, 2024
Dec. 07, 2023
Oct. 18, 2023
Jul. 01, 2023
Jul. 21, 2021
Apr. 25, 2018
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2013
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2020
Jun. 03, 2023
Apr. 03, 2023
Feb. 06, 2023
Oct. 18, 2017
Commitments and Contingencies [Line items]                                              
Revenue                         $ 863,533   $ 414,055 $ 1,800,337 $ 929,275            
Bad debt expenses                         53,608   168,153 67,727 367,638            
Cash                         $ 21,961     $ 21,961              
Preferred shares (in Shares)                                        
Settlement expense                                   $ 175,000          
Escrow deposit                           $ 225,000                  
Accrued expenses $ 175,000                       $ 1,000     $ 1,000   $ 1,000          
Other expense 50,000                                            
Management agreed shares (in Shares)     120 312                                      
Common stock shares forfeited (in Shares)     5,250,000                                        
Debt extinguishment                               347,097              
Annual salary increased                                             $ 300,000
Annual salary increase percentage                                             10.00%
Debt or equity financing                                             $ 1,000,000
Capital raise rate                                             5.00%
Shares acquired (in Shares)                                             3,000,000
Shares acquired price (in Dollars per share)                                             $ 0.31
Stock options shares issued (in Shares)                                             500,000
Strike price (in Dollars per share)                                             $ 0.85
Common shares per share (in Dollars per share)                                       $ 0.0011 $ 0.0045 $ 0.006  
Annual base salary               $ 240,000                              
Salary percentage               50.00%                              
Bonus percentage               50.00%                              
Aggregate amount                         373,548   441,181 $ 1,152,667 868,053            
Bonus amount       $ 312,000                                      
Bonus paid                                   10.00%          
Equity amount                                   $ 162,000          
Dilutive transaction                         206,369 $ 127,640                  
Exercise price per share (in Dollars per share)                   $ 0.85                          
Issued percentage                               20.00%              
Outstanding percentage                               20.00%              
Common stock percentage                               300.00%              
Option period, percentage                               20.00%              
Share value percentage             300.00%                                
Non-refundable cash fee           $ 25,000                                  
Transaction rate           6.50%                                  
Break up fee percent           10.00%                                  
Professional fees                         $ 88,030   $ 193,263 $ 229,614 $ 380,953            
Restatement Adjustment [Member]                                              
Commitments and Contingencies [Line items]                                              
Revenue                                     $ 102,569        
Bad debt expenses                                     $ 102,569        
Maximum [Member]                                              
Commitments and Contingencies [Line items]                                              
Agreed to pay                               175,000              
Minimum [Member]                                              
Commitments and Contingencies [Line items]                                              
Agreed to pay                               $ 50,000              
Property, Plant and Equipment [Member]                                              
Commitments and Contingencies [Line items]                                              
Cash                                   18,000          
Ms. Tomek [Member]                                              
Commitments and Contingencies [Line items]                                              
Bonus amount                                   180,000          
Option to Purchase 20% of Mobile Tint [Member]                                              
Commitments and Contingencies [Line items]                                              
Issued percentage                               20.00%              
Outstanding percentage                               20.00%              
Curtis Stout Inc. [Member]                                              
Commitments and Contingencies [Line items]                                              
Transaction rate           4.00%                                  
Mr. Silverman [Member]                                              
Commitments and Contingencies [Line items]                                              
Cash                                   150,000          
Equity investments                                             $ 500,000
Aggregate amount                                   300,000          
Board of Directors Chairman [Member]                                              
Commitments and Contingencies [Line items]                                              
Aggregate amount         $ 480,000                                    
Chief Executive Officer [Member]                                              
Commitments and Contingencies [Line items]                                              
Accrued compensation                                   150,000          
Option to Purchase 20% of Patriot Glass [Member]                                              
Commitments and Contingencies [Line items]                                              
Interest expense             $ 240,000                                
Employment Agreements [Member] | Mr. Silverman [Member]                                              
Commitments and Contingencies [Line items]                                              
Financing triggered                 $ 1,240,000                            
Percentage of bonus provision                 5.00%                            
Term of base salary                               1 year              
Common shares per share (in Dollars per share)                         $ 0.85     $ 0.85              
Uncovered medical/dental expenses                               $ 10,000              
Subscription Agreements [Member]                                              
Commitments and Contingencies [Line items]                                              
Common shares per share (in Dollars per share)                   $ 0.85 $ 0.77                        
Anti-dilution rights on common stock sales (in Shares)                   1,175,902 3,880,480 2,425,300                      
Dilutive transaction                       $ 2,000,000                      
Subscription Agreements [Member] | Minimum [Member]                                              
Commitments and Contingencies [Line items]                                              
Common shares per share (in Dollars per share)                   $ 0.85                          
M&A Advisory Agreement [Member]                                              
Commitments and Contingencies [Line items]                                              
Professional fees                               14,383              
Former Consultant [Member]                                              
Commitments and Contingencies [Line items]                                              
Debt extinguishment                                   $ 347,097          
Equity Method Investment Ownership [Member]                                              
Commitments and Contingencies [Line items]                                              
Equity percentage                                   50.00%          
Equity Method Investment Ownership [Member] | Ms. Tomek [Member]                                              
Commitments and Contingencies [Line items]                                              
Equity percentage                                   90.00%          
Equity Method Investment Ownership [Member] | Employment Agreements [Member]                                              
Commitments and Contingencies [Line items]                                              
Equity percentage                                   50.00%          
C-Bond Systems, LLC [Member] | Subscription Agreements [Member]                                              
Commitments and Contingencies [Line items]                                              
Common shares per share (in Dollars per share)                     $ 0.77                        
Chief Executive Officer [Member]                                              
Commitments and Contingencies [Line items]                                              
Cash $ 21,961                       $ 21,961     $ 21,961              
Series B Preferred Stock [Member]                                              
Commitments and Contingencies [Line items]                                              
Preferred shares (in Shares)                         197     197              
Common stock shares forfeited (in Shares)                               317            
Series B Preferred Stock [Member] | Chief Executive Officer [Member]                                              
Commitments and Contingencies [Line items]                                              
Preferred shares (in Shares) 197                                            
Common stock shares forfeited (in Shares)   197                                          
v3.24.2.u1
Concentrations (Details) - Customer Concentration Risk [Member]
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Customer [Member] | Sales [Member]      
Concentrations [Line Items]      
Concentration risk percentage 41.00% 14.80%  
Customer [Member] | Accounts Receivable [Member]      
Concentrations [Line Items]      
Concentration risk percentage 63.20%   41.80%
Customer One [Member] | Sales [Member]      
Concentrations [Line Items]      
Concentration risk percentage 14.50%    
Customer One [Member] | Accounts Receivable [Member]      
Concentrations [Line Items]      
Concentration risk percentage 11.80%   29.50%
Customer Two [Member] | Sales [Member]      
Concentrations [Line Items]      
Concentration risk percentage 26.50%    
Customer Two [Member] | Accounts Receivable [Member]      
Concentrations [Line Items]      
Concentration risk percentage 11.00%   12.30%
Customer Three [Member] | Accounts Receivable [Member]      
Concentrations [Line Items]      
Concentration risk percentage 13.50%    
Customer Four [Member] | Accounts Receivable [Member]      
Concentrations [Line Items]      
Concentration risk percentage 12.70%    
Customer Five [Member] | Accounts Receivable [Member]      
Concentrations [Line Items]      
Concentration risk percentage 14.20%    
v3.24.2.u1
Segment Reporting (Details) - segments
6 Months Ended
May 08, 2023
Jun. 30, 2024
Segment Reporting [Abstract]    
Number of reportable business segment 2 2
v3.24.2.u1
Segment Reporting (Details) - Schedule of Reportable Business Segments - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Schedule of Reportable Business Segments [Line Items]            
Revenues $ 863,533   $ 414,055   $ 1,800,337 $ 929,275
Depreciation and amortization 24,508   20,545   49,015 41,395
Interest expense 53,608   168,153   67,727 367,638
Net income (loss) (245,969) $ (307,648) 3,774,273 $ (723,087) (553,617) 3,051,186
C-Bond [Member]            
Schedule of Reportable Business Segments [Line Items]            
Revenues   31,166   124,372
Depreciation and amortization   132   569
Interest expense 171   357   171 357
Net income (loss) (225,255)   3,759,343   (147,411) 3,483,967
Patriot Glass [Member]            
Schedule of Reportable Business Segments [Line Items]            
Revenues 863,533   382,889   1,800,337 804,903
Depreciation and amortization 24,508   20,413   49,015 40,826
Interest expense 18,140   6,655   27,081 11,798
Net income (loss) 21,033   (93,201)   68,584 (176,813)
Other [Member]            
Schedule of Reportable Business Segments [Line Items]            
Interest expense [1] 35,297   161,141   40,475 355,483
Net income (loss) [1] $ (41,747)   $ 108,131   $ (474,790) $ (255,968)
[1] The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
v3.24.2.u1
Segment Reporting (Details) - Schedule of Identifiable Long-Lived Tangible Assets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Identifiable Long-Lived Tangible Assets [Line Items]    
Identifiable long-lived tangible assets $ 147,842 $ 171,606
C-Bond [Member]    
Schedule of Identifiable Long-Lived Tangible Assets [Line Items]    
Identifiable long-lived tangible assets
Patriot Glass [Member]    
Schedule of Identifiable Long-Lived Tangible Assets [Line Items]    
Identifiable long-lived tangible assets $ 147,842 $ 171,606
v3.24.2.u1
Revenue Recognition (Details) - Schedule of Revenue by Product - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Schedule of Revenue by Product [Line Items]        
Total $ 863,533 $ 414,055 $ 1,800,337 $ 929,275
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems [Member]        
Schedule of Revenue by Product [Line Items]        
Total     33,537 9,709
C-Bond Nanoshield solution sales [Member]        
Schedule of Revenue by Product [Line Items]        
Total     112,413
Window tint installation and sales recognized over time [Member]        
Schedule of Revenue by Product [Line Items]        
Total     1,766,800 804,903
Freight and delivery [Member]        
Schedule of Revenue by Product [Line Items]        
Total     $ 2,250
v3.24.2.u1
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Details) - USD ($)
6 Months Ended 12 Months Ended
May 31, 2022
Feb. 28, 2022
Sep. 30, 2021
Jun. 30, 2024
Jun. 30, 2023
May 31, 2021
Nov. 30, 2020
Oct. 31, 2019
Operating Lease Right-of-Use (“ROU”) Assets And Operating Lease Liabilities [Line Items]                
Lease term 1 year             18 months
Rent payable per month $ 5,283 $ 788 $ 365 $ 5,600   $ 4,577 $ 4,444  
Lease terms       12 years        
Rent expense       $ 16,800 $ 40,845      
Maximum [Member] | MDW Management, LLC [Member]                
Operating Lease Right-of-Use (“ROU”) Assets And Operating Lease Liabilities [Line Items]                
Ownership percentage       100.00%        
Minimum [Member] | MDW Management, LLC [Member]                
Operating Lease Right-of-Use (“ROU”) Assets And Operating Lease Liabilities [Line Items]                
Ownership percentage       80.00%        
v3.24.2.u1
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Details) - Schedule of Right-of-Use Asset - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Right-of-Use Asset [Abstract]    
Office leases and office equipment right of use assets $ 279,162 $ 279,162
Less: accumulated amortization (150,440) (120,678)
Balance of ROU assets $ 128,722 $ 158,484
v3.24.2.u1
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Details) - Schedule of Operating Lease Liabilities Related to the ROU Assets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Operating Lease Liabilities Related to the ROU Assets [Abstract]    
Lease liabilities related to office leases right of use assets $ 128,722 $ 157,752
Less: current portion of lease liabilities (60,773) (60,503)
Lease liabilities – long-term $ 67,949 $ 97,249
v3.24.2.u1
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Details) - Schedule of Future Minimum Base Lease Payments Due Under Non-Cancelable Operating Leases - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Future Minimum Base Lease Payments Due Under Non-Cancelable Operating Leases [Abstract]    
2025 $ 72,715  
2026 67,200  
2027 5,600  
Total minimum non-cancelable operating lease payments 145,515  
Less: discount to fair value (16,793)  
Total lease liability on June 30, 2024 $ 128,722 $ 157,752
v3.24.2.u1
Related Party Transactions (Details) - USD ($)
3 Months Ended 12 Months Ended
May 31, 2024
May 08, 2024
May 31, 2023
May 02, 2022
Jun. 30, 2024
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Related Party Transactions [Line Items]                
Cash         $ 21,961      
Preferred stock, shares issued (in Shares)            
Settlement expense           $ 175,000    
Escrow deposit             $ 225,000  
Due from related party       $ 175,000 $ 50,000      
Due from related party     $ 21,961   71,961    
Related Party [Member]                
Related Party Transactions [Line Items]                
Agreed to pay   $ 175,000            
Cash   21,961     21,961      
Settlement expense           $ 175,000    
Escrow deposit     21,961         $ 225,000
Chief Executive Officer [Member]                
Related Party Transactions [Line Items]                
Cash $ 21,961       $ 21,961      
Chief Executive Officer [Member] | Related Party [Member]                
Related Party Transactions [Line Items]                
Agreed to pay   $ 50,000            
Series B Preferred Stock [Member]                
Related Party Transactions [Line Items]                
Preferred stock, shares issued (in Shares)         197      
Series B Preferred Stock [Member] | Related Party [Member]                
Related Party Transactions [Line Items]                
Preferred stock, shares issued (in Shares)   197     197      
Cancelled shares $ 197   $ 197          
Series B Preferred Stock [Member] | Chief Executive Officer [Member]                
Related Party Transactions [Line Items]                
Preferred stock, shares issued (in Shares) 197              
v3.24.2.u1
Sale of Nanoshield Product Line (Details) - USD ($)
6 Months Ended 12 Months Ended
May 08, 2023
Apr. 04, 2023
Mar. 17, 2023
Mar. 08, 2023
Dec. 27, 2022
Nov. 22, 2022
Nov. 08, 2022
Nov. 04, 2022
Sep. 06, 2022
Jul. 26, 2022
Jun. 23, 2022
May 02, 2022
Mar. 14, 2022
May 05, 2021
Jun. 30, 2024
Dec. 31, 2022
Sale of Nanoshield Product Line [Line Items]                                
Purchase price       $ 4,000,000                        
Net proceeds                             $ 1,989,755  
Repaid debt                             160,893  
Issuance shares of common stock (in Shares)                               998,008
Sale of the product line $ 4,051,709                              
BOCO Investments, LLC [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Repaid debt                             200,000  
BOCO Investments, LLC [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Principal balance amount                             400,000  
Accrued interest payable                             $ 317,293  
GS Capital Partners, LLC [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Repaid debt                 $ 419,260 $ 419,260 $ 419,260          
Mercer Street Global Opportunity Fund, LLC [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Repaid debt           $ 271,825             $ 271,825      
Jeff Badders [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Repaid debt   $ 875,000         $ 875,000             $ 875,000    
1800 Diagonal Lending, LLC [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Repaid debt     $ 288,035   $ 288,035     $ 288,035                
CEO [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Repaid debt                       $ 250,000        
Common Stock [Member] | BOCO Investments, LLC [Member]                                
Sale of Nanoshield Product Line [Line Items]                                
Issuance shares of common stock (in Shares)                             22,000,000  
v3.24.2.u1
Subsequent Events (Details) - USD ($)
1 Months Ended 6 Months Ended
Aug. 15, 2024
Jul. 31, 2024
Feb. 08, 2024
Jan. 02, 2024
May 01, 2023
Apr. 01, 2023
Sep. 06, 2022
Jul. 26, 2022
Jun. 23, 2022
Aug. 31, 2024
Apr. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Subsequent Events [Line Items]                          
Received net proceeds             $ 176,000 $ 176,000 $ 176,000        
Management agreed shares (in Shares)     120 312                  
Stock converted amount         $ 62,000 $ 62,000              
Monthly payment                       $ 17,877  
Total payback to the holder                       $ 160,893  
Conversion price percentage                     65.00% 65.00%  
Conversion of discount rate                     35.00% 35.00%  
Subsequent Event [Member]                          
Subsequent Events [Line Items]                          
Aggregate principal amount   $ 75,000                      
Received net proceeds   73,030                      
Net fees   1,970                      
Principal interest payment   $ 3,022                      
Interest expense                   $ 14,850      
Principal amount $ 157,000                        
Principal amount 67,500                        
Promissory Note [Member]                          
Subsequent Events [Line Items]                          
Monthly payment                       $ 21,980  
Total payback to the holder                       $ 197,820  
Conversion price percentage                       65.00%  
Conversion of discount rate                       35.00%  
Promissory Note [Member] | Subsequent Event [Member]                          
Subsequent Events [Line Items]                          
Interest Rate percentage                   6.00%      
Principal amount $ 127,693                        
Series C Preferred Stock [Member]                          
Subsequent Events [Line Items]                          
Stock converted amount                       $ 60,000 $ 184,000
Forecast [Member]                          
Subsequent Events [Line Items]                          
Cash proceeds                   $ 190,000      
Stock converted amount                   800,000      
Forecast [Member] | Promissory Note [Member]                          
Subsequent Events [Line Items]                          
Cash proceeds                   190,000      
Forecast [Member] | Series C Preferred Stock [Member]                          
Subsequent Events [Line Items]                          
Aggregate principal amount                   $ 990,000      
Management agreed shares (in Shares)                   8,000      

C Bond Systems (PK) (USOTC:CBNT)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024 Haga Click aquí para más Gráficas C Bond Systems (PK).
C Bond Systems (PK) (USOTC:CBNT)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024 Haga Click aquí para más Gráficas C Bond Systems (PK).